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Abstract
Myotonic dystrophy type 1 (DM1), is one of a number of genetic diseases whose phenotype is 
associated with the expansion of a CTG#CAG repeat. In the human population the DM1 triplet 
repeat locus demonstrates moderate variations in repeat length, the normal range being 
between 5 and 37 repeats. However, repeat lengths present in patients are far larger, beyond 50 
and into the thousands, with variation in a patient, within gametes and somatic mosaicism 
between and within tissues. The repeat instability level in DM1 patients is effected by several 
factors including the initial size of the progenitor allele and the patients age. Expansion over 
time and mutation rate variation between the somatic tissues of an individual is thought to 
contribute to the tissue specificity and progressive nature of the symptoms, whilst the size of 
the repeat inherited tends to expand through successive generations. This mechanism 
correlates with the incidence of ‘anticipation’ observed in affected families, that is the disease 
becomes more severe in each successive generation. To investigate the mechanism of repeat 
expansion murine models have been developed containing the Dmt-162 transgene, which 
consists of ~162 CTG repeats derived from the human DM1 locus. Previous studies had 
shown some repeat instability in the somatic tissues of young (male) mice of each line. Dmt- 
162 mice have already shown parent-of-origin-effects, with paternal repeat transmissions 
prone to expansion and maternal repeat transmissions prone to deletion. Further pedigree data 
analysis confirmed this effect and allowed the repeat transmission patterns to be analysed in 
more depth. The effects of the parents age on the transmitted repeat size was examined but 
was found not be significant in either sex.
Initially the repeat instability in a number of somatic tissues from mature mice in four of the 
lines generated was investigated using small pool PCR. Whilst minimal instability was 
observed in three of the lines, the fourth, Dmt-D demonstrated expansion biased instability 
which varied greatly between tissues. Investigation at earlier timepoints revealed the 
mosaicism to increase with age. Microdissection of the brain and the kidney revealed the 
repeat instability patterns to be region specific. Examination of the repeat mosaicism presented 
by the regions of the kidney observed dramatic repeat instability within the cortex. This in turn 
lead to the investigation of a candidate cell type for the dramatic repeat instability, the 
glomereli.
Investigation of transgenic transcription using reverse transcriptase PCR has identified tissue 
specific transcription of the repeat in three of the investigated lines and ubiquitous 
transcription in the fourth. The orientation of the transcribed CTG*CAG repeat has also been 
determined.
Finally to investigate the effect of an incomplete mismatch repair complex (MMR), Dmt 
transgenic mice were crossed on to a background deficient in the MMR protein Pms2 and the 
effect on repeat transmission and somatic instability studied.
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Chapter 1
Introduction
1.1 Triplet repeat diseases
In 1991 the mutations associated with the disorders spinal and bulbar muscular atrophy 
(SBMA) (La Spada et al., 1991) and Fragile X syndrome (Frax A) (Fu et al., 1991; Verkerk et 
al., 1991) were identified as tracts of trinucleotide repeats that had expanded beyond a normal 
threshold. In the human population triplet repeat loci often show moderate variations in repeat 
length, but the repeat lengths present in patients are far larger with additional variation within 
a patient, including within gametes and somatic mosaicism within and between tissues. By 
1997, when this project began, 12 gene loci of inherited genetic diseases were found to contain 
an expanded triplet repeat tract within patients. These include the neurodegenerative disorders, 
Huntington’s disease (HD) (Huntington's Disease Collaborative Research Group, 1993;
Zuhlke et al., 1993), Denatorubral pallidoluysian atrophy (DRLPA) or Haw River Syndrome 
(Tsuji, 1997), and the spinocerebeller ataxias, (SCA) type 1 (Orr et al., 1993), type 2 (Imbert 
et al., 1996; Pulst et al., 1996; Sanpei et al., 1996), type 3 (Stevanin et al., 1995), type 6 
(Zhuchenko, 1997) and type 7 (David, 1997) as well as Frax E, (Flynn et al., 1993; Knight et 
al., 1993), myotonic dystrophy type 1 (DM1) (Aslanidis et al., 1992; Brook et al., 1992; 
Buxton et al., 1992; Fu et al., 1992; Harley et al., 1992; Mahadevan et al., 1992) and 
Friedreich’s ataxia (FA) (Campuzano et al., 1996). The addition of spinocerebellar ataxia’s 
(SCA) type 8 (Koob et al., 1999) and type 12 (Holmes et al., 1999), brings the current total 
number of loci associated with such inherited disorders to 14. The disorder Machado-Joseph 
disease (Kawaguchi et al., 1994) is associated with the SCA 3 locus and there is evidence that 
the two disorders are distinct clinical entities (Haberhausen et al., 1995).
The significance of the expanded trinucleotide mutation is the correlation of the repeat tract 
expanding over successive generations and the phenomenon of anticipation. Anticipation is 
the occurrence of an inherited disorder in which successive generations are subject to a 
progressively earlier age of onset (Harper et al., 1992; Nagafuchi et al., 1994). Until the 
discovery of expanded trinucleotide repeat tracts at gene loci, the anticipation observed in 
many inherited human diseases was thought possibly to be just the consequence of 
ascertainment bias (Penrose, 1948). Although Penrose, (1948), did concede that in the case of 
DM1, “the pedigree data required further explanation.” It is now known however, that the
1
expansion of the repeat between generations correlates inversely with the reduction of the age 
of onset in such disorders. The size of the repeat that is transmitted tends to expand through 
successive generations while pedigree analysis has revealed disorder dependent sex related 
transmission patterns.
Although each disease is associated with an unstable triplet repeat expansion, they can 
themselves be subdivided into three distinct groups according to the location of the repeats 
within the gene (Figure 1.1 and Table 1.1):
• The repeat tracts are located within intronic regions. Such tracts are removed before the 
mRNA is exported to the cytoplasm.
• The repeat tract is located within an untranslated region of an exon. The expanded repeat 
tract may influence the processing and or export of the mRNA into the cytoplasm, but 
would not code for the resulting protein.
• The repeat tract is located within an exon. The repeat is translated as part of the associated 
protein. The translated tract diseases all contain an in frame CAG expansion and the 
resulting polyglutamine tracts are associated with neurodegenerative disorders.
With the exception of the polyglutamine tract associated disorders, the triplet repeat diseases 
appear to have little in common. They are located on a range of chromosomes and there is 
variety in the repeat motifs. Although the CAG motif is the most common, other untranslated 
expansions are transcribed as triplets of CTG, GCC, and GAA. Also not all CAG tracts are 
translated, the CAG expansion of SCA 12 precedes the promoter region (Holmes et al., 1999), 
while the CAG-CTG repeat found in the 3’ UTR of SCA 8 has been reported to be transcribed 
only as a CTG tract (Koob et al., 1999).
The identification of the expansion of trinucleotide repeats as the genetic fault that underlies 
these disorders has lead to the investigation of expansion mechanisms.
2
FR
AX
 
A 
(X
q 
27
.3)
177
0X0
PT
0o
X (Smo 0?Xo
rn
0
g
a*
T f
0
.qj. w £7
Cl
O.
CN <N
co
<
CL VO U Oncn C/5
j tH v£>
< < Q <
U 2 O Uc/5 Q c/5 2 C/5
00<NO'
&w
on
3
Fi
gu
re
 
1.1
 
Lo
ca
tio
n 
of 
the
 
kn
ow
n 
tri
pl
et
 r
ep
ea
t 
di
se
as
es
Sc
he
m
ati
c 
dia
gra
m 
sh
ow
ing
 
the
 l
oc
ati
on
 
and
 
se
qu
en
ce
 
mo
tif
 o
n 
the
 c
od
ing
 
str
an
d 
of 
eac
h 
tri
pl
et 
re
pe
at 
di
so
rd
er
.
t—*U> h-*VO V*
Ui
►o Xo
X
xs
Ul •1CD■o OX>
to
1—k
hO
t—ku> w
u»M‘ 1U)w
to
00
too
u>
sSB
CDP«-*■
Pr^ -
©*
P
ol-*5
'CA
9
00TP
5 ’o
3
Si—k
s03o»—f-
1
2 00TO
B*o
3i-tPX
Tr|i-iPOQ
Tcjl-lpCTQ
g
5 ’o
•1
00 o o o 3 CD o ’ CLCD*-»CDcr
SL
pTi-i
p
o ’
0-VJos
1-t
(SC
A
12
CDi-tCDa*CD^
pTi-»
3
gp
X
OS
po-►-1
CD
P o p
p
r-f* o’X3cr EL 3CD>1 *< X i-tCD
P
h-*&3 !-*•P 3►-rt i-l I-lvj wCD 03 CL pTO TP P XCD 1—k CD £00 OP
TO a* s
o
op
T* Tcj Trj hdo
"d
s5
►tOrt*CD»-*•p
03OSr-ri-lo"a
TP
?
*ito it—^
o
2
B*x*
B’POSCD
^<f o *L/lOlTjO
TPi-iO
CD
B*
TPi-lO
CD
5 ’
O o O O o
H H > n a CD
O O o n o CDP
so
25o Xp
2o sp
zo Sp
Zo sp
TdI-lCD zo CDT3S' p 3 p p 3 p 3 g CD
&3 h^* p p p p 3^ Po o O O O £3p p P P P
107 16 50 Ul OV t—k i—k OV
230
OP
L/\O ON
P
PCTQCD
i l i -37 Ov 00 i i lh-*to
37 u>o io
• 1
00
i
to h-11o too
52
—} o 00 to Ui Ul o oo o o
3 S
h-kvo |—kvo 3
H-kVO 3
h-Vo 3 &CDo P VO vo os o o vo p P9oa*
CD
P*
Pa .
CD
<S
to
ffiPS
JO
wp
pTp
CLH- •
3
CDOS
u> p
p
CD
1—^ CDr—l-
EL
CD
►1
CD
P
CD
EL
i—^VO
CD «—*■
P
i-i
cT
CD
Xr^ -op
CD
OS
CD
P
CD
EL
EL
h-vvo
i—1VOvoI—*
CD
VOvo I—4VOVOto
EL
h-kVOVO
EL
i—1VO
1—k
VO
VOJO
i—^
VO
VO
VO
VOu>
£
<CD
K*CDi-tto vOJO
Td
wi-too
'§•
o
X*
CD
ELp X- r^ -
CD <—► CD EL
P Ph—
4
i—k cd 
U )  Xo
3  
U )
T3
h-k
t O
U >
u >
I
tO
4L CD
X3 Xo
I—1 3
On i—k
U>
to
4 ^
CD CDX Xo o
3 3
i—k
g *
c  §
to  ^
od
•t M
cd L
n  «
S  £
©  
d
O  
i-t#
'ryj 00 GO ^
5  5 'l >  O
J S  CD
—  i - t
CDcr
EL ►—* 
pi-t
p
px
P
o ;T3
CD
P
o
cr 
' C
W
S
>
c/3T3
5 '
PI—*
P
3
c l
cr
S
a 1
pi-t
3
$
s
p
S  C
S  B
5 ’
CTQ«■+
O
d
5  5’!> o
to oCDi-l
CD
O '
£ L
p-I-l
p
p
x
*->•
p
o -T3
CD
to
O  Tl
“  i - t
>  S'w  cu i-t
CD
Ocr
VI
O
•-ta
cd
i- j
i- i
CD >
O 3
CD C LT3 i-lf“+ oo CTQ
CD
>
3
nS
ffi
3
d
5 *
CTQ to
►n
i- i
pr^-
P
X
5 ’
h d
i-t
o«-►
2
S’
£
o
o>
o
£
o
£
o
o * 3
cd
T 3
CD
P
S  2
*= 2  
p  B
o' BL
d
o o
(50 ' O
U >  ' Oo
I  ?
p B 
o  £ ■d
u >  £  
00 ^  
I I
O n  ^  
Q \ O J
£  § p 3
S' I
3
U >
O n  0 \  
■ i h-k U>
to 'O
£  2  
£  S  
£  3 
5' £
d
U >  ^  Ut 4l 
t i
O n W  4l ^
£  2
c  2  
p  3 
5' 3k
d
t o
0  "O1 I
vo to © to 
o
* 3
CD
T 3
CD
P(■*■
•"I
Pd
CTQ
CD
a
p<
VO
VO
- o
r
p
GO
*T3
P
C L
P
CD«-+
P
NO
NO
NO
NO
u >
=fc
O n
n
o
p *
o 'o
I - t
p
o  55
N
3cr *CD
p*r cd
CD P
CD “
P
ocr
O
o
NO C  
NO ^ 3  U> “
f f i
3
3l-+
S '
CTQ1-+
O
3
NO
NO
O n
GO
P
3
*13
CD
CD
3cr
CDi-tr k
CDi^ -
P
NO
NO
O n
3NONO _  
O n czj
CDr^>
p
O
p
3
3
N
P
3
O
CD
P
NO
NO
O n
* 3
CD
5 s
3
3
o
CD
5
Table 
1.1 
Location 
and 
m
utation 
range 
of triplet repeat diseases
t—1 CD I—* CD
NO X t o X
B oB hO
O
3
i—1 
U> 4L<1
u>to
L 1
NO
ON CD I—1 CD
B Xo
to X
o
to B B B
u> 00 (-J> U> Ul
13 £
s  s
o 0 
o"*9
3OO
cd*-»
cd
cr
EL
STi-t
p
PX
P
r tvj
B
CD
ON
B‘oo
CD•-t
CDa*o
p  o  
cr  
p  t»
p
a*o
o P3 
►2
^3 B  cx n>
u>
GO hq
Q  B*J> O^ °s ' " ,  CD
CD
a*
EL
STi-t
p
px
P
B
CD
a
CD3
P
O
2cr
p
pr*+-
o
B  cr03
o
3  -os: i
O  CL O
cT
c»
P
3
C/5O•1a«
on
£
cr
£
3
Ocr
p
B
B
CL
CD P1 > >
B <3 P &5
CD O X X
B
CL
i—■
P B‘
!-*•
3
P
3 CTQCDi
u>
o
bcr
5'
o
25’
n>
a
o>
o
£
o
9
o
£B
CD
p
£  2C 2 znp 3£• 03O S- 
B
<1
to £  
■^J ON
Ncrcocr
CD3p?o
NO
VO<1
£
£
p 3
O  £ -  B
4l0
1
00■PL
CD
to
VO
VO-P
C/3 P  £ - 
r -  cd <
^  g 
B*
CD 
P
NO
NOL/i
P
3
PCTQB
Ocr
p
ON
££^  LJp 3
g  I
B
Ui
ON
00 u>
h-1 NO 00 w  00 <■/>
NO
VO
U)
p
NO
NO-P»
B*
CL
CD
CD
p
NO
NO
4l
2
p
CTQ
P
s*
O
crH-*
cr>
5B
CD
Pf-K
2
£
CD
ff
3
Bo
CD
6
1.2 Myotonic dystrophy (DM1)
The disease, myotonic dystrophy type 1, (DM1) was categorised in its own right in 1909, 
when it was defined as a clinical disorder distinct from the nonprogressive channelopathy 
myotonia congenita (Batten and Gibb, 1909; Steinert, 1909). The name itself describes the 
impaired muscle relaxation (myotonia) and muscle weakness (dystrophy) exhibited by 
patients. In 1989, the incidence of DM1 was reported as one in 8,000 in the Caucasian 
population, where it occurs most frequently (Harper, 1989). This makes it the most common 
adult onset muscular dystrophy, yet it is unusual among both the muscular dystrophies and the 
expanded triplet diseases in its multisystemic nature. It is an autosomal dominant disorder, 
like most but not all of the triplet repeat disorders and its genetic basis is a CTG expansion in 
the 3’ untranslated region of the MYOTONIC DYSTROPHY PROTEIN KINASE GENE 
(DMPK) (Aslanidis et al., 1992; Brook et al., 1992; Buxton et al., 1992; Fu et al., 1992; 
Harley et al., 1992; Mahadevan et al., 1992)located on chromosome 19. The repeat expansion 
that a patient inherits will dictate to some extent the nature of the symptoms that will affect 
that person over their lifetime, while the progressive nature of the disorder means that the 
expansion of the repeat correlates with the presentation of certain disease symptoms.
Generally the larger the repeat carried, the more severe the symptoms and the earlier the age 
of onset. The boundaries however, are not tightly defined, due possibly to a combination of 
patients presenting the disorder on diverse genetic backgrounds, being diagnosed at different 
stages of progression and in some cases retrospective recollection as to the order of symptom 
onset. Despite this, the degree to which the disease affects a patient has lead to the subdivision 
of the disorder into three groups (Table 1.2) with an indication of the range of the repeat sizes 
associated with each phenotype. The normal repeat size found at the DM1 locus is between 5 
and 37 repeats, patients who are mildly affected have around 50 to 150 repeats, classical adult 
onset patients have between 100 and a 1000 repeats, while congenital patients have repeats 
into the thousands (Harper et al., 1992; Mahadevan et al., 1992).
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Number of repeats Phenotype Clinical symptoms
50-150 Mild cataracts
100-1000 Classical myotonia, muscle wasting, testicular atrophy, 
premature balding, cardiac conduction defects
>1000 Congenital mental retardation, facial displegia and jaw 
weakness, hypotonia
Table 1.2 The association between the DM1 phenotype and the size of the triplet repeat 
tract (Harper et al., 1992; Mahadevan et al., 1992).
It has already been mentioned that DM1 is distinct amongst muscular dystrophies in its 
multisystemic nature. Unlike other muscular dystrophies, muscles other than skeletal muscle 
are affected, as seen with the conduction defects in the heart. The smooth muscle is affected 
extensively resulting in a patient having problems swallowing, and within the digestive tract. 
The pattern of skeletal muscle degeneration is distinct too, with the distal muscles of the limbs 
predominately affected as well as many of the muscles controlling the face and jaw including 
those controlling the eyelids. As the disease progresses the diaphragm and intercostal muscles 
become affected, causing breathing difficulties, yet certain muscles types are not affected at 
all, such as the posterior calf and thigh muscles of the leg, suggesting a difference in muscles 
vulnerable to the mechanism of deterioration (Harper, 1998). In addition to these symptoms it 
is also well documented that DM1 patients exhibit an increased resistance to insulin (Hudson 
et al., 1987; Krentz et al., 1990; Moxley et al., 1987).
1.3 Origins of the DM1 repeat
The incidence of DM1 is reported as 1 in 8000 in the Caucasian population (Harper, 1989), 
with a lower incidence of 1 in 18000 in the Japanese population. The disorder is rarely 
reported in African populations.
Anticipation through successive generations of DM1 families infers a correlation between 
increasing repeat size and decreasing reproductive fitness. This results in the termination of 
disease range pedigrees (Neville et al., 1994). However, the continued incidence of DM1
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within the population suggests the presence of a pool of pre-disease range alleles or 
protomutations.
The triplet repeat at the DM1 locus is polymorphic. Examination of the triplet repeat in DM1 
alleles in the general population has lead to their allocation into pools or modes. Of the 
resulting three modes; 5 CTG repeats or (CTG)5 account for 35 - 40 %, (CTG)ll, (CTG)12, 
and (CTG)13 account for a further 50 %. The final 10 % consists of a group with repeats in the 
range (CTG)19-30. There are no clearly defined sub groups within this third group, the 
increase in repeat number having already conferred some instability to this mode (Imbert et 
al., 1993). This trimodal distribution was observed in African, European, Japanese and Native 
American populations (Brunner et al., 1992). The (CTG)5 mode occurs most frequently in 
European populations (Brunner et al., 1992; Davies et al., 1992) followed by its incidence in 
the Asian population (Yamagata et al., 1996). The second mode is most common in non 
Eurasian populations (Davies et al., 1992; Watkins et al., 1995; Zerylnick et al., 1995).
The CTG repeat in the untranslated region (UTR) of DMPK is in total allelic association with 
an Alu deletion / insertion (-/+) polymorphism (Mahadevan et al., 1993). A stretch of five Alu 
elements is associated with (CTG)5 and (CTG)19-30 alleles. This suggests that the repeats in 
the (CTG)19-30 group originate from a single expansion event from a (CTG)5 allele. That the 
(CTG) 19-30 mode, the allelic pool from which the probands of DM1 pedigrees originate are 
from a genetic background in common with that of the stable (CTG)5, that is both modes in 
the first instance were subject to the same cis and trans acting factors, suggests that the 
instability present in the DM1 pedigrees is a consequence of the dosage of repeats and not the 
acquisition of another novel factor. The (CTG)ll, (CTG)12, and (CTG)13 alleles are 
associated with two contiguous Alu elements (Neville et al., 1994).
Deka et al. (1996), examined the DM1 CTG repeat tract and the associated Alu (-/+) 
polymorphism in samples collected from 16 ethnically and geographically diverse 
populations. They confirmed the (CTG)5 allele to be the most common allele in the majority 
of populations, but observed its absence from the Costa Rican and New Guinea highlander 
population. They also detected a (CTG)4 repeat allele, in a single American Samoan. This is 
the smallest reported CTG allele.
Although the (CTG)5 and (CTG)19-30 modes are almost always associated with the Alu+ 
element, Deka et a l  (1996), report the presence of the (CTG)5 tract associated with an Alu- 
polymorphism in several populations including native Africans. They hypothesise that the
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ancestral haplotype is (CTG)5 Alu+ and it gave rise to (CTG)5 Alu-. The larger (CTG) modes 
arose from either (CTG)5A/w+ or (CTG)5 Alu-.
1.4 Somatic mosaicism, within and between tissues
The expanded allele of a DM1 patient is likely to appear on a genomic Southern blot as an 
expanded smear, though this depends on the age of the patient and the size of their repeat. In 
contrast to the normal range allele whose appearance is as a tight band (Jansen et al., 1994; 
Joseph et al., 1997; Lavedan et al., 1993a; Tachi et al., 1993; Tachi et al., 1995b; Wohrle et 
al., 1995). However, the application of a more sensitive allele resolution technique, small pool 
(SP) PCR, (Martorell et al., 1998; Wong et al., 1995) has lead to the resolution of the smear 
into individual alleles, each of which has a different length of repeat. As the repeat gets larger, 
the more prone to expansion events it appears to become (Monckton et al., 1995). Scrutiny of 
expanded DM1 repeats reveals expansion biased instability and variation of stability levels 
between different tissues taken from the same patient at the same timepoint (Jansen et al., 
1994; Joseph et al., 1997; Lavedan et al., 1993a; Tachi et al., 1993; Tachi et al., 1995b; 
Wohrle et al., 1995). It has been observed that the expanded repeat tract in skeletal muscle 
expands more quickly than in blood, but both tissues have a common lower boundary when 
subjected to small pool PCR, suggesting a common sized progenitor allele (Monckton et al., 
1995).
Examination of tissues; skeletal muscle, cardiac muscle, liver, lung, bowel, brain, skin and 
bone, of a 20 week old foetus with the CTG expansion at the DM1 locus (Lavedan et al., 
1993a), and thirty five tissue types obtained from congenital DM1 identical twins that had ~ 
(CTG)1500 repeats, who were born at 28 weeks and who both died 2 weeks after birth 
(Jansen et ah, 1994), showed small fluctuations of stability between tissues types. More 
importantly the same tissue type when compared between the twins revealed no difference in 
stability level at birth (Jansen et al., 1994). To try to understand the repeat stability, or lack of 
stability observed between the same tissues from identical CDM twins it should be noted that 
identical or monozygotic twins separate at the earliest at the two cell stage, around 36 hours 
after fertilisation and at the latest just before the bilaminar disc develops into the primitive 
steak at around three weeks. It is most common however, for them to split at the early 
blastocyte stage around a week into development (Sadler, 1985). Comparison of blood 
samples between two further sets of monozygotic DM1 twins, one set with 180 and the other 
with 400 repeats showed no noticeable differences between the same tissues samples taken
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from the twin pairs (Jansen et al., 1994). The twin pair data suggests that some somatic 
differences may be laid down very early in embryonic development but that the repeat in 
developing twins will be subject to similar stability effecting factors as they develop. 
Precedence for this can be seen in the examination of day 10 embryos at the highly variable 
mouse tetranucleotide repeat Hm-2 (Gibbs et al., 1993). Gibbs et al. (1993) examined the 
result of 61 conceptions, studying the embryo and when possible, extraembryonic tissue. The 
extraembryonic tissue was usually the trophoblast. The mouse embryo or morulla splits from 
the body that will become the trophoblast when it reaches the 32 cell stage on the fourth day of 
development in both mice and humans. Examination of the Hm-2 loci found mutations in 56% 
of the studied embryos, this rate was higher than that observed in live young, which was 
observed at 20%. Of the 46 trophoblast / embryo pairs studied five shared the same mutation. 
In these mice the mutation event must have therefore occurred within the first five cell 
divisions. So it is possible that a mutation event may occur at the effected disease loci before 
twins split. However, the tissues in each twin would be subject to the same rate of 
development and any specific factors, including environmental effects, acting on the different 
tissues would be the same. So, far from instability patterns being laid down in the one day to 
21 day window defined by twin separation, the tissue specific differences could have occurred 
later in development, a consequence of common tissue specific factors. After all it is with the 
emergence of the primitive streak, laying foundations for brain, central nervous system and 
heart at around 3 weeks in humans and 7 days in mice, that the first evidence of tissue 
differentiation can be observed. So for tissue specific repeat mutations to have occurred prior 
to this, cells must be programmed early with their future function. Indeed, if the events 
contributing to tissue specific instability are laid down early in embryonic development, that is 
before differentiation, it could be that the rate of repeat expansion would be uniform across the 
tissue types.
Analysis of leukocyte DNA from disease range patients at timepoints ranging from neonates 
to those aged over 50 found that the diffuse band observed in genomic Southern blots of 
unstable disease range alleles wasn’t present in the neonates. Indeed the band appeared to 
become more diffuse as the age of the patients analysed increased (Wong et al., 1995) 
suggesting that somatic expansion events occur postnatally.
Initial comparison of the developmental timing of cell types (Sadler, 1985) located within 
tissues exhibiting phenotypes associated with DM1 found there to be no correlation with either 
the appearance or severity of the DM1 symptoms and the order of tissue development. 
Furthermore examination of the rate of cell proliferation and migration in adult rats and mice
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using thymidine H3 across static expanding and renewing tissue populations (Messier and 
Leblond, 1960), also shows no correlation with DM1 phenotype tissues or tissues known to 
show repeat instability.
1.5 Gametic instability
The sex of the transmitting parent and the size of the repeat expansion that they carry effects 
the size of the repeat inherited. Study of DM1 pedigrees found the transmitting grandparent 
most likely to be male (Bell, 1948) an observation confirmed in more recent studies (Lavedan 
et al., 1993a). When a number of DM1 transmissions were studied the average size of repeat 
transmitted by fathers was found to be shorter than the average repeat length transmitted 
maternally (Lavedan et al., 1993a). Fathers with a small repeat expansion tend to transmit 
large repeats to their offspring, while fathers with larger repeat sizes themselves do not tend to 
transmit as large jumps (Ashizawa et al., 1994).
It should be noted that testicular atrophy is a common symptom in classic DM1 patients 
although it is also possible that there is a ceiling over which male gametes cannot expand. 
Comparison of blood and sperm samples of nine DM1 males showed the smeared expanded 
band characteristic of genomic Southern blot analysis present in the sperm samples. Sperm 
samples showed a higher degree of repeat mosaicism than the blood samples, the smear being 
indicative of the presence multiple repeat sizes (Jansen et al., 1994). This observation is 
echoed in three of the DM1 patients studied by Monckton et al. (1995) and five out of the six 
DM1 patients from whom blood and sperm samples were examined using small pool PCR by 
Martorell et al. (2000). The expansion threshold for paternal DM1 transmission has been 
suggested at around 1000 repeats (Jansen et al., 1994) although examples beyond this have 
been observed (Martorell et al., 2000). Such expansion events however, appear to be rare and 
sperm with repeat expansions larger than 1000 CTG may be selected against as the sperm 
matures, or mechanisms may exist which act against large expansions in sperm. It may also be 
that the maturation time of sperm may not give it time to be subject to multiple small 
expansion events while the rare individuals who present sperm with repeats beyond the 1000 
CTG repeat threshold may be subject to unusual expandability factors (Martorell et al., 2000). 
Congenital myotonic dystrophy (CDM) was found to be transmitted almost exclusively 
maternally (Ashizawa et al., 1994), although cases of paternal CDM transmission have been 
observed (Tachi et al., 1997), contractions, when they occur, are more often transmitted by
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fathers (Ashizawa et al., 1994). Even when the CDM transmissions are excluded from the 
maternal mean, the average maternal transmission was still found to be larger.
These observations suggest that the phenotype a patient presents is related not only to 
inherited repeat size (Lavedan et al., 1993a), but to other factors, such as the presence of 
neighbouring cis acting elements (Jansen et al., 1994), or the effect of trans acting elements, it 
may be that certain individuals carry polymorphisms in genes involved in the mechanism of 
instability that make them more vulnerable to the effect of the triplet repeat (Wells, 1996).
1.6 DMWD and SIX5
As the investigation of the effect of the expanded CTG tract in the 3’ UTR of DMPK in DM1 
patients grew, the effect of the expansion on the genes closest to DMPK was also examined. 
DMWD, formerly referred to as 59 in humans (Shaw et al., 1993) and Dmr-n9 in mice (Jansen 
et al., 1995; Jansen et al., 1992), is located ~1.1 kbp upstream of the start of transcription of 
DMPK (Figure 1.2) in both humans and mice. This gene contains five exons and encodes a 
650 amino acid protein (Jansen et al., 1992) which includes two inner domains that show 
significant homology to a WD motif (Jansen et al., 1995). The WD amino acid sequence is a 
conserved motif found in a family of proteins involved in signal transduction or cell 
regulation. Jansen et al. (1992) observed the presence of two weak adenylation sites adjacent 
to the genes and hypothesised contiguous transcription with the adjacent DMPK gene, arguing 
that factors affecting the DMPK transcription could have an affect on flanking DNA. The 
observation that normal Dmwd expression is most prominent in the brain and testis (Jansen et 
al., 1995) and that DMWD is expressed in the heart, brain, liver, kidney spleen and testis in 
humans has lead to the suggestion that the expansion of the DM1 repeat is polygenic in its 
effect. SIX5, formerly known as DMAHP, (MYOTONIC DYSTROPHY LOCUS ASSOCIATED 
HOMEOBOX PROTEIN) ~ 1.2 kbp downstream from the final DMPK exon (Boucher et al., 
1995; Heath, 1997) (Figure 1.2) in both humans and mice. A homeobox gene encodes a 
conserved domain of ~60 amino acids, a homeodomain. This “homeodomain” can bind to a 
specific DNA sequence (Engelkamp and van Heyningen, 1996). SIX5 has been identified as a 
member of the growing sine oculis related homeobox (Six) subfamily named after the first 
member identified, the Drosophila eye development gene sine oculis (so). Indeed Six5 (-/+) 
and (-/-) mice have been generated by two groups and both models exhibit ocular cataracts, a 
disease phenotype manifested in late onset patients (Klesert et al., 2000; Sarkar et al., 2000a). 
The Six5 -/-, mice reported by Sarker et al. (2000a), have been reported as being sterile
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Figure 1.2 Genomic structure of DM1 region
Schematic diagram of DMPK and the flanking genes DMWD and SIX5. Indicated is the 
location of each exon, the expanded triplet repeat, the Alu insertion/ deletion polymorphism 
and the SIX5 homeobox and six box.
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demonstrating a role for Six5 in gametogenesis or embryogenesis (Sarkar et al., 2000b). They 
also report muscle wasting and suggest that decreased expression of Six5 may contribute to 
DM1 skeletal myopathy.
1.7 The effects of the triplet repeat expansion on flanking DNA
As the DMPK trinucleotide repeat is located outside the open reading frame of the protein 
coding region it is unlikely that it influences the actual protein structure in the manner of the 
polyglutamine tracts of CAG triplet repeat diseases (Cummings and Zoghbi, 2000). As yet no 
patient with DM1 symptoms has been reported with a point mutation within DMPK that would 
knockout its function. What the resulting phenotype of such a mutation might be is therefore 
the subject of speculation. To investigate the effect of the loss of the DMPK protein, Dmpk -/- 
mouse models have been generated (Figure 1.3). Such knockouts (Jansen et al., 1996; Reddy 
et al., 1996), were viable both as heterozygotes and unexpectedly as homozygotes but did not 
result in the manifestation of all of the disease associated symptoms. The Jansen et al. (1996) 
(-/-) mice exhibited minor muscle fibre changes in the head and neck muscle fibres, but no 
myotonia. Although the effects of the Dmpk (-/-) mutation appeared to be minor when looking 
at the gross mouse, observation of Ca2+ homeostasis at the cellular level in the Jansen et a l 
(1996) (-/-) mice found voltage-dependent L-type Ca2+ and Na2+ channels to exhibit smaller 
and slower Ca2+ responses to acetylcholine or high external K+ stimuli (Benders et al., 1997). 
While more recently abnormality in the sodium gating channels in the myocytes of the Reddy 
et al. (1996), Dmpk -/- mice have been observed to resemble the sodium channel abnormalities 
presented by DM1 patients (Mounsey et al., 2000).
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Figure 1.3 DM1 related transgenes
Schematic diagram of A. the human DM1 region and derived transgenes and B. the 
homologous murine region and the related murine models.
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The Reddy et al. (1996), mice presented a progressive skeletal myopathy increased muscle 
fibre degeneration, fibrosis, a 50% loss of force generation and ultrastructural changes. They 
share some pathological features with DM1, suggesting that Dmpk is functionally necessary to 
maintain the structural integrity of skeletal muscle fibres and normal force generation (Reddy 
et al., 1996). Berul et al. (1999), reported that the Reddy et al. (1996), Dmpk -/- mice 
developed cardiac conduction defects while the Dmpk +/- mice defects developed a similar 
condition. This cardiac defect resembled the heart defects observed in DM1 patients (Berul et 
al., 1999).
Over expression of a DMPK transgene in mice revealed an expression pattern in common with 
that of Dmpk but 20 transgenic copies were required to increase DMPK expression to 5 -  10 
times the levels of Dmpk expression (Jansen et al., 1996). The mice appeared fundamentally 
normal, although histopathological analysis of the heart revealed a striking dysmorphology 
which included patches of degeneration, yet cardiac function appeared normal, so any 
correlation this effect may have with the cardiac conduction defects presented by DM1 
patients was not apparent. It should be noted before drawing conclusions from the lack of 
manifestation of disease phenotype that neither of the mouse models for DMPK repeat 
expansion (Figure 1.3), (Gourdon et al., 1997; Monckton et al., 1997) exhibit disease 
phenotypes although variation in the repeat is observed both somatically and gametically.
It is known that expanded CTG triplet repeat blocks from DM1 form the strongest known 
natural nucleosome positioning elements (Wang et al., 1994). DNA fragments containing 75 
and 130 repeats respectively were observed to be 6 and 9 times stronger in nucleosome 
formation than that of the somatic 5S RNA gene of Xenopus borealis, previously one of the 
strongest known positioning elements. The consequence of the expanded repeat tract is a 
region of condensed chromatin and also the loss of a DNAse I hypersensitivity site, located 3' 
of the triplet repeat (Otten and Tapscott, 1995), suggesting that access to transcription factor 
sites might also be effected by structural changes to the region. Examination of the 
methylation pattern of the CpG island 3’ to DMPK revealed no sex related differences in the 
methylation pattern (Steinbach et al., 1998). However, a difference in methylation status has 
been observed in different classes of DM1 patients. The CpG island in the classic cases of 
DM1 examined were reported to be normal while the same region in all of the CDM cases 
studied were found to be hypermethylated.
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1.8 RNA effects and pathology
The role of DMPK and the mechanisms by which the expansion of the triplet repeat tract leads 
to the DM1 phenotype are not known. Speculation as to what the pathogenic mechanism 
might be has lead to the proposal that the expansion leads to a failure in the processing and / or 
export of the mRNA transcripts of DMPK and that the DMPK expanded repeat tract, (mutant), 
interacts with the transcript of the DMPK allele that does not contain the expansion, (normal), 
(Fu et al., 1993; Hamshere et al., 1997; Krahe et al., 1995; Roses et al., 1996; Sabourin et al., 
1993; Wang et al., 1995) and / or the transcripts of the flanking genes DMWD (Alwazzan et 
al., 1999; Hamshere etal., 1997) and SIX5 (Hamshere et al., 1997; Klesert et al., 1997; 
Thornton et al., 1997).
In the first instance, investigation of the levels of transcription of the mutant and the normal 
alleles of DMPK produced conflicting results. For example Wang et al. (1995) observed that 
the level of DMPK polyA RNA was reduced for both the mutant and the normal transcript 
when compared to a non disease range control. In contrast Fu et al. (1993), observed a lack of 
coequal expression of the mutant and normal DMPK transcript levels. The transcription level 
of the normal allele was uneffected, however, a reduction of mutant levels was detected and 
this reduction increased as the size of the repeat increased. Krahe et al. (1995), detected equal 
levels of each DMPK allele in the analysed pool of heteronucleic RNA. Analysis of the DMPK 
levels in the pool of mRNA revealed a reduction in the level of mutant DMPK detected. Again 
this reduction increased with the increasing repeat size. A similar observation was made by 
Davis et al. (1997) and Hamshere et al. (1997). Sabourin et al. (1993), conversely reported 
elevated levels of DMPK mRNA transcript in the tissues and cell lines that they examined and 
attributed this to an elevated level of mutant DMPK mRNA.
The data presented in these studies consists of analysis of transcript levels of the mutant and 
normal allele in the messenger RNA fraction and / or the heteronucleic RNA fraction. The 
RNA was extracted from either the whole cell (Krahe et al., 1995; Wang et al., 1995), or 
separated into nuclear and cytoplasmic fractions (Alwazzan et al., 1999; Hamshere et al., 
1997). The RNA has been derived from a number of sources, including congenital patients 
(Sabourin et al., 1993) and classic onset DM1 patients (Fu et al., 1993; Krahe et al., 1995), as 
well as DM1 patient derived cell lines (Alwazzan et al., 1999; Davis et al., 1997; Hamshere et 
al., 1997; Krahe et al., 1995). It is now clear that congenital cases have different symptoms to 
classic onset patients.
The methods used to analyse allele levels were also diverse and will have varied in their 
sensitivity. They included northern blotting (Davis et al., 1997), RNA fluorescent in situ
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hybridisation (Taneja et al., 1995), quantitative multiple fluorescent (QMF) PCR (Wang et al., 
1995) and RT-PCR (Fu et al., 1993; Hamshere et al., 1997; Sabourin et al., 1993) including 
allele specific RT-PCR, (Alwazzan et al., 1999; Klesert et al., 1997; Krahe et al., 1995). This 
vast variation in the methods used to analyse the transcript levels goes some way to explain 
the conflicting results.
Current thinking about the expression of and the export of the mutant and normal DMPK 
allele is based on RT-PCR carried out on mRNA prepared from separated nuclear and 
cytoplasmic fractions (Hamshere et al., 1997) and allele specific expression of DMPK (Krahe 
et al., 1995). These studies have shown the level of transcription is not effected by the 
expanded allele but that processing and maturation of the transcript is (Krahe et al., 1995). The 
rate that DMPK transcripts accumulate for both normal and myopathic controls when 
compared to accumulation of levels of both the normal and expanded allele of DM1 saw a 
small decrease in DMPK RNA levels amongst the pool of total RNA and as the myopathic 
control showed a similar decrease, this fluctuation did not appear to be disease specific 
(Taneja et al., 1995). All of the RNA under examination was extracted from biopsied muscle. 
However, dramatic decreases of both the mutant and normal DMPK mRNA transcript was 
observed and this was disease specific. This suggested that the expanded repeat contributes to 
the nuclear retention of both transcripts. Meanwhile RNA in situ hybridisation revealed that 
the expanded DMPK transcript is retained within the nucleus and forms distinctive RNA foci 
(Taneja et al., 1995). It might be assumed that the reduction of DMPK mRNA in DM1 
patients would result in a reduction of the DMPK protein product and that this loss contributes 
to the symptoms manifested by a DM1 patient.
1.8.1 The effect of the DMPK expanded triplet repeat on flanking genes
Having explored the consequences of the expansion on the transcription and translation of 
DMPK, the effect that the expanded repeat may have on the outlying genes, DMWD which is 
located upstream of DMPK and SIX5 which is located downstream of DMPK (Figure 1.2) was 
studied.
Hamshere et al. (1997), analysed SIX5 levels in RNA fractions prepared from either the 
nuclear or cytoplasmic fraction of a DM1 derived cell line. They observed there to be no 
difference in the level of SIX5 RNA present in the two fractions. Klesert et al. (1997) and 
Thornton et al. (1997), also analysed the transcription level of SIX5. They examined levels in 
both the normal and mutant alleles using allele specific RT-PCR. This revealed a reduction in
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the level of mutant transcript that was 2-4 times less than that observed for the normal allele 
(Klesert et al., 1997). While Thornton et al. (1997) observed that as the repeat expansion 
increased the SIX5 transcript level dropped. The DNase I hypersensitive site that was reported 
by Otten and Tapscott, (1995), was found to contain an enhancer element that regulated the 
transcription of SIX5 and the disruption of this site by the expanded triplet repeat reduced the 
level of transcription (Klesert et al., 1997; Thornton et al., 1997). Klesert et al. (1997) and 
Thornton et al. (1997) have demonstrated that the reduction of SIX5 transcript levels is 
because of a reduction in transcription initiation and not as in DMPK a problem with transcript 
processing. This explains the co-equal levels of SIX5 transcript observed in the nuclear and 
cytoplasmic fractions observed by Hamshere et al (1997). Allele specific RT-PCR analysis of 
the same DM1 cell lines reported by Hamshere et al. (1997) also revealed a reduction in the 
level that the SIX5 was transcribed from the mutant allele (Alwazzan et al., 1999), and that the 
larger the repeat expansion the greater the reduction in mutant transcript level, that is the cell 
lines containing the larger expansions, 3 -  5.5 kb had a greater effect reducing expression 
levels than the repeats between 240 bp and 1.2 kb in size.
To assess the effect of the CTG expansion on the level of transcription of DMWD, Alwazzan 
et al. (1999), designed allele specific primers for both the mutant and normal allele of DMWD. 
Thus allowing the level of each of these transcripts to be monitored both in the nucleus and the 
cytoplasm. A series of DM1 patient derived fibroblast cell lines containing a selection of 
repeat lengths were used for the study. Comparison of the level of normal transcripts versus 
mutant transcripts isolated from the nucleus found a reduction in the level of mutant transcript 
to between 20 -  50% of that of the level of the normal transcript. However, no correlation 
between the reduction of DMWD transcription levels and repeat length was observed. 
Comparison between DMWD transcript levels in cytoplasmic and nucleic fractions found there 
to be a reduction in the levels of the mutant allele. This suggests that the level of DMWD 
transcription is influenced at the initiation stage and this is in some way effected by the size of 
the triplet repeat expansion, influencing the cytoplasmic levels of the transcript.
1.8.2 Consequences of the expanded repeat in DMPK transcripts
It has been observed that the expansion of the mutant DMPK CTG repeat results in a reduction 
of transcript levels of DMPK detectable in the cytoplasm (Hamshere et al., 1997). So what 
could the mechanism of transcript retention in the nucleus involve?
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Mankodi et al. (2000) generated several mouse lines using a transgene containing a genomic 
fragment of the human skeletal actin gene. They introduced a tract of either (CTG)5 or 
(CTG)250 repeats between the stop codon and the polyadenylation site of the transgene. Thus 
mimicking the location of the expanded repeat in DM1.
One of the long repeat carrying transgenic lines, LR32a was analysed because the transgenic 
repeat was expressed at a high level and silenced infrequently. These mice gained weight 
normally and histological analysis of non-muscular tissue showed this to be normal also. 
However, the mortality rate at 44 weeks had increased from 5% in non transgenic mice or 
transgenic lines generated with the (CTG)5, repeat to 41%. The LR32a mice showed 
abnormal hind limb posture after a period of inactivity and presented myotonia as young as 4 
weeks although the muscles appeared histologically normal. Yet mice expressing the 
(CTG)250 repeats did develop histologically defined myopathy not observed in (CTG)5 mice. 
The long CUG transcripts were observed to be retained in the nucleus in discrete foci 
reminiscent of those observed by Taneja et al. (1995) in the myoblasts of DM1 patients. The 
presence of the expanded CUG repeat would appear to be enough to result in this retention. 
This in itself begs questions about what the mechanism of retention may be. What is the nature 
of the structure that is retained in the nucleus? It has been observed in vitro that CUG tracts 
can form hairpin structures as they are transcribed (Tian et al., 2000). Examination of the 
structures formed by a selection of CUG repeats in vitro. Study of transcripts of (CUG)35, 
(CUG)69, and (CUG) 140 found the preferred structure formed to be a simple hairpin 
containing an extended stem (Figure 1.4) rather than the alternative looping structures. The 
retention of the transcript could be accounted for by the assumption of such a structure by the 
expanded CUG tract. Koch and Leffert (1998), suggested that the giant hairpin structures 
might sterically block RNA export through nuclear pores. Successfully exported DMPK 
hnRNA’s are 9-25 nm, when measured cross sectionally through the diameter. However, as 
the repeat expands the steric demands of the hairpin may result in a structure that is too large 
to be exported out of the nucleus. Although the presence of hairpin structure in vivo has not 
yet been confirmed, the consequences of such a structure might explain the multiple disease 
phenotypes of DM1.
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Figure 1.4 Secondary structures adopted by expanded CUG repeats.
Examples of secondary structures that could be adopted by CUG repeat tracts.
A. Simple hairpin with its extended stem
B. An alternative multiloop structure.
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It has been hypothesised that the hairpin structures act as protein sinks removing some cellular 
proteins from their normal functions which may include RNA processing or export 
(Timchenko et a l, 1999). The removal of a protein or proteins with multiple functions could 
in some way account for some of the symptoms of the DM1 disease phenotype. As may the 
retention of the CUG transcripts within the nucleus. The accumulation of an “overdose” of 
transcript may in some way interfere with the balance within the nucleus and disrupt the 
normal function of proteins located there (Tian et al., 2000).
The CUG binding protein (CUG-BP) or hNab50 is observed to bind preferentially to CUG 
repeats, although not necessarily expanded ones (Timchenko et al., 1999). It is known that 
CUG-BP accumulates in the nucleus and this could be explained by the presence of the repeat 
expansion. CUG-BP had been found to bind to the pre mRNA transcript of human cardiac 
troponin T (cTNT) where it regulates alternative splicing. It occurs in multiple isoforms and its 
function can be reliant on its phosphorylation status. The theory that the increase in potential 
binding sites resulting from the increasing number of repeats results in a “mopping up” effect 
and consequential loss of CUG-BP to its normal functions is confounded by the observation 
that CUG-BP binds to single stranded repeats (Michalowski et al., 1999). Michalowski et al. 
(1999), used electron microscopy to observe repeat tracts generated in vitro. These CUG 
hairpins are double stranded structures uniformly paired along the repeat tract, without kinks, 
bubbles and bends restricting the potential binding region to the base of the hairpin. In vivo 
however, CUG-BP could potentially bind to the repeat tracts as they are generated.
The disruption of this protein or one like it with multiple functions may account for the variety 
observed in the disease phenotypes manifested in DM1 patients, (Phillips et al., 1998). 
Alternatively if the in vitro observations of Michalowski et al (1999), also occur in vivo and 
the repeat binds into a double stranded structure unaffected by CUG-BP, then this protein is 
not responsible, or solely responsible for the disease phenotype and it may act in tandem with 
a protein which recognises double stranded tracts. Tian et al (2000), report that CUG repeats 
bind to the double stranded RNA binding domain of PKR, the double stranded RNA activated 
protein kinase (Tian et al., 2000). Their in vivo studies have revealed that the CUG repeat tract 
must be in excess of (CUG)15 for binding to occur and that the affinity of PKR to the repeat 
tracts increases as the length of the repeat tract increases. It is possible that the retention or 
activation of PKR may have subsequent consequences that may result in DM1 disease 
symptoms. Whilst Miller et a l (2000), were investigating double stranded RNA binding 
proteins they isolated proteins homologous to the Drosophila muscleblind proteins (Miller et
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al., 2000). These proteins are required for the terminal differentiation of muscle and 
photoreceptor cells. Both the eye and an extensive number of muscles are affected by DM1, 
suggesting that such proteins may account for some of the DM1 phenotype. The expression of 
muscleblind proteins is activated during mammalian myoblast differentiation and they have 
been shown to aggregate as nuclear foci in DM1 cell lines.
There has also been one case reporting an expanded CTG repeat causing trans RNA 
interference (Sasagawa et al., 1999), where the interaction of an expanded (CTG)140 
transcript with the (CAG)35 repeat of the TFIID binding protein results in an abnormal double 
stranded structure. This could result in not only nuclear retention of the transcript but affect 
post-transcriptional processes and result in a transcript unviable for nuclear export.
1.9 Transgenic mouse models of triplet repeat disease
There are many problems when it comes to studying the progression of the triplet repeat 
diseases. Access to a selection of tissue types from an individual is limited, indeed the means 
to examine the progression of the disorder in a range of tissues is restricted to post mortem 
tissue (Jansen et al., 1994; Joseph et al., 1997; Wohrle et al., 1995). The observation of the 
repeat instability over time in DM1 is limited to blood samples (Lavedan et al., 1993a; 
Martorell et al., 2000; Massari et al., 1995; Tachi et al., 1993; Tachi et al., 1997), biopsied 
muscle (Massari et al., 1995; Tachi et al., 1993), which is limited due to the invasive nature of 
the procedure and semen samples (Martorell et al., 2000; Massari et al., 1995), the latter is a 
source which becomes limited as the disease progresses. Other factors which confound 
investigation include the difficulty in determining the initial size of the disease range repeat. 
This is especially difficult as patients are diagnosed at a range of ages and at different stages 
of disease progression. They have been subject to a variety of environmental factors and 
knowledge of disease progression is limited as even within families there will be variation in 
the genetic background and thus variation of the cis and trans acting factors that are acting 
upon the repeat.
The study of intergenerational repeat variation is confounded by the low numbers of offspring 
in affected families. Large timepoints between generations and limited diagnosis of earlier less 
affected generations make it difficult to follow repeat transmission patterns. That parental age 
has been observed to effect only the size of the transmitted Huntington repeat (Duyao et al., 
1993) and DRPLA repeat (Sato et al., 1999) may reflect limited pedigree data.
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The lack of consistent sources of triplet repeat tissues has lead to the development of both 
murine and cell models. There are arguments against the use of mouse models after all, how 
appropriate is it to use the mouse, with its short lifespan to study a late onset disorder? Factors 
affecting repeat stability and thresholds above which a triplet repeat tract might expand may 
vary between species or indeed between strains of model organisms. However, the short 
lifespan lends itself to the study of successive generations as well as the study of mature 
individuals. There is also ease of access to multiple tissues of known progenitor repeat size at 
any time point. Use of inbred strains means that the expanded repeat is presented on a uniform 
genetic background and variation of the repeat length can be the only difference between 
individuals as even environmental variation is within the control of the experimenter. A 
number of murine models have been developed to investigate the effect of either an expanded 
CAGCTG triplet repeat tract or any of a number of triplet repeat disorders in the hope of 
increasing understanding of somatic and / or intergenerational stability, the mechanisms 
involved and any variation in the mechanisms of stability that may exist between the two. The 
transgenic models split into two groups, those which involve transgenes based on the disease 
associated expanded repeat tract and differing amounts of flanking sequence which have 
integrated randomly into the genome (Bingham et al., 1995; Burright et al., 1995; Goldberg et 
al., 1996; Gourdon et al., 1997; Ikeda et al., 1996; La Spada et al., 1998; Mangiarini et al., 
1997; Monckton et al., 1997; Sato et al., 1999) and more recently those generated by the 
recombination of the expanded repeat tract into the murine homologue of the disease affected 
gene (Lorenzetti et al., 2000; Shelboume et al., 1999; Wheeler et al., 1999).
Not all of the generated mouse models show detectable instability. These include two 
transgenic lines generated to study SBMA containing either 45 or 24 CAG repeats derived 
from the human androgen receptor (AR) (Bingham et al., 1995), cDNA derived Huntington 
constructs of 82 CAG repeats (Goldberg et al., 1996) and an expanded CAG sequence (Ikeda 
et al., 1996). These models did not exhibit intergenerational or somatic instability or any 
evidence of disease phenotypes. All of these stable models contain what could be considered 
short repeat tracts although many of these repeat tracts may manifest symptoms in affected 
patients. It should be noted that these models contain multiple transgenic integrants, this factor 
and the sensitivity of methods used to detect the instability may make subtle changes in repeat 
size difficult to detect.
It might be that short repeat tract models do not reach a possible instability threshold during 
the lifetime of the mouse and that the level of instability observed is a function of the “dosage 
of repeats”. Indeed this point is illustrated by the three “knock in” models of CAG expansion
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at the murine HD loci, which contain an expanded repeat of (CAG)48, (CAG)90 and 
(CAG)109 generated by Wheeler et al. (1999). Minimal, (less than 2%), intergenerational 
instability was observed in the (CAG)48 line, while the frequency of mutations associated 
with the expanded repeat in the (CAG)90 and (CAG)109 is over 70% (Wheeler et al., 1999). 
However, among the murine models of triplet repeat expansion which do exhibit gametic 
instability (Burright et al., 1995; Gourdon et al., 1997; La Spada et al., 1998; Mangiarini et 
al., 1997; Monckton et al., 1997; Sato et al., 1999; Shelbourne et al., 1999; Wheeler et al.,
1999) and somatic instability (Gourdon et al., 1997; Mangiarini et al., 1997; Monckton et al., 
1997; Sato et al., 1999; Shelbourne et al., 1999; Wheeler et al., 1999) is the DM1 transgenic 
model, DM 55 (Gourdon et al., 1997).
The DM 55 transgene consists of an expanded CTG repeat, derived from a DM1 patient, 
contained within ~ 45 kb of sequence that includes the coding sequence for DMPK, DMWD 
and SIX5. Despite the relatively short repeat tract (CTG)55, moderate intergenerational and 
somatic instability is observed, suggesting that the somatic instability observed is a function of 
the flanking DNA and when the transgene contains a minimal amount of flanking sequence 
(Ikeda et al., 1996; Monckton et al., 1997) a consequence of the integration site or other 
stability affecting factors. The consequence of such factors can be further observed in the 
somatic instability profiles of the R6 transgenes of Mangiarini et al. (1997), as instability is 
observed in the mature mice of the R6/1, R6/2 and R6/5 lines but not the R6/0 line (Bates et 
al., 1997). Indeed between the unstable lines the instability profile, which was visualised using 
Genescan® software, varied. The SCA type 1 CAG repeat in normal range individuals 
contains a CAT repeat which is not present in expanded alleles and is thought to confer a 
stabilising effect (Jodice et al., 1994). A point mutation in a transgenic repeat tract may confer 
the same effect. More likely to influence stability of the transgene is the position of the 
integration site and the DNA packaging of the transgene which may result in it being silenced 
yet still allowing it to be inherited (Clark, 1997). While Brock et al. (1999) observed that the 
GC content flanking the 10 triplet repeat disease loci examined correlated with the degree of 
repeat expandability observed there. That it is the variation in the integration sites which 
effects the observed instability in the same transgenic repeat tract can be seen when 
investigating different lines generated with the same transgene (Bates et al., 1997; Monckton 
et al., 1997).
Examination of the transmission patterns of triplet repeat murine models found the repeat size 
difference of parent offspring transmissions to be smaller than those observed in affected 
families (Burright et al., 1995; Gourdon et al., 1997; La Spada et al., 1998; Mangiarini et al.,
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1997; Monckton et al., 1997; Sato et al., 1999; Shelbourne et al., 1999; Wheeler et al., 1999). 
A dosage of repeat effect could also be observed in the transmission of one of the Dmt 
transgenes. Line Dmt-A, which contains multiple copies of the Dmt-A transgene, was 
observed to transmit deletions of up to 38 repeats (Monckton et al., 1997). The effect of the 
age of the transmitting parent on the size of the repeat transmitted has been studied in several 
models of triplet repeat instability and again sex related differences have been observed, 
Lorenzetti et al. (2000) observed that paternal transmissions of their targeted Sea type 1 model 
showed a low level of instability on which the age of the transmitting parent had little effect, 
while the deletions associated with the majority of the maternal transmissions increased with 
the age of the mother (Lorenzetti et al., 2000), while Kaytor et al. (1997) also observed that as 
the age of the repeat transmitting mother increased so did the size of the deletion transmitted. 
They also examined the repeat size in oocytes isolated from mice of increasing age and found 
the same correlation, leading them to conclude that the transgenic repeat instability event 
occurs after meiotic recombination and prior to oocyte fertilisation.
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1.10 Mismatch repair genes
Study of E. coli strains found those lacking one of 4 mutator genes, mutS, mutL, mutH, or 
mutU, resulted in an elevated level of spontaneous mutations (Modrich and Lahue, 1996). 
These mutator genes were thought to play a role in DNA mismatch repair, (MMR) a 
mechanism by which the integrity of the genome is maintained. A summary of the known 
roles of these mutator genes is shown in table 1.3 (Buermeyer et al., 1999).
Homologues for two of the mutator genes, mutS and mutL have been found in eukaryotes, both 
in yeast and mammals, although not all of these are thought to have a role in mutation 
avoidance. The homologues, which consist of heterodimers, are summarised in table 1.4 
(Buermeyer et al., 1999).
Eukaryotic homologues of mutH and mutU have not been identified. However, there is 
evidence to suggest that proliferating cell nuclear antigen (PCNA) has a role in MMR. It is 
known to interact with either human or yeast MutS and MutL homologues (Johnson et al., 
1996; Kokoska et al., 1999). Mutations in PCNA have been observed to disrupt MMR, 
resulting in simple frameshifts and its role in MMR is prior to or at the point of excision 
(Umar et al., 1994b), and a role has been hypothesised for PCNA which involves 
differentiating between the template and the nascent strand (Buermeyer et al., 1999; Johnson 
et al., 1996; Kokoska et al., 1999) Of the mutator gene homologues, defects in at least five, 
hMSH2, hMSH6, hMLHl, hPMSl and hPMS2 (Akiyama et al., 1997), (Liu, 1996; Peltomaki 
and Vasen, 1997) have been implicated in the incidence of HNPCC (Lynch and Smyrk, 1996). 
A person with a mutation in one of these genes also has an increased risk of suffering from 
Muir-Torre syndrome and Turcots syndrome (Paraf et al., 1997), which also involve 
colorectol cancers, as well as developing tumours in the endometrium, ovary, stomach and 
small intestine, (Lynch et al., 1997; Peltomaki and de la Chappelle, 1997). However, of the 
MMR mutations observed in mismatch repair kindreds, the majority, are found in either MSH2 
or MLH1, which are thought to play a primary role while mutations in PMS1, PMS2 and 
MSH6 are apparently rarer (Liu, 1996).
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Mutator gene Role
mutS An ATPase- which acting as a homodimer binds to both base / base 
mismatches and small insertion / deletion loops, that have not been 
connected by the replicating polymerase.
mutL Couples mismatch recognition and downstream MMR events:
• mutL homodimer forms complex with mutS complex- enhances ATP 
hydrolysis dependant translocation.
• mutL stimulates mutH endonuclease activity in an ATP dependant 
manner
• mutL required to load mutU helicase onto the site of a mutH induced 
nick
mutH An endonuclease: introduces a nick in the nascent strand at hemi 
methylated GATC sequences allowing discrimination between the template 
and the newly replicated strand.
mutU Helicase 11/ UvrD- facilitates DNA unwinding.
Table 1.3 Summary of the role of the MMR mutator genes of E.coli
E.coli H. sapiens heterodimer
mutS MutSa (hMSH2/hMSH6)
MutS(3 (hMSH2/hMSH3)
mutL MutLa (hMLHl/hPMS2)
MutL(3 (hMLHl/hPMSl)
mutH Not known
mutU Not known
Table 1.4 Summary of the known human homologues of the MMR mutator genes of 
E.coli.
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1.10.1 Mismatch repair genes and microsatellite instability
Mismatch repair genes ‘proof read’ the DNA, correcting errors in base pairing, unpaired 
regions and removing unusual DNA structures, such as hairpins (Umar et al., 1994a; Yu et al., 
1995). However, it is now emerging that mismatch repair gene homologues also have other 
cellular functions including roles in transcription coupled repair (Leadon and Avrutskaya, 
1997; Mellon and Champe, 1996), recombination (Chen and Jinks-Robertson, 1999; 
Rayssiguier et al., 1989; Selva et al., 1995) and possibly cell cycle regulation (Narayanan,
1997).
The absence or loss of function of these MMR genes result in mismatch errors accumulating 
over time with repair deficient yeast cells having been observed to accumulate mutations at a 
rate 700 times that of a non mutated yeast (Lynch and Smyrk, 1996).
Accumulation of such errors can eventually lead to the cancerous mutations observed in 
HNPCC patients. The repair of DNA errors acquired during the replication, repair and 
recombination of DNA is a balance between the survival of the organism and the acquisition 
of advantageous mutations. There are regions within the genome, which appear more 
vulnerable to mutation than others. These regions or “hot spots” are often associated with 
repeated DNA sequences, for example, inverted, mono, di, tri, and tetra nucleotide repeats and 
also some repeat tracts of higher magnitude, yet the trinucleotide repeats appear even more 
unstable than expected (Sinden, 1999). The migration of linearised triplet repeat sequences 
through acrylamide gels at a rate slower than that expected suggests the adoption of alternative 
structures by the triplet repeat tracts. It has been observed that several different hairpin 
structures can form when the triplet repeat tract is unpaired (Pearson et al., 1998) and that 
DNA polymerase has difficulty passing through triplet repeat tracts, and that this itself is 
dependent on the repeat motif (Kang et al., 1995; Ohshima et al., 1996; Pamiewski et al.,
2000). This leads to suggestions that the stalling of the DNA polymerase could lead to primer 
template misalignment resulting in the formation of alternative DNA structures, whose 
“repair” from the genome could result in the expansion and deletion events observed at 
expanded triplet repeat tracts.
Observation of a selection of CAG*CTG triplet repeat tract containing plasmids that were 
transformed into Escherichia coli revealed that all of the observed lengths of repeat tract were
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subject to small deletions, that is deletions of less than 8 repeats when the mismatch repair 
pathway was inactivated while an active MMR pathway resulted deletions larger than 8 
repeats. It was also observed that the larger the CAG-CTG triplet repeat tract was the larger 
the deletions observed (Jaworski et al., 1995). To further confirm this observation CAG-CTG 
triplet repeat tract containing plasmids which varied in length and purity were transformed 
into E.coli strains that were isogenic except when a mismatch repair protein coding gene was 
mutated (Parniewski et al., 2000), thus controlling the variation of cis and trans acting factors. 
It was observed that the loss of MMR proteins reduced the level of instability observed in the 
repeat tracts. The degree to which the CAG-CTG triplet repeat tract was vulnerable to 
deletions increased with the length of the tract as it did the less pure the tract under 
examination was. Deletions greater than 8 repeats were almost always observed when the 
repeat tracts were greater than 100 only. While the repeat tracts of less than 100 in the 
Parniewski et al. (2000), model, in common with other models both in E. coli (Schumacher et 
al., 1997) and Saccharomyces cerevisiae (Schweitzer and Livingston, 1997) exhibited low 
levels of instability, +/-1 repeat when MMR was functional. The observation that MMR 
promotes large deletions over a certain repeat tract threshold suggests at least 2 pathways 
promoting long or short deletions (Schumacher et al., 1997) and the larger the repeat tract the 
greater the chance of the formation of alternative structures which may be edited out as large 
deletions.
When the triplet repeat tract within the plasmid was interrupted with another repeat motif the 
level of deletions observed varied. Interrupted repeat tracts included (GCT)27ACT(GCT)57, 
(GCT)25ACT(GCT) and (GCT)27ACT(GCT)20ACT(GCT)106 as well as a range of pure 
repeats (Parniewski et al., 2000). It was observed that in a strain of E. coli with a functioning 
MMR that larger deletions occurred in disrupted tracts. It is possible that the transition 
between the repeat motifs stalls DNA polymerase function in a manner not observed in pure 
tracts allowing single strands more time to form alternative structures.
It has already been discussed that the mutation of mismatch repair gene products effect the 
stability of microsatellite DNA. In a study of HNPCC cases the majority of patients showing a 
germline mutation in a mismatch repair gene also showed microsatellite instability in their 
tumours (Liu, 1996). Cases of early breast cancer carcinoma showing microsatellite instability 
were examined across the trinucleotide repeat of SBMA, SCA type 1 and DM1. 
Approximately 5% of the tumours under examination exhibited triplet repeat instability, and 
when it was detected, it was present at all three loci. The DM1 locus was found to be the most 
unstable in all the tumours under investigation (Shaw et al., 1996). The differences in the
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stability levels at the different loci suggests there are cis acting factors effecting the degree of 
stability of the repeat DNA. For example quantification of repeat expandability at 10 unstable 
CAG-CTG loci has found that flanking sequence modifiers, in this case the GC content of the 
flanking region, influence the degree of expandability at these loci with identical repeat motifs 
(Brock et al., 1999), while it has already been observed that the purity of the repeat tract 
effects its stability levels (Parniewski et al., 2000).
1.10.2 PMS2
Although there are two MutL complexes, MutLa and MutL(3, it is the MutLa complex which 
has the primary role. This MMR protein complex consists of both MLH1 and PMS2 however, 
examination of the outcome of the loss of either protein on MMR finds them to have an 
unequal effect. For example, examination of the rate of mutation at long and short tracts of 
mononucleotide repeats in murine null homozygotes, Mlhl (-/-) or Pms2 (-/-), observed that 
the mutation rate is 2-3 times higher in Mlhl (-/-) mice. Interestingly comparison of the 
mutator phenotype in Mlhl (-/-) mice with those deficient in Mlhl (-/-) and Pms2 (-/-) found 
there to be little difference (Yao et al., 1999). It was also noticed that the tumours developed 
by Mlhl (-/-) or Pms2 (-/-) mice also differed. Yao et al. (1999) observed that 83 % of the 24 
Mlhl (-/-) mice studied developed intestinal tumours, in contrast, although 95% of the 20 
Pms2 -/- mice examined developed tumours by 6 months they were mostly lymphomas and 
the remainder sarcomas (Qin et al., 1999). These observations, coupled with the knowledge 
that loss of MLH1 along with MSH2 accounts for the majority of MMR mutations in HNPCC 
kindreds and the rarity of PMS2 derived tumours (Prolla et al., 1998) might suggest that PMS2 
has a residual role in MMR and its function in MMR is Mlhl dependent (Qin et al., 1999). In 
fact, inactivation of PMS2 results in different sorts of tumours to its MutLa partner may 
indicate differences in primary function of the proteins. Sterility in male Pms2 (-/-) mice 
where problems were observed with chromosome alignment and pairing indicates a role in 
meiosis (Baker et al., 1995), although sterility was observed in male and female Mlhl (-/-) 
mice (Baker et al., 1996).
Investigation of the mutation frequency at the hypoxanthine-guanine
phosphoribosyltransferase (hprt) locus in the human uterine tumour cell line, HEC-l-A, a cell 
line which produces a truncated human PMS2 protein product, observed the frequency of 
mutations to be around 100 times higher than those observed in cells proficient in wild type
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repair and all of the observed mutations were point mutations. The majority of which 66% 
were +/-1 bp insertion / deletions, occurred at repetitive mononucleotide regions (Kato et al.,
1998). This effect was observed to be in common with that observed at the hprt locus in 
MLH1 deficient tumour cell lines (Ohzeki et al., 1997). However, C->T transitions at a CpG 
site in MLH1 deficient tumour cell lines were observed to be high, this was not the case in the 
HEC-l-A cell line. This reduction in C->T transition at CpG sites was in common with a 
similar observation made in Pms2 (-/-) mice (Narayanan, 1997) suggesting that PMS2 may 
have a role in the repair of the mismatch that results in C-*T transition at CpG sites.
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1.11 Aims and General Strategy
The progressive expansion of the triplet repeat associated with DMPK is associated with 
increasing severity of symptoms observed in DM 1 patients. Although there are several 
hypothesis as to the mechanism of expansion there is little data available about the progression 
of repeat instability within either somatic tissues or germline transmissions.
Several lines have been generated using the Dmt transgene (Monckton et al., 1997) (Figure 
3.2) and initial study of somatic tissues of the Dmt lines has revealed that there is little 
instability in the seven tissues examined in the young mice of the Dmt-B, Dmt-C and Dmt-E 
lines. A small amount of repeat instability, +/- 5 repeats, was observed in the Dmt-D line. 
Maternal and paternal germline instability was however, observed in all four of the lines 
investigated.
The aim of this project was to characterise the Dmt transgenic mice further and examine the 
effect of cis and trans acting modifiers on the repeat. Specifically I have:
• Investigated the level of somatic instability in mature mice and the progression of any 
repeat instability.
• Investigated whether or not the transgenes are transcribed and the effect this may have on 
triplet repeat instability.
• Studied the repeat transmission pattern and how this develops over the lifetime of the 
transmitting parent.
• Investigated the effect a mutated mismatch repair mechanism has on the stability of the 
repeat.
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Chapter 2
Materials and Methods
2.1 Materials
2.1.1 Chemicals and Reagents
Chemicals of molecular biology grade were obtained from Merck Ltd. (BDH Laboratory 
Supplies) and Sigma Chemical Company Ltd.. Reagents obtained from alternative sources are 
mentioned when appropriate.
2.1.2 DNA sources
2.1.2.1 Dmt-D 3111 kidney cell line
Dmt-D 3111 kidney cell line was provided by Mr Mario Pereira, Division of Molecular 
Genetics, University of Glasgow.
2.1.2.2 Mice
The Dmt transgenic mice were generated by Dr Darren Monckton (Monckton et al., 1997) and 
I was given access to archived tissues as well as breeding mice from each line, Dmt-A, -B, -C, 
-D and -E. All Dmt mice were on an FVB/n background. Supplementary FVB/n wild type 
mice were obtained from Harlow, UK, Ltd.
C57/black 6 mice, transgenic for the disrupted murine Pms2 gene (Baker et al., 1995) were 
obtained and bred onto the FVB/n background.
2.1.2.3 DNA markers
All DNA samples that were electrophoresed on agarose gels were measured against Hae III 
digested <(> X I74 DNA and / or Hind. Ill digested X DNA. Lambda and <j) X 174 DNA were 
supplied by New England Biolabs.
When fluorescent labelled PCR products were sized on a 6% acrylamide denaturing gel using 
Genescan® software the size of the product was estimated against either ROX 1000 or ROX 
2500 molecular weight size standard (Applied Biosystems, Perkin Elmer).
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2.1.2.4 Probes
DNA probes used included, DM56, a CTG#CAG repeat PCR product, DM-F / DM-PRENK, a 
non repeat Dmt transgenic PCR product, a 1019 bp fragment from the mouse Usf2 gene, 
amplified with mUSF-A and mUSF-BR, a Dmpk PCR product generated between exon 2 
/exon 4 and PCR products generated with mPMS2-l, mPMS2-2 and mPMS2-3. The probes 
were generated using PCR, resolved on an agarose gel and purified using the Qiagen PCR 
Purification Kit.
2.1.3 Enzymes
Restriction enzymes and their buffers were obtained from Boehringer Mannheim (BM), Life 
Technologies and New England Biolabs. Other enzymes and their source are listed in table 
2 .1.
Enzymes Company
FPLC pure klenow, cloned Pharmacia
Amplitaq Perkin Elmer
Biotaq Bioline
RNasin Promega
Proteinase K Boehringer Mannheim
Superscript™ II Gibco BRL
RQ1 RNase free DNase Promega
Table 2.1 Enzymes and suppliers
2.1.4 Hormones
PMSG, and HCG, were both supplied by Sigma.
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2.1.5 Kits
The kits listed in table 2.2 were used during the project.
Kit Supplier
Bac II, soft tissue extraction kit Nucleon
Qiagen Plasmid DNA Mini prep kit Qiagen
Qiagen Gel Purification Kit Qiagen
Ready-To-Go™ DNA Labelling Beads (- 
dCTP)
Pharmacia Biotech
TOPO TA Cloning® Invitrogen®
Table 2.2 Kits and suppliers
2.1.6 Oligonucleotides
The oligonucleotide primers were supplied by Genosys. The fluorescent oligonucleotides were 
supplied by Oswell. The primer sequences are listed in table 2.3. The locations of Dmt 
transgenic primers are indicated in Figure 2.1.
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nucleotide sequence 5'-3* TM target sequence
CLW2F GAATTCAGGCTTAAGGAGGTCCGA
CTG
61°C Dmpk, exon 2
CLW4R GAATTCGCAAAATGCAGCTGTGTG
ATC
61°C Dmpk, exon 4
DM-BR CGTGGAGGATGGAACACGGAC 68°C Dmt transgene (9)
DM-C AACGGGGCTCGAAGGGTCCT 66°C Dmt transgene (4)
DM-DR CAGGCCTGCAGTTTGCCCATC 68°C Dmt transgene (7)
DM-DRF DM-FAM-linker-
CAGGCCTGCAGTTTGCCCATC
68°C Dmt transgene
DM-DR12 CAGGCCTGCAGT 40°C Dmt transgene (8)
DM-ER AAATGGTCTGTGATCCCCCC 60°C Dmt transgene (6)
DM-GR GCAGGGCGTCATGCACAAGAAA 68°C Dmt transgene (10)
DM-H TCTCCGCCCAGCTCCAGTCC 74°C Dmt transgene (2)
DM-H12 TCTCCGCCCAGC 38°C Dmt transgene (3)
DM-
PRENK
GTCCGGTACCGAATTCCGCTAGCT
CCTCCCAGACCTTC
Dmt transgene (12)
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nucleotide sequence 5'-3' TM target sequence
DM-QR CACTGTGGAGTCCAGAGCTTTG 66°C Dmt transgene (11)
DM-R GTCCTCCGACTCGCTGACAG 68°C Dmt transgene (5)
mDmtD-I CCAACGTTCATTTGCCATTTTTAGA
C
60°C Dmt-D novel sequence
a )
mGDH-A CACTTGAAGGGTGGAGCCAAAC 69°C mouse Gapdh
mGDH-BR TGGGTGGTCCAGGGTTTCTTAC 68°C mouse Gapdh
mP2-l TTCGGTGACAGATTTGTAAATG 61°C mouse Pms2 
(Baker et al., 1995)
mP2-2 TTTACGGAGCCCTGGC 62°C mouse Pms2 deficient 
homozygote 
(Baker et al., 1995)
mP2-3 TCACCATAAAAATAGTTTCCCG 61°C mouse Pms2 
(Baker et al., 1995)
mUSF-A GCCCCTGCCTCACCGTATAG 66°C mouse upstream 
stimulatory factor 2
mUSF-BR CTGGGGTCCACCACTTCAAG 67°C mouse upstream 
stimulatory factor 2
XYT CGAGGGGGATGGTCGACGGAAGC
GACCTTTTTTnTlTTlTTTlT
anneal to poly A 
sequence
(Friedrich et al., 1993)
Table 2.3 Oligonucleotides
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2.1.7 Solutions
Solutions were sterilised by autoclaving at 121 (C for 15 minutes. Filter sterilisation was 
carried out by passing the solution through a Gelman Science 0.2 (M pore filter.
Ampicillin
Stock solution: 50 mg ml'1, store at -20 °C 
Working solution: 50 pg/ ml'1.
Cell lysis buffer
500mM Tris-HCl (pH 9.0), 50mM EDTA, 2.5% SDS (w/v).
Denaturing solution 
1.5M NaCl, 0.5M NaOH.
Depurinating solution 
0.25 M HC1.
DNA Dilution buffer
Stock solutions of 50 X Te and lOpM primer are diluted to a working stock of IX Te and 0.1 
pM oligonucleotide.
5 X DNA loading dye
0.5 % (w/v) SDS, 0.25% (w/v) xylene cyanol, 0.25 % (w/v) bromophenol blue, 1.5% (w/v) 
Ficoll®400, 3 X TBE.
DL-Dithiothreitol (DTT)
Stock solution, 0.1M in H20 (stored at -20°C).
11 X PCR buffer
At 1 X concentration in the final PCR amplification, 45 mM Tris-HCl (pH 8.8), llm M  
ammonium sulphate, 113 pgml^BSA, ImM dATP, ImM dCTP, ImM dGTP, ImM dTTP, 4.4 
pM EDTA, 4.5 mM MgCl2, 6.7 mM 2-mercaptoethanol.
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Low concentration dNTP 11 X PCR buffer
At 1 X concentration in the final PCR amplification, 45 mM Tris-HCl (pH 8.8), llm M  
ammonium sulphate, 113 pgml^BSA, 0.2mM dATP, 0.2mM dCTP, 0.2mM dGTP, 0.2mM 
dTTP, 4.4 pM EDTA, 4.5 mM MgCl2, 6.7 mM 2-mercaptoethanol.
Ethidium bromide 
Stock solution: 10 mgml'1.
Working solution: 200 ngml'1.
Gelatine coated slides
Glass slides were coated in 0.1% gelatine (w/v) in IX PBS and incubated for ~ 3 hours at 37 
°C.
5 X Genescan blue loading dye
Ficoll 400-DL (50 mg ml'1), Dextran sulphate (MW 500,1.7 mg ml'1), Blue dextran (41.5 mg 
ml'1) in 2X TBE. Store at 4 °C.
Genescan mix
1 X Genescan blue loading dye, 27% ROX 2500 or 1000 (v/v) and 63% deionised formamide 
(v/v).
Ipegal CA-630 lysis buffer
0.65 % Ipegal CA-630 (Sigma), 10 mM Tris-HCl pH 7.9,150 mM NaCl, 1.5 mM MgCl2. 
Lysis buffer
50 mM Tris (pH8.0), 100 mM EDTA (pH8.0), 0.5% SDS (w/v), 600 ng(Lxl_1 proteinase K.
Neutralising solution
1.5 M NaCl, 0.5M Tris H-Cl (pH 6.5).
Orange G
0.06 % (w/v) Orange G, 50 % (v/v) glycerol.
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Phenol
Phenol saturated in 10 mM Tris pH 8.0,1 mM EDTA.
Phenol: chloroform : isomavl alcohol. 25 : 24 : 1
Phenol: chloroform : isomayl alcohol, 25 : 24 : 1 saturated in 10 mM Tris pH 8.0,1 mM 
EDTA.
10 X Phosphate buffered saline (PBS)
1.4 M NaCl, 0.027 M KC1, 0.1M Na2HP04, 0.021 M KH2P 04 (pH 7.2 with HC1). 
Phosphate hybridisation solution
Solution A: 14% w/v SDS, 2 mM EDTA; Solution B: 1M NaP04 (4°C). Was mixed A:B, 
50:50, and warmed to 65 °C.
Potassium Hydroxide lysis buffer 
200mM KOH.
Proteinase K
Working stock of 20 mgml'1 in filter sterilised H20.
Proteinase K Lysis buffer
50 mM Tris (pH8.0), 100 mM EDTA (pH8.0), 0.5% SDS, 600 ngpT1 proteinase K.
RNA loading buffer
10 mM NaH2P 04 (pH7.0), 50% (v/v) glycerol, 0.4% (w/v) bromophenol blue.
Sephadex G50 ^Pharmacia Biotech)
Sephadex G50, equilibrated with TE (pH7.6).
10% (w/v) SDS 
10% (w/v) SDS in H20.
20 X SSC
6 M NaCl, 0.6 M Na3C6H507.2H20.
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20 X SSPE
0.2 M NaHP04.2H20 , 3 M NaCl, 0.02 M EDTA (pH 8.0).
Standard cell culture medium
10% Fetal Bovine Serum, 100 Units ml'1 penicillin, 100 [xg1 streptomycin in Dulbecco’s 
modified eagle medium, all supplied by Gibco BRL, Life technologies.
1X TA E
0.04M Trizma base, 0.04M acetic acid, 0.001M EDTA (pH 8.0).
0.5 X TBE
0.045M Trizma base, 0.045 orthoboric acid, 0.001 M EDTA (pH 8.0).
Te
10 mM Tris-HCl (pH 8.0), 0.1 mM EDTA (pH 8.0), and autoclaved.
TE
10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0), and autoclaved.
Tricene buffer
200 mM Tricene in distilled water and autoclaved.
1M Tris (pH 8.01
1M Trizma base and HC1 to pH 8.0.
1M Tris (pH 7.91
1M Trizma base and HC1 to pH 7.9.
Tris-HCl (pH 9.01
1M Trizma base and HC1 to pH 9.0.
Oligo labelling buffer
Oligo labelling buffer was made up to the ratio 2 A: 5 B: 3:C and stored in aliquots at -20 °C.
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Solution A: 1.2 M Tris (pH 8.0), 121 mM MgCl2, 0.48 mM dATP,
0.48 mM dGTP, 0.48M dTTP, 18 pi of 2- |3-mercaptoethanol in a final volume of 1033 pi. 
Solution B: 2 M Hepes, pH6.6 with NaOH (4 °C).
Solution C: Pharmacia Biotech Ultrapure dNTPs set suspended in 0.2 mM EDTA (pH 7.0) to 
an Optical Density of 90 OD units m l1 (-20 °C).
X r g a l
50 mg ml'1 of 5-bromo-4-chloro-3-ondoyl-B-D-galactoside (X-gal) in dimethylformamide. 
Store at -20 °C.
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2.2 Methods
2.2.1 Polymerase chain reaction
All PCR amplifications were carried out in either a Biometra Uno thermal cycler or a 
Biometra T 3 thermal cycler, in either Costar 96 well plates or Anachem thin walled 200 pi 
tubes. Each reaction was overlaid with mineral oil (Sigma) and then sealed. The thermal cycler 
lid was preheated to 105 °C. Every reaction was carried out with either Promega Amplitaq or 
Bioline Biotaq.
2.2.1.1 Polymerase chain reaction conditions
Except where stated otherwise each PCR amplification was carried out in a volume of 7 pi 
with 0.175 units of Taq polymerase in which 11 X PCR buffer had been diluted to 1 X and 
each primer was at a final concentration of lpM. The reactions were cycled under the 
following PCR conditions:
96 °C for 45 seconds,
*°C for 45 seconds,
70 °C for 3 minutes for 30 cycles 
* °C for lminute,
70 °C 10 minutes for 1 cycle, hold at 4 °C.
Where * is the primer annealing temperature.
2.2.2 Agarose gel electrophoresis
Gels of between 0.8 and 3 % were made up with Agarose MP, Boehringer Mannheim and / or 
Nusieve agarose (FMC BioProducts), with either 0.5 X TBE or 1 X TAE and cooled with 
agitation to ~ 50 °C before the gel was poured. Ethidium bromide (EtBr) was either added to 
the gel at a concentration of 200 ngml'1, just before pouring, or used to stain the gel after it had 
been electrophoresed by shaking the gel for ~ 1 hour in distilled water containing EtBr.
Each gel was electrophoresed for between 1 and 16 hours and at between 20 and 300 V. At 
least 1 lane per gel was run with 1.0 pgpl'1 of X Hind III / (j>X174 Hae III marker. The DNA 
samples / marker were visualised using a UV transilluminator (X 260 nm) and photographed 
onto thermal paper (Mitsubishi) using a UVP gel documentation 7500 system.
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2.2.3 Maintenance of mouse colony
2.2.3.1 Mouse tailing
When each mouse was at least 4 weeks old, it was anaesthetised using Fluorothane, Zeneca 
Ltd., (halothane, 100% w/w) a numbered tag placed in its ear, ~ 1cm of tail was removed with 
a sterile scalpel and the tipped tail cauterised. The removed tail was placed in 500 \i\ of 
proteinase K lysis buffer and incubated overnight at 60 °C.
2.2.3.2 Mouse typing and sizing
After overnight incubation each tail was vortexed vigorously and debris pelleted. 1 \i\ of the 
lysate was removed and diluted 1/100 in distilled water, assuming 1 pi of diluted lysate to 
contain ~ 1 ng of DNA. The proteinase K was heat inactivated by incubating the dilution at 95 
°C for 5 minutes. This diluted lysate was used as the template for PCR amplification to 
determine the presence of the transgene. The same diluted lysate was also used as the template 
for transgenic repeat sizing.
2.2.3.3 Phenol / phenol: chloroform extraction of DNA
To purify the DNA from each tissue an equal volume of phenol was added to the tissue lysate, 
mixed thoroughly by vortexing, and centrifuged at 10 000 rpm in a bench top centrifuge. The 
upper layer was removed and placed into a clean tube before adding an equal volume of 
phenol: chloroform : isoamyl alcohol, 25 : 24 :1, vortexing and centrifuging. The upper layer 
was again removed and placed in a clean tube. The phenol: chloroform : isoamyl alcohol 
extraction was repeated if necessary. A volume of 2M sodium acetate 1/10 of the aqueous 
fraction was added and mixed. The DNA was precipitated by adding 7/10 volume of 
isopropanol, mixing and spinning for 5 minutes at 10 000 rpm in a bench top centrifuge. The 
pelleted DNA was washed in 1 ml of 80 % ethanol (v/v), the supernatant removed and the 
pellet air dried for ~ 20 minutes. The pellet was resuspended in an appropriate volume of Te, 
and incubated for 1 hour at 60 °C. To determine the concentration of the DNA it was diluted 
1/ 80 in distilled water to a final volume of 400 |il and the absorbance of the DNA at X 260 nm 
measured. The concentration of the DNA was determined by taking into account the dilution 
factor and that 50 mgml'1 of DNA gives an absorbance of 1 at X 260nm. Alternatively the 
DNA concentration was determined from an agarose gel. A known volume of DNA was 
electrophoresed on an agarose gel against a DNA marker of known concentration. A 
photograph was taken and scanned into Adobe Photoshop. The concentration of the unknown
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DNA was determined from this image using the Kodak 1 dimension programme. All DNA 
was stored at -20 °C.
2.2.3.4 PCR product transfer by “squash blotting”
After the gel had been visualised using the transilluminator it was cut to an appropriate size 
including markers and rinsed in distilled water. The gel was then shaken at 100 rpm in a series 
of solutions, with thorough rinsing in distilled water between each stage. Firstly depurinating 
solution was added for not more than 10 minutes, followed by 30 minutes in denaturing 
solution and 30 minutes in neutralising solution. The gel was placed onto two pieces of 
Whatman 3 MM chromatography paper soaked in neutralising solution cut to the size of the 
gel. A piece of nylon transfer membrane pre soaked in distilled water followed by neutralising 
solution was placed on top of the gel and all bubbles and creases removed. Membrane for the 
transfer of DNA was either Hybond-N nylon DNA transfer membrane obtained from 
Amersham International PLC or Magna nylon membrane obtained from Micron Separations 
Inc through GSI. Two further layers of neutralising solution soaked Whatman were placed on 
top followed by paper towels, a glass plate and a weight. After transfer of between 3 and 16 
hours the blot was disassembled and the membrane baked at 60 °C for 40 minutes before 
exposure for 30 seconds to UV. The filter could then be stored indefinitely between dry 
Whatman paper.
2.2.3.5 Southern hybridisation of squash blot transfer filters
Each filter was soaked in distilled water before being transferred into a hybridisation tube. The 
phosphate based hybridisation solution was prewarmed to 65 °C before adding 5 mis to each 
hybridisation tube and incubating the filter at 65 °C in a Biometra OV 5 hybridisation oven. 
The buffer was changed after 20 minutes and this was repeated once more before the 
appropriate probe was added. The filters were incubated with the probe overnight before 
rinsing with wash solution, twice in the hybridisation oven and once flat in a shaking tray. 
Each wash was for 20 minutes. The membranes were then exposed to X-ray film supplied by 
Konica and developed using a X-Ograph Compact X2, (X-Ograph Ltd).
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2.2.4 Labelling probes for Southern hybridisation
2.2.4.1 Labelling probes for Southern hybridisation with oligo labelling buffer
40 ng of probe of interest and 2 ng of X Hind III / (j)X174 Hae III marker were made up to 20 
i^l in distilled water boiled for 2 minutes and cooled on ice. 6 pi of OLB, 1.2 pi of BSA, and 
25 pCi of [ a P 32] dCTP, (3000 Ci/nmol), (ICN or Amersham) and 1 unit of Klenow were then 
added before incubating at 37 °C for at least 1 hour.
2.2.4.2 Labelling probes for Southern hybridisation with Pharmacia Biotech Ready-To- 
Go™ DNA Labelling Beads (-dCTP)
20 ng of probe of interest and 2 ng of X Hind III / (j)X174 Hae III marker were made up to 20 
pi in distilled water, boiled for 2 minutes and cooled on ice. A Pharmacia Biotech Ready-To- 
Go™ DNA Labelling Bead (-dCTP) was resuspended in 10 pi of distilled water before the 
precooled probe was added. To this mixture 50 pCi of [aP 32]dCTP was added, mixed and the 
reaction incubated at 37 °C for at least 30 minutes for a triplet repeat template and less than 30 
minutes for a simple template.
2.2.4.3 Clean up of labelled oligo by a Sephadex® G50 spin column
The reaction was made up to 200 pi with distilled water before passing through a Sephadex ® 
G50 spin column. The probe was boiled for 5 minutes before adding to the prehybridised 
filters.
2.2.4.4 Clean up of labelled probe by precipitation
Unincorporated radioactivity and dNTP’s were removed from the labelled probe by 
precipitation. 30 pi of 2M Na Ac, 90 mg of salmon sperm DNA, (Sigma) and 140 pi of 
distilled water were added and mixed before adding 500 pi of 100% ethanol. The DNA was 
pelleted by briefly centrifuging in a bench top microfuge. The supernatant was removed and 
the pellet washed with 1 ml of 80% (v/v) ethanol. Again, the supernatant was removed and the 
pellet resuspended in 150 pi of distilled water. The probe boiled for 5 minutes before adding 
to the prehybridised filters.
2.2.5 Mouse dissection
2.2.5.1 Removal of blood from mouse
Immediately after sacrifice, a 23 gauge needle was placed into the thoracic cavity and blood 
removed into a syringe. This blood was quickly transferred into a 1.5ml tube containing 500 pi
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IX SCC, 10 mM EDTA and mixed thoroughly to prevent clotting. The blood was frozen 
overnight, thawed and the white cell nuclei pelleted by centrifugation. The supernatant was 
decanted off and the white cell nuclei resuspended and washed in 1 ml of 1 X SSC. 
Resuspension of the pellet was achieved by vortexing. The rinsed nuclei were again pelleted 
and the supernatant removed. The pellet was resuspended in 100 pi of proteinase K lysis 
buffer and was incubated overnight at 60 °C. The DNA was then extracted by the phenol / 
phenol chloroform method.
2.2.5.2 Treatment of tissues removed from mouse
The tail, muscle, testes / ovary, uterus, colon, kidney, spleen, liver, diaphragm, lung, heart, 
tongue, brain and eyes, were dissected out, diced where necessary and placed in 500 pi of 
proteinase K lysis buffer. “Dirty” tissues such as the colon were “washed” in 1 X SSC and 
any “matter” removed before lysis. Dilutions were made from each proteinase K tissue lysate, 
assuming that 1 pi of the lysate contained ~ 1 ng of DNA. Serial dilutions of 1/10 (~ 1000 
pgpl'1), 1/100 (~ 100 pgpl'1), 1/1000 (~ 10 pgpl'1) were carried out in filter sterilised water or 
dilution buffer containing 0.1 pM DM-H. lp l of the 1/10 and 1/1000 serial dilutions was used 
as templates for small pool PCR. Alternatively DNA was purified from 250 pi of the 
proteinase K lysate and the concentration estimated by spectrophotometry. The DNA was 
diluted to 1200 pgpl'1, 120 pgpl'1, 12 pgpl'1 in dilution buffer containing 0.1 pM DM-H. The 
1200 pgpl"1 and 12 pgpl'1 concentrations were used as templates for tissue comparison using 
small pool PCR. A master mix containing everything except the appropriate DNA was 
dispensed into a 96 well plate. The DNA under investigation was added to the mastermix at an 
appropriate concentration. A small pool PCR amplification was carried out in duplicate for 
each tissue at each concentration for each mouse. The amplifications for each mouse at a 
specific concentration were resolved on the same gel, this made the detection of subtle 
differences in stability possible. Water was added in duplicate to the stock master mix to 
identify external contaminants.
2.2.5.3. Preparation of sperm
The vas deferens was removed and placed in a petri dish and covered in several microlitres of 
1 X SSC. One end was held firm using forceps and using curved forceps sperm squeezed out 
of the vas deferens. Alternatively, the plugged uterus of a wild type mouse, set up in a mating 
with the male mouse of interest was removed after sacrifice and placed into a petri dish
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containing 1 X SSC. The sperm was flushed out using 1 X SSC. The sperm / IX SSC 
suspension was placed into a fresh microfuge tube. DNA was prepared from the sperm using 
the Nucleon Bac II kit and a protocol scaled down for a starting volume of 200 pi of sperm 
suspension.
2.2.5.4 Super ovulation of mice for the isolation of single oocytes
All of the injections and isolation of the ova were carried out by Mr Tony McDermott of the 
University of Glasgow Biological Services. Each injection was carried out intraperitoneally. 
Day one, each female mouse was injected with 5 units of PMSG.
Day three, (+47 hours after injection 1) 5 units of HCG were injected and the mouse mated 
with a vasectomised male overnight.
Day four, plugged females were sacrificed the oviduct removed and individual ova flushed out 
into M2 media.
2.2.6 Preparation of DNA for small pool PCR analysis
Small Pool PCR is a sensitive technique which is based on the principle of diluting known 
concentrations of DNA into “small pools” to be used as template for PCR. Thus small 
numbers or known numbers of molecules can be amplified and visualised. Its sensitivity 
makes it vulnerable to contamination and all stages of small pool PCR were carried out in a 
laminar flow hood, using filter tips and dedicated equipment. The lower concentration 
dilutions are diluted as appropriate on the day of amplification to ensure amplification of the 
required concentration.
2.2.6.1 Preparation of DNA for small pool PCR analysis by extraction with phenol
After overnight incubation in proteinase K lysis buffer the lysed tissue was vortexed 
vigorously before debris was pelleted. 250 pi of lysate was removed and DNA extracted by 
phenol, phenol / chloroform extraction. lpg  of DNA was digested for 1 hour with 1 unit of 
Hind. Ill, ImM spermidine in a final volume of 200 pi, the reaction was incubated at 37 °C. 
The DNA was diluted to 1200 pgpl'1, 120 pgpl’1, 12 pgpl'1 in dilution buffer containing 0.1 pM 
DM-H.
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2.2.7 Preparation and manipulation of RNA
To determine whether the Dmt transgenes were transcribed, RNA was isolated from several 
tissues from each line. RNA is vulnerable to degradation from nucleases, to optimise the 
successful handling of RNA, the following precautions were taken. The restriction of RNA 
work to a dedicated bench, the use of dedicated equipment and stock reagents wherever 
possible and the wearing gloves at all times. All solutions required for RNA related techniques 
were made using DEPC treated water. DEPC was added to a concentration 0.1 % (v/v) to 
distilled water, mixed and allowed to stand overnight before the inactivation of the DEPC by 
autoclaving. All plasticware was soaked in active DEPC water before autoclaving, all 
glassware soaked in active DEPC water before baking. Each tissue was snap frozen in N (1) 
immediately after sacrifice and stored at -70 °C to minimise the action of RNases.
2.2.7.1 Extraction of RNA
When preparing RNA, tissue of known mass was defrosted on ice in a bijou before the 
addition of a minimum of 1ml of TRI REAGENT™(Sigma) per mg. The tissue was 
homogenised using a sterile 0.5mm Polytron probe with a Polytron Kinematica AG PT-3000 
homogeniser and the RNA prepared according to the TRI REAGENT™ protocol. The pelleted 
RNA was dissolved in 75 pi of DEPC treated water and incubated at 65°C for ~ 20 minutes.
To this 15 pi of RQ1, RNase free DNase (Promega, 1 unit pi'1) and 10 pi of 10 X buffer was 
added. This was incubated at 37 °C for 30 minutes before being made up to 400 pi with DEPC 
water and extracted with an equal volume of phenol: chloroform: isoamyl alcohol (25: 24: 1) 
vortexed and centrifuged at maximum speed for 5 minutes. The upper layer was removed and 
precipitated with 40 pi of 2M sodium acetate and 280 pi isopropanol and precipitated at 13 
000 rpm in a bench top centrifuge, for 5 minutes. The pellet was rinsed in 80% ethanol and air 
dried for not more than 30 minutes before being resuspended in DEPC water. The RNA 
concentration was determined by spectrophotometer by diluting 1/ 80 in distilled water to a 
final volume of 400 pi where the absorbance of the RNA at X 260 nm was measured. The 
concentration of the RNA was determined by taking into account the dilution factor and that 
40 mgml'1 of RNA gives an absorbance of 1 at X 260nm.
2.2.7.2 First Strand cDNA synthesis
Between 0.5 -  1 mM of oligonucleotides were added to 2.5 pg of total RNA and made up to a 
final volume of 9.5 pi with DEPC water for the reverse transcriptase positive (RT+) reaction.
A no reverse transcriptase (RT-) control was made up to a final volume of 11.5 pi. The tubes
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were then heated at 70 °C for 10 minutes, centrifuged briefly and placed on ice. 20 units of 
RNAsin (Promega), 10 pM of DTT, lpM  of dNTP’s and Superscript I I 5 X buffer were then 
added, to a final volume of 18 pi (RT+), 20 pi for the (RT-). Each sample was mixed and 
incubated at 42 °C for 2 minutes before 2 pi, 400 units of Superscript II reverse transcriptase 
was added to the (RT+) tubes only. The tubes were incubated 42 °C for a further 90 minutes. 
The reaction was heat inactivated by heating at 70 °C for 15 minutes. 10 pi of DEPC water 
was added to each reaction before storing the cDNA at - 70 °C.
2.2.7.3 Separation of cytoplasmic and nucleic cell fractions
This protocol was modified from Hamshere et al., (1997), 3 X 106 cells from the Dmt-D 3111 
kidney cell line, were washed in 1 X PBS and transferred into a 1.5 ml tube before the cells 
were pelleted in a bench top centrifuge. The supernatant was removed and the cells 
resuspended in 1ml of cell lysis buffer. The nuclei of the lysed cells were pelleted in a bench 
top centrifuge and 800 pi of the supernatant removed. This cytoplasmic fraction was 
transferred into a fresh tube. The remainder of the supernatant was removed from the pelleted 
nuclei and discarded. The nuclear fraction was resuspended in 400 pi of water. 100 pi of 
Ipegal CA-630 lysis buffer was added to the nuclear fraction and 200 pi to the nuclear 
fraction. RNA was then extracted from these fractions following the TRI REAGENT™ 
protocol and DNase treated.
2.2.7 Cloning and sequencing of PCR products
PCR products of interest were gel purified using the Qiagen PCR Purification Kit and 
cloned into the pCR®2.1-TOPO vector using the TOPO TA Cloning kit™ as described in the 
kit’s protocol. The vector was transformed into F Escherichia coli TOP 10 bacterial strain, 
with the genotype mcrA, A (mrr-hsdRMS- mcrBC), 080 lac ZAM15 Mac X74 recAl deoK 
ara D139 A (ara, leu) 7697 gal U galK rpsL (Str R) endAl nupG.
Between 50-100 pi of transformed cell / SOC medium (Invitrogen®) mix was spread onto LB 
plates containing 50 pg/ml ampicillin and previously spread with 40 mg/ml of X-gal. The 
resulting white colonies were grown up overnight in LB medium containing 50 pg/ml 
ampicillin and purified using the Qiagen Plasmid DNA Mini Prep Kit.
The Molecular Biology Support Unit performed DNA sequencing on either an ABI373A 
sequencer or an ABI 377 sequencer, at the University of Glasgow. Reactions were carried out 
as stated in the ABI PRISM™ Dye Terminator Cycle Sequencing Ready Reaction Kit 
protocol.
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Chapter 3
Somatic instability in the Dmt transgenic lines
3.1 Introduction
The expanded triplet repeat of DM1 patients accumulates somatic mosaicism over time (Wong 
et al., 1995), the observed large expansions from the progenitor allele are apparently the 
consequence of multiple mutations over time giving rise to small length changes (Monckton et 
al., 1995) the majority of which are expansion biased (Martorell et al., 1998).
The mechanism of expansion is not known. It has been surmised that as a cell replicates the 
repeat tract could form alternative structures or “loop outs” which depending on the strand and 
the interpretation of the alternative structure by the mismatch repair complex might lead to 
expansions or deletions in the repeat tract (Figure 3.1). However, in older individuals it has 
been observed that the most severely affected tissue, the skeletal muscle, has acquired more 
increases in repeat length than that observed in blood (leukocytes) (Anvret et al., 1993; 
Ashizawa et al., 1993). This confounds the notion that the degree to which a cell replicates is 
the major mechanism of repeat expansion as the analysed blood DNA is derived from 
leukocytes, a cell population which is completely renewed over a matter of months. Cells are 
added to the skeletal muscle at a much slower rate, as the muscle develops and grows.
Our knowledge about the degree to which different tissues are unstable and how their 
instability levels relate to each other are limited. However, there appears to be a consensus that 
the smallest level of instability is observed in blood, with heart and kidney as well as muscle 
displaying the largest expansions (Jansen et al., 1994; Joseph et al., 1997; Lavedan et al., 
1993a; Tachi et al., 1995a; Tachi et al., 1993; Wohrle et al., 1995; Wong et al., 1995). 
Furthermore the limited data that is available about the degree of instability has been studied 
in a variety of ways. In the most common, digested genomic DNA is resolved on an agarose 
gel and transferred to a nylon membrane before the repeat was detected with suitable probe by 
Southern hybridisation, repeat instability was indicated by the diffuse nature of the hybridised 
band of the repeat DNA (Jansen et al., 1994; Joseph et al., 1997; Lavedan et al., 1993a; Tachi 
et al., 1995a; Tachi et al., 1993; Wohrle et al., 1995), although use of a more sensitive method 
of instability detection, small pool PCR is becoming more common
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Model for triplet repeat expansion
Thick solid lines indicate the repeat regions, thinner lines correspond to the random sequence 
flanking DNA. N represents nucleotide T or G and N1 represent nucleotide A or C. Pos and neg. 
refer to positive and negative supercoiling respectively. Figure taken from Gellibolian et al. (19
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(Martorell et al., 1998; Wong et al., 1995), as is displaying instability profiles using Genescan 
software® (Mangiarini etal., 1997; Sato et al., 1999; Wheeler et al., 1999).
The study of mosaicism within DM1 is further confounded by the limits in the amount and 
nature of the tissues available, as well as the degree to which the disease has progressed within 
an individual. When a mature person is diagnosed after the onset of DM1 the progenitor repeat 
size of the disease range allele can only be surmised. Alternatively, might there be a 
mechanism affecting stability that is present only in certain tissue types? If multiple tissues 
were available for analysis might a pattern emerge which correlated with the affected tissues 
or that might suggest part of the instability process? Could the detection of such a pattern be 
restricted both by the limited range of tissues available, but also the diverse genetic 
backgrounds that the patients present? The advantage of a murine model for instability would 
be access to unlimited tissue of known progenitor size on a uniform genetic background.
The Dmt transgenic lines were generated to contain the Dmt 162 transgene (Figure 3.2) to 
provide a murine model for expanded triplet repeats which would allow investigation of the 
mechanisms of repeat instability. The repeat tract is asymmetrically flanked by only a small 
amount of non-coding DNA, 133bp on the 5’ side and 609 bp on the 3’ side. It contains no 
known promoter elements. This would suggest that the flanking transgenic DNA would have 
little effect on the repeat instability. Therefore the integration site of the transgene could 
instead account for any variation in stability levels between the almost identical transgenic 
lines. The Dmt mice provide access to all tissue types and a record of the progenitor repeat 
allele size is available. The size of the repeat of a tail sample taken from each mouse shortly 
after weaning at ~ 6 weeks was taken to be the progenitor repeat size. The investigation in the 
first instance was the level of somatic mosaicism in the Dmt lines. Of the five lines generated, 
Dmt-A was found to contain multiple copies of the transgenes and analysis of the somatic 
mosaicism in this line would be confusing. The other four lines Dmt-B, Dmt-C, Dmt-D and 
Dmt-E (Figure 3.2) are the result of simpler integrations and have been investigated. An initial 
study of somatic instability in young Dmt mice revealed little instability in most of the seven 
tissues examined. Dmt-D did exhibit a little expansion biased instability, although this was not 
greater than +/- 5 repeats (Monckton et al., 1997).
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D M W D 3 ’ untranslated region of DMPK SIX 5
D m t 162 transgene C T G (l6 2 l
133 bp 609bp
D m t -B n ( T G ( U G Transgene undergone deletion. Possible 
chromosomal rearrangement
D m t -C I -]<;,] '-4 )| | ( T G ( 1 6 l J Integration site unknown
D m t -D | Bj CTG(161 Integrated into uncharacterised region of
  chromosme 11, syntenic to human chromosome 17
D m t -E |C T G (1 6 2 Integrated into LINE-1 repetitive element
Figure 3.2 D m t transgene and integrants (Monckton et al 1997)
Schematic representation of the D m t transgene and the resulting integrants. The repeat size 
indicated for each integrant represents the repeat size of the founder mouse for each line
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When the work encompassed in this chapter began little was known about the integration sites 
of the Dmt lines (Figure 3.2). An investigation into the integration sites of Dmt-D and Dmt-E 
was carried out by Dr Graham Brock of the University of Glasgow in parallel with my work. 
Dmt-D was found to have integrated into an uncharacterised region of chromosome 11, 
syntenic to human chromosome 17, while Dmt-E has integrated into a LINE-1 repetitive 
element. The aim of this chapter was to determine whether a murine model, with its short 
lifespan could be used:
1 to study a disease with a progressive component;
2 to establish the level of repeat stability in mature mice across a range of tissues in each 
of the lines; and
3 to establish whether the Dmt lines would be a suitable model with which to study the 
mechanisms and patterns of repeat expansion.
3.2 Identification of transgenic mice
The mice were bred on a FVB/n background. Each mating was set up between a parent 
hemizygous for the transgene Dmt (+/-) while the other was wild type (-/-). This meant that all 
of the mice examined in this part of the study were hemizygous for the transgene. The 
transgenic mice were identified from each litter by using transgene specific primers to amplify 
transgenic products. A 7 pi PCR reaction containing 1 pi of tail dilution ~ 1 ng of DNA, 1 X 
PCR buffer, 0.35 units of Taq polymerase and 1 pM of mouse typing mix 1 oligonucleotide 
primers (MTM-1) was set up. MTM-1 consists of the following primer pairs, mUSF-A and 
mUSF-BR which amplify a 1019 bp fragment from the mouse Usf2 gene, DM-R and DM-QR 
which amplify a 175 bp none repetitive region of the transgene and DM-C and DM-ER which 
amplify across the transgenic repeat. The mouse Usf2 gene PCR product was expected to be 
present in every successful PCR amplification irrespective of the presence of the transgene. 
Any MTM-1 reactions that did not result in a Usf2 product were repeated. The presence of the 
non repetitive transgenic product and not the product including the repeat might indicate that 
the repeat was too large for the Taq polymerase to amplify. No case of this was observed 
during this study. Each primer in the stock MTM-1 was at a concentration of 10 p,M. The 
transgenic typing PCR amplifications were cycled 30 times under the standard conditions with 
an annealing temperature of 63 °C. The samples were then electrophoresed on a 1.4 % agarose 
gel (w/v) in 0.5 X TBE. Photographs were taken (Figure 3.3.A) and the PCR products 
transferred by squash blot to a nylon membrane before hybridisation with a CTG*CAG repeat 
probe, DM 56 (Figure 3.3.B).
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Identification of Dmt transgenic mice
PCR amplification to detect presence of the transgene by amplifying 1 pel of tail lysate 
(~ 1 ng of DNA) in a l \ i\  volume containing l|aM  of MTM primer mix in the final 
volume. MTM primer mix consists of mUSF-A and mUSF-BR, which amplify a 1019 
bp fragment in all mice, DM-R and DM-QR which amplify a non-repeat region of the 
transgene and DM-C and DM-ER which amplify across the transgenic repeat, this will 
result in a product around ~515bp, but this band will vary in size according to the repeat 
that the mouse carries.
A: MTM PCR products were resolved on a 1.4 % agarose gel before being B: transferred 
onto a nylon membrane and hybridised with DM56. This CAG*CTG repeat probe will 
hybridise with the DM-C / DM-ER product only.
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3.3 Examination of triplet repeat instability using small pool PCR
Small pool PCR is a technique whereby template DNA is diluted to known concentrations. 
This can result in the DNA template containing as little as an average of one molecule. This 
technique is therefore very sensitive as it can allow the amplification of individual molecules 
and an accurate estimation of the size of that molecule. When this is applied to microsatellite 
regions, the level of instability of a known allele can be monitored. Each SP-PCR 
amplification was cycled in a 7 pi reaction containing 1 X buffer, and 0.2 pM each of the 
forward and reverse primer, 0.175 units of Taq polymerase and between 5 and 1000 pg of 
template DNA. The samples were cycled 28 times under standard PCR conditions with a 
suitable annealing temperature. Each SP-PCR amplification was made up to 10 pi with DNA 
loading dye before 5 pi of this sample was resolved on an agarose gel.
3.3.1 Optimal conditions for small pool PCR agarose gel electrophoresis
To ensure comparison of repeat alleles that may vary by as little as +/-1 or 2 repeats could be 
achieved the PCR products were resolved on an agarose gel 40 cm in length. Low 
concentrations of template DNA means that the PCR product of a small pool PCR 
amplification was routinely not visible on the agarose gel. Therefore to visualise each small 
pool PCR amplification the DNA products were transferred onto a nylon membrane using the 
squash blot method of transfer and hybridised using the triplet repeat probe DM56. The repeat 
size was routinely estimated for each distinct molecule by sizing against the DNA marker. As 
estimation of the repeat size was reliant on this comparison the gel running conditions were 
optimised to ensure that each of the small pool PCR reactions and the markers progressed 
through the agarose gel at a steady rate relative to each other. Initially SP-PCR products were 
resolved on 1.5% agarose gels (w/v) in 0.5 X TBE at room temperature at 200V for 5 minutes 
followed by 130V O/N ( -1 6  hours) at room temperature. These gels were found to “smile”, 
that is the samples and markers did not resolve in a uniform manner (Figure 3.4.A). This was 
possibly due to the gel overheating during electrophoresis. All further SP-PCR electrophoresis 
was carried out at 4 °C and this improved the quality of the gels (Figure 3.4.B). Further 
improvements in the resolution of SP-PCR products were achieved by reducing the agarose 
gel percentage to 1.25% (w/v) in 0.5 X TAE and equilibrating the gel in 0.5 X TAE for -1 
hour before loading the samples (Figure 3.4.C, D and E). The optimal gel running conditions 
were determined to be a 1.25 % agarose gel (w/v), initial voltage was 300V for 15 minutes 
followed by 185 V for -16 hours at 4 °C.
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Figure 3.4 Small pool PCR products resolved using a selection of conditions
A The tail DNA of a D mt-D mouse, mosaic for the transgenewas amplified using DM-H /DM-BR.This 
primer pair combination resulted in a secondary PCR product, ~ 90 repeats, which appeared to shadow 
the 161 repeat product pattern. It exhibits 2 transgenic repeat sizes of 161 and 110 repeats. It was assumed 
that this mouse was mosaic for both repeat sizes and that this mosaicism occured during embryonic 
development. Only the 161 repeat was transmitted to the offspring. The template DNA is at 3 different 
concentrations. The SP-PCR amplifications were resolved on a 1.5 % gel, at 200V for -1 6  hours at room 
temperature.
B. Duplicate SP-PCR amplifications were carried out on a selection of tissues from a 13 month old Dmt- 
D mouse w ithl61 repeats using DM-H /DM-BR. Approximately lOOOpg of DNA was present in each 
reaction. The tissues from left to right are: spleen, blood, sk. muscle, lung, heart, kidney, marker, brain, 
colon, eye, diaphragm, tongue, mature tail and weaned tail.
The spurious secondary product can be seen as well as expected product. The SP-PCR amplifications 
were resolved on a 1.5 % gel, at 300V for -1 6  hours at 4°C. The tissues are in the same order as B.
C. Duplicate SP-PCR amplifications were carried out on a selection of tissues from a 6 month old Dmt- 
D mouse using DM-H /DM-DR. Approximately lOOOpg of DNA was present in each reaction. The SP- 
PCR amplifications were resolved on a 1.25 % gel, at 130V for -1 6  hours at 4°C.
D. SP-PCR was carried out on -100 molecules of lung DNA from a male mouse with 176 repeats. The 
SP-PCR amplifications were resolved on a 1.25 % gel, at 130V for -1 6  hours 4°C.
E.SP-PCR was carried out on -1 0  molecules of kidney DNA from a male mouse with 160 repeats. The 
SP-PCR amplifications were resolved on a 1.25 % gel, at 130V for -1 6  hours at 4°C.
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3.3.2 Choice and primer pair for small pool PCR amplification
The sensitivity of the small pool PCR technique for amplification from a template which may 
contain only 1 cells worth of DNA is reliant on the oligonucleotide primer pair chosen to 
amplify across the transgenic repeat resulting in a single band. When DM-H and DM-BR were 
used to amplify SP-PCR products it resulted in multiple PCR bands. The hybridisation of 
these bands with the DM56 probe confirms that these bands are transgenic in origin. It became 
apparent that one molecule could result in more than one transgenic band. As we wished to 
quantify the level of repeat stability this result would distort the resulting data. However, 
observation of the bands suggested a degree of shadowing occurring and suggested that one 
template molecule was producing a product of the expected size and also a smaller secondary 
(possibly single stranded) product (Figure 3.4.A and B). Whilst the template DNA was stable 
this shadowing effect had little influence on the interpretation of the results. However, when 
the molecules under examination are exhibiting instability there is a possibility that the true 
repeat product and its unstable shadow might confound the results (Figure 3.4.B). Alternative 
transgenic repeat spanning combinations were tried to determine the optimal SP-PCR 
combination. DM-H and DM-DR were found to result in a single product band for each 
molecule amplified (Figure 3.4.C, D and E).
It was suggested that the stringency of the small pool PCR reaction would be improved if the 
transgenic primers were further away from the repeat. In the case of Dmt-D, novel sequence 
was available on the 5’ side (133bp) of the Dmt transgene (Figure 2.1). The efficiency of a 
primer, mDmtD-I, using this novel sequence was also examined (Figure 3.5).
Each PCR reaction was carried out in a 7 pi volume that contained, ~ lng of DNA, 1 X buffer, 
the forward and reverse primers under test at a lpM concentration and 0.175 units of Taq. The 
PCR amplifications were cycled 30 times under standard conditions using the stated 
temperature. The PCR products were resolved on a 1.5% agarose gel (w/v) and photographed. 
The mDmtD-I and DM-BR primer combination produced no bands at all at annealing 
temperatures of 60, 62 and 64°C when mDmtD-I was combined with either DM-ER, DM-GR 
or DM-QR multiple bands occurred at 60, 62 and 64°C and increasing the annealing 
temperature to 66 and 68°C resulted in the loss of all bands. The combination of mDmtD-I 
with DM-DR also resulted in multiple bands at 60, 62 and 64°C as well as 66 and 68°C. 
Increasing the annealing temperature to 70, 72 and 74°C resulted in the loss of all bands. It 
should be noted that although not all of the bands would result in multiple misleading PCR 
products of transgenic origin, they would decrease the efficiency of the transgenic product 
reaction which can rely on template DNA from a single molecule. It was concluded that the 
most efficient primer pair to use to amplify across the transgenic repeat would be DM-H and 
DR at 68 °C. An advantage to this primer combinations is that their transgenic nature meant
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Figure 3.5
Combinations of oligonucleotide primers at a selection of temperatures
Each PCR amplification was carried out in a 7 pi volume that contained, ~ lng  of DNA, 1 X buffer, 
the forward and reverse primers under test at a lpM  concentration and 0.175 units of Taq. The PCR 
reactions were cycled 30 times under standard conditions using the stated temperature. The amplified 
template DNA had a repeat size of 162. The DM-H / DM-BR oligonucleotide primer combination 
produces an 829 bp product, DM-H / DM-DR a 674 bp product, Dmt-DI / DM-BR a 749 bp product, 
Dmt-DI / DM-DR a 754 bp product, Dmt-DI / DM-ER a 700 bp product, Dmt-DI / DM-GR an 852 
bp product and Dmt-DI / DM-QR an 1187 bp product. Each PCR product was resolved on a 1.5% 
agarose gel (w/v) and photographed.
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that the same pair could be used to study all 4 lines.
It was determined that the PCR product of an amplification with DM-H / DM-DR would be 
around 670 bp in size. As the majority of the SP-PCR products resolved on the agarose gels 
were not visible until after hybridisation, the 603 bp band of the cj) X I74 Hae III digested 
marker was used as a guide to the location of the SP-PCR products. 10 cm of the gel above 
and below this band was transferred on to a nylon membrane in the first instance. This would 
encompass the gel between the 271 band and the 1353 band. Again assuming the PCR product 
to be 670 bp in size these boundaries would allow deletions of up to 133 repeats and 
expansions beyond 230 repeats to be visualised. If a particular tissue appeared to be unstable 
beyond this 10cm limit then this limit was modified appropriately.
3.3.3 Choice and preparation of tissues
Tissues were chosen for a selection of reasons. This included tissues known to be affected in 
DM1 patients, including the eye and brain as well as a selection of muscles. The nature of the 
cells that made up a tissue type was also taken into account. Autoradiography has 
been used to examine the rate of cell proliferation and cell migration (Messier and Leblond, 
1960) by examining the uptake and migration of radiolabelled precursors. The pattern of the 
incorporation of the radiolabel into the nuclei and its subsequent dispersal was collated and 
used to classify the cell populations. They were categorised into three groups, these include:
Static; no radiolabelled nuclei were observed in such a population, indicating no change in the 
cell population.
Expanding; a small number of radiolabelled nuclei appear. These appear to be incorporated 
permanently into the cell population. This group includes all muscle cells and most connective 
tissues.
Renewing; a large number of radiolabelled nuclei appear and subsequently decrease, 
indicating cell loss. Such cells are being constantly replaced. These include cells found in the 
blood.
The tissues that were investigated and the reasons for that choice are summarised in table 3.1. 
Small pool PCR products were consistently amplified for all of the tissues under examination 
with the exception of blood. Although the preparation method included steps to remove the 
haem group from the pelleted leukocytes before they were lysed, it is possible that this was not 
always the case and the presence of haem within the leukocyte DNA could be inhibiting the
67
tissue reason for choice cell population (Messier 
and Leblond, 1960)
blood, spleen Source of leukocytes; leukocytes 
are the most easily assessable 
tissue obtained from all patients
Leukocytes; renewing.
Quadriceps femoris 
(skeletal muscle)*, heart*,
colon*, diaphragm, tongue
DM1 is the only muscular 
dystrophy that affects non 
skeletal muscles
All muscle cells; 
expanding. Tongue / colon 
epithelium; renewing.
eye* A common initial symptom in 
DM1 pedigrees is the 
development of cataracts
Retinal cells; static. Lens 
epithelial; expanding. 
Corneal epithelial; 
renewing.
brain* Congenital DM1 patients exhibit 
mental retardation; many 
CAG*CTG tract disorders 
exhibit neurodegeneration
Neurones; static. Glial; 
expanding.
kidney Observed to be unstable in other 
triplet repeat models
Glomoreli, proximal and 
distal tubules; renewing.
liver Observed to be unstable in other 
triplet repeat models
Parenchymal and littoral 
cells; expanding
lung An example of a high turnover 
tissue
All cells renewing
tail Weaned tail used to define 
progenitor repeat size
Table 3.1 Summary of none tail tissues examined in investigation of somatic instability. 
^Tissues effected in DM1 patients.
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PCR amplification. However, the when the instability pattern of blood was present it was 
found to echo that of the spleen which also has a large leukocyte population. The spleen was 
consistently amplified and it was assumed that this tissue exhibited the behaviour of the repeat 
in the leukocyte. The tissues examined included tail DNA taken from each mouse shortly after 
weaning at ~ 6 weeks. The transgenic repeat size of weaned tail was taken to be the 
progenitor repeat size. A sample of this progenitor allele DNA was resolved on the same gel 
as the tissues taken after sacrifice again making subtle changes in repeat length detectable. 
Each tissue sample that was studied using small pool PCR was amplified at least 2 different 
concentrations, at approximately 1 molecule per reaction and around 100 molecules per 
reactions. The repeat profile of the lower concentration reaction always fell within the profile 
of the higher concentration reaction for the same sample.
3.4 Somatic mosaicism in Dmt mice
3.4.1 Somatic mosaicism in mature Dmt 162 transgenic mice
It is known that the unstable repeat of the disease allele expands over the lifetime of a DM1 
patient (Wong et al., 1995). The effect that the age of the mouse has on the transgenic repeat 
in the different tissues was initially investigated in 20 month old mice in Dmt-B, -C -D and -E 
(Figure 3.6). A male and female mouse was examined for each line to examine whether the 
sex of the mouse had an effect on the somatic instability observed. Dmt-B, -C and -E exhibited 
minimal instability, that is they did not show a length change beyond a +/- 20 limit in either 
sex. Dmt-D however, exhibited a significant expansion biased instability that varied according 
to the tissue in both sexes. Most notably the repeat was strikingly unstable in kidney and this 
instability was clearly expansion biased. Indeed a group of kidney cells contained as many as 
650 repeats, which means that these alleles have gained in excess of 500 repeats from the 
progenitor repeat size. Other tissues that were particularly unstable included the liver, colon, 
skeletal muscle, diaphragm and eye. The repeat in the tail, spleen, heart and lung however, 
was relatively stable. There was no correlation observed between the level of stability and the 
level of turnover of cells populating that tissue. A high level of instability was observed in 
brain and eye which contain non dividing cells, while the constantly renewing cells in both the 
lung and the spleen demonstrated some of the lowest levels of instability observed.
3.4.2 Age dependence of somatic mosaicism in Dmt-D
To investigate whether the somatic instability observed in the tissues of the mature Dmt-D 
mice progressed over the lifetime of the mouse, DNA was extracted and examined from mice
69
&
X  X  o '
&
Dmt-D
j t a  0<#v / k /  yv*c$ s y  c*r s$y S? XT c° ^  v° <x *
-2 9 8
Dmt-B
Dmt-C
167 —I 
155“ ’
Dmt-E
171-
§A A A A A A A AM - — a A A A A A A A A A A AR RR RR RR RR RR iR RR Hi RR RR RR 
• •  • •  •  * •  •  • • * •  • * • * ■ }wm
-1 3 9
139
Figure 3.6
Somatic variation in mature Dmt transgenic mice
Multiple tissues were taken from 20 month old male mice, these included a Dmt-B with 
a transgenic repeat size of 169, a Dmt-C  with transgenic repeat sizes of 155 and 167, 
a D m t-D with a transgenic repeat size of 152 and a Dmt-E  with transgenic repeat size 
of 155. Between -1 0  and 100 molecules from each tissue were used as the template for 
duplicate small pool PCR amplifications which were resolved on a 1.25% (w/v) agarose 
gel before transfer to a nylon membrane and Southern hybridisation with DM56. The 
molecular weight marker has been converted to indicate the number of triplet repeats.
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at 2, 6 and 13 months (Figure 3.7). At 2 months of age all of the examined tissues appear to be 
relatively stable with the exception of the kidney and colon, tissues which had been observed 
to be particularly unstable in the mature mouse. At this stage some large expansion events, 
beyond 20 repeats have already occurred in the kidney. The tissues at 6 months reveal the 
instability to be progressing over time, and this progression was confirmed when the tissues 
were studied at 13 months. However, the rate of this expansion
appeared to vary according to the tissue tested. As the Dmt-D mice were investigated there 
appeared to be a tissue specific pattern of repeat instability. To confirm this the tissue selection 
was compared in three male and three female mice 12-13 months of age. The instability 
pattern was consistent from mouse to mouse, with the kidney persisting as the tissue 
demonstrating the largest variation in repeat length. Comparison of up to 10 molecules of 
kidney DNA for each small pool PCR reaction at each timepoint (Figure 3.8) reveals an age 
dependent pattern of mosaicism.
3.4.3 Single molecule analysis of somatic mosaicism in the lung and kidney of Dmt-D 
mice
To allow quantification and analysis of the pattern of stability of the unstable kidney and 
relatively stable lung of Dmt-D mice at each of the different timepoints, multiple SP-PCR 
amplifications (10 or 11) were carried out with each concentration as the template, either 1200 
pgpT1, 120 pgpT1 or 12 pgpl'1. These preliminary reactions were used to determine more 
accurately the number of molecules in each lane produced at the lower concentrations using 
the Poisson distribution. As the concentrations have been derived by dilution, lanes which 
contain molecules may contain more than one molecule of similar size thus using positive 
lanes to calculate the number of molecules may under estimate the concentration. However, 
the blank lanes, (p(0)), all lack one molecule therefore p(0) is calculated as:
total number of lanes - number of positive lanes / total
Calculation of p(0) allows the number of molecules present in each SP-PCR amplification at 
this concentration to be derived from the Poisson distribution where
number of molecules per reaction = -In p(0)
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Figure 3.7
Somatic variation in Dmt-D transgenic mice increases with age
Multiple tissues were taken from Dmt-D male mice at 2 months, 6  months and 13 months, 
with a progenitor allele size of 176 repeats, 175 repeats and 160 repeats respectively. 
Between -1 0  and 100 molecules from each tissue were used as the template for duplicate 
small pool PCR amplifications which were resolved on a 1.25% (w/v) agarose gel before 
transfer to a nylon membrane and Southern hybridisation with DM56. The molecular 
weight marker has been converted to indicate the number of triplet repeats.
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From these calculations it was possible to carry out reactions on single molecule templates. 
Around 100 molecules was taken as the minimum number that should be examined for each 
mouse at each time point. Also at least 32 SP-PCR amplifications were carried out with 100 
molecules of DNA from each tissue and time point as the template. As well as giving an 
indication of the nature of the distribution of the repeat length (Figure 3.4.D), it also meant 
that rarer expansion events could also be observed. For each tissue the same stock of master 
mix was used, with the appropriate amount of DNA added to achieve the correct number of 
molecules for that reaction a set of negative reactions using water in lieu of DNA was also set 
up with the stock mastermix to detect external contamination. Study of the pattern of 
instability in lung cells at each time point found a steady rate of expansion biased events, and 
that the average size of the alleles steadily increased over time. At 2 months when compared 
to the progenitor allele length (weaned tail DNA) it was found that more than 30% of the 
kidney cells analysed had increased in allele length by more than 10 repeats. However, the 
same distribution revealed that -  7% of the cells had deletions greater than 5 repeats. These 
data indicate that although there is an overall bias toward expansion of the transgenic repeat, a 
portion of the expansion events result in loss of repeats. By 13 months the kidney distribution 
contains repeats that are more than 200 repeats larger than the progenitor allele. The expansion 
pattern within the kidney does not appear homogenous, in fact the repeat distribution suggests 
that there are at least three different modes of repeat expansion within the kidney. The most 
stable group of cells, which make up -35% of the molecules studied, exhibit expansions of -  7 
repeats from that of the progenitor allele (peak I). The largest proportion of the cells, -  40% 
exhibit mean gains of -  50 repeats from the progenitor allele (peak II), whereas the -25 % of 
cells which had gained the largest increase had expanded -150 repeats beyond the progenitor 
size (peak III). These modes, which first became apparent at 13 months are even more striking 
at 20 months, with peaks I, II and III exhibiting increases of around +10, +100 and +270 
respectively. When approximately 200 molecules of kidney DNA at 13 and 20 months were 
used as the template for each SP-PCR amplification (Figure 3.9), the trimodal distribution of 
the cell population can be seen clearly on the resulting Southern hybridisation (Figure 3.10). In 
contrast, this multimodality was not observed in the lung, although there was a gradual 
increase in the allele length at each timepoint.
3.4.4 Somatic mosaicism in a 25 month old Dmt-E mouse with a tumour
A 25 month old Dmt-E female was sacrificed because it had developed multiple muscle 
sarcomas. This and subsequent tumours were preliminarily identified and classified by 
Chuing-Mei Cheng, MD, University of Glasgow. DNA was prepared from a selection of
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Figure 3.8
SP-PCR analysis of age dependent variation in kidney fom Dmt-D mice
Kidney DNA from D m t-D male mice aged 2, 6 , 13 and 20 months with a transgenic 
repeat size of 176,175, 160 and 156 repeats respectively was used as the template for 
small pool PCR amplifications. Between 1 and 10 molecules of DNA were used as 
template and a representative selection of reactions are shown. The molecular weight 
marker has been converted to indicate thenumber of triplet repeat
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Figure 3.9
Quantification of age-dependant variation in lung and kidney from Dmt-D mice
Histograms of repeat length distibutions relative to the progenitor allele in the lung 
and kidney of male Dmt-D mice aged 2, 6,13 and 20 months with a transgenic repeat 
size of 176,175,160 and 156 repeats respectively was used as the template for small 
pool PCR at low DNA concentrations (1-5 molecules). Allele lengths have been grouped 
into 10 repeat size ranges. The three peaks of variability within the kidney cell 
distributions derived from the older mice are also shown.
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tissues, including the muscles the tumours appeared to have developed from as well as the 
tumours themselves. The DNA was diluted to 1200 pgpl'1, 120 pgpl'1, 12 pgpT1 in dilution 
buffer containing O.lpM DM-H. The 1200 pgpT1 and 12 pgpl'1 concentrations were used as 
templates for duplicate SP-PCR amplifications. Tissue by tissue comparison revealed 
incidences of deletion biased instability in the tumour derived DNA greater than anything 
previously observed in Dmt-E tissues (Figure 3.11). Examination of the repeat in the heart, 
lung, colon, kidney tail and skin found it to be stable, whilst instability was observed in DNA 
derived from the blood and part of the muscle which one of the tumours had been associated 
with.
3.4.5 Somatic mosaicism in Dmt 162 transgenic mice using Genescan software®
Genescan® software has been used to visualise the instability profile of different tissues in 
several mouse models of expanded triplet repeat instability (Mangiarini et al., 1997; Sato et 
al., 1999; Wheeler et al., 1999). To examine further the instability profile of Dmt-D mice, 1 pi 
of tail DNA lysate (~lng) was used as the template of a PCR amplification which contained 1 
X PCR buffer, 0.25 Units of Taq, 5% DMSO and DM-H and DM-DRF (a fluorescently 
labelled Genescan® primer) in a final concentration of lpM  in a 10 pi volume. Each reaction 
was cycled 30 times under standard conditions, with an annealing temperature of 68 °C and 
resolved on a 6% acrylamide gel (v/v). The conditions and precautions taken while preparing 
samples for Genescan® analysis are discussed in Chapter 5.
Around lng of DNA was amplified for a selection of Dmt-D tissues taken from the 20 month 
old male Dmt-D mouse in (3.4.1). Instability profiles distinct to each tissue type were 
observed and the pattern of instability levels of the different tissues relative to each other were 
in common to those observed on SP-PCR (Figure 3.6). However, although the kidney tissue is 
found to be the most unstable of all of the tissues, the level of instability observed is not as 
great as that detected in the same tissue using SP-PCR and indeed can be detected at much 
lower concentrations. Increases greater than 500 repeats from the progenitor were observed in 
the 20 month old Dmt-D kidney using SP-PCR. Repeats of not larger than 80 repeats were 
detected Genescan® software (Figure 3.12) to detect repeat expansions in a higher 
concentration of template DNA of the same sample. This lack of sensitivity to the level of 
instability present in a sample was a consistent observation when using Genescan® analysis.
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Figure 3.10
Multimodality of repeat length disribution in kidney cells from Dmt-D mice
Approximately 200 molecules of kidney DNA were used as the template for small 
pool PCR amplification to demonstrate the multimodality present in the kidney cell 
population of mature male D m t-D mice. The 20 month old mouse has a transgenic 
repeat size of 156 and the 13 month old mouse has a transgenic repeat size of 160. 
The molecular weight marker has been converted to the number of triplet repeats.
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Figure 3.11
Somatic mosaicism in a 25 month old Dmt-E mouse with multiple tumours
DNA from a 25 month old Dmt-E  female with a repeat size of 165 was extracted from multiple 
tissues including muscle sarcomas and the muscles associated with the tumours. Between 50 and 
100 molecules of DNA were used as the template for quadruplicate SP-PCR amplifications, the 
PCR products were resolved on a 1.25% agarose gel (w/v) before transfer to a nylon membrane 
and Southern hybridisation with DM56. The marker has been converted to show the number of 
repeats. Expansions / deletions have also been indicated.
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Figure 3.12
Genescan profiles of tissues from a 20 month old male mouse
Approximately lng of the A; weaned tail, B; kidney, C; mature tail, D; colon,of a 20 month old Dmt- 
D mouse with a 156 repeat progenitor size was used as the template in a PCR amplification which 
contained 1 X PCR buffer, 0.25 Units of Taq, 5% DMSO and DM-H and DM-DRF at a final concentration 
of ImM in a 10 pi volume. 1.5 pi of a 1:1 mixture of PCR product and Genescan® mix was denatured 
at 90°C before resolving products on a 6% acrylamide gel.
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3.5 Regional mosaicism in Dmt-D mice
3.5.1 Regional mosaicism in the kidneys of Dmt-D mice
The instability events observed in Dmt-D appear to be the accumulation of multiple small 
events, the majority of which are expansion biased. It has become apparent that the transgenic 
repeat within cells that make up the kidney population are subject to a different amount of 
repeat expansion events. That is different cells have a different rate of expandability. Are these 
different cell populations located in different regions within the kidney?
To investigate and possibly identify what these cells might be, kidneys from mature Dmt-D 
mice, 12,15 and 30 months were dissected out and placed into a petri dish containing ~50 pi 1 
X SSC. They were placed under a dissecting microscope or magnifying glass. The outer 
membrane, the capsule, was removed before they were sliced transversely and succinct 
punches removed from distinct regions (Figure 3.13.A). Discrete punches from each region 
were removed and placed into 50 pi of proteinase K lysis buffer in a 200 pi PCR tube and 
incubated overnight at 60 °C. The tissue was diluted 1/100 in distilled water and the proteinase 
K heat inactivated.
DNA generated from these regions was used as a template for SP-PCR analysis and reactions 
were carried out in quadruplicate. The samples were resolved along side total kidney and 
weaned tail DNA (Figure 3.13.B).
It appeared that the alleles with the most unstable repeat length were located in the cortex of 
the kidney. Investigation of cell types within this region found it to contain highly specialised 
structures such as the glomereli and tubules, which include cell types that were not present in 
the rest of the kidney. An attempt was made to isolate specific structures within the kidney.
The kidneys were removed from mice aged 15 and 30 months and placed in a petri dish 
containing 1XPBS before slicing transversely and placing in an Eppendorf that contained 
enough tissue culture buffer to cover the kidney. The kidney was then snap frozen in liquid 
nitrogen until needed, when the tissue was allowed to defrost to an optimal temperature, ~ -18 
°C.
The kidney was sliced at 30 microns, the finest setting available on the AS 620 Cryotome, 
(Anglia Scientific Instruments Ltd.) that was used. Every fifth slice was placed onto gelatine 
coated slide. The kidney slices were dissected under 1 X PBS using a microscope. Succinct 
structures, including tubules (the proximal and distal tubules could not be separated) and 
glomereli were isolated and placed in 5 pi of PBS in 200 pi PCR tubes. The structures were 
removed using a combination of fine gauge needles and a mouth pipette. The cells were lysed
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using 5(0,1 KOH lysis buffer and incubated for 10 minutes at 60 °C before neutralising in 5.2pl 
200mM tricene. All of the lysate was used as the template for the SP-PCR amplification of the 
repeat that was carried out in a 30pl volume under standard conditions for DM-H and DM- 
DR. In the first instance 1 pil of this PCR product was used as the template for a second round 
of SP-PCR amplification in a 7 pi volume, under standard conditions for DM-H and DM-DR. 
The PCR products from each round of amplification were resolved on a 1.25% (w/v) agarose 
gel before transfer to a nylon membrane by squash blotting (Figure 3.14). Not all of the 
isolated structures were resolved as PCR products. It was thought that the failure of some of 
the PCR reactions could be due to the failure of the isolated cells to lyse properly to release the 
DNA template. An attempt was made to increase the efficiency of the lysis of the discrete 
structures by lysing the cells in 10 pi of proteinase K lysis buffer for 10 minutes and briefly 
heat inactivating the proteinase K before using the total lysate as the template for SP-PCR 
amplification. This method of lysis appeared to be no more efficient than the KOH lysis. As 
this series of experiments progressed, the presence of the structures within the thin walled 
tubes was confirmed under the microscope.
The structures that were resolved did not allow conclusions to be drawn about the identity of 
the cell type or types that were responsible for most dramatic changes in allele length. 
Comparison of glomereli and tubules were inconclusive.
3.5.2 Regional mosaicism in the brains of Dmt-D mice
Given that the majority of CAG*CTG repeat expansion disorders are neurodegenerative 
diseases and that the brain in Dmt-D was one of the more unstable tissues an investigation of 
repeat mosaicism within the brain regions was carried out.
The brain of a 12 month old Dmt D mouse was completely dissected out of the skull and 
placed in 1 X PBS in a petri dish. Microdissection of the hippocampus, cerebellum, striatum, 
cortex and olifactory bulb were carried out under a dissecting magnifying glass before each 
region was placed into 500 pi of proteinase K lysis buffer and incubated overnight at 60 °C. 
The microdissection of the brain was carried out by an Honours student, Mr Christos 
Vassilopoulos under the guidance of Dr Heather Johnstone of the University of Glasgow.
Serial dilutions of 1/10 (~ 1000 pgpl'1), 1/100 (~ 100 pgpl'1), 1/1000 (~ 10 pgpl"1) were carried 
out in dilution buffer containing 0.1 pM DM-H. lp l of the 1/10 and 1/1000 serial dilutions 
were used as templates for duplicate small pool PCR amplifications for each region after the
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Figure 3.14
Isolation of discrete structures of mature Dmt-D kidney
Structures were isolated from a 30 micron D mt-D kidney slice taken from a 15 month old female 
with a repeat size of 161. The cells were lysed with 200mM KOH and neutralised with 200 mM 
tricene. All of the lysate was used as the template of a SP-PCR reaction in a 30 pi volume in the 
first round of PCR. 1 pi of of the first round of PCR product was used as the template in the second 
round of SP-PCR amplifcation in a 7 pi volume. The PCR products were resolved on a 1.25 % 
agarose gel (w/v) and transferred onto a nylon membrane before hybridisation with DM56.
A Autoradiograph after 3 hours exposure. B Autoradiograph after 16 hours exposure.
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proteinase K was heat inactivated. The samples were resolved alongside weaned tail DNA 
(Figure 3.15.A). Clear differences in the degree of stability were observed in the different 
regions with a high level of variation observed in the hindbrain and the striatum while a low 
level of instability was observed in the cerebellum.
Quantification of the degree of stability of the cerebellum and striatum was carried out. DNA 
was prepared by phenol / phenol: chloroform extraction. The concentration of the DNA was 
determined and diluted to 1200 pgpl'1, 120 pgp l1 and 12 pgpl'1 and the repeat length of single 
molecules determined (Figure 3.15.B).
It was observed that the mean increase of repeat length in the striatum was +25 repeats and 
that although the cerebellum was relatively stable there was a shift of the average allele size 
from that of the progenitor repeat size of +10 repeats.
3.6 Conclusion
The aim of the work in this chapter was to establish the suitability of the Dmt transgenic lines 
as models for triplet repeat instability. The investigation of the 4 lines found that one, Dmt- D 
replicates the gross somatic mosaicism observed in DM1 patients, with some cells exhibiting 
expansions beyond 500 repeats which is 3 times the progenitor allele size. Although it is not 
possible to compare the tissue instability spectrum of Dmt-D to the same tissues in DM1 it 
would appear that the kidney of Dmt-D is as unstable as tissues observed in DM1 patients. 
This would suggest in the first instance that the mouse metabolism can display a mechanism 
of instability parallel to that observed in man and in the second that in the Dmt-D triplet repeat 
model, we have a model suitable for investigating mechanisms of triplet repeat expansion. 
Comparison of the level of cell turnover within the different tissue types to the pattern of 
stability found no correlation between the two. Indeed the level of cell turnover of the kidneys 
is much lower than that of the lung, one of the most stable tissues (Messier and Leblond,
1960). Also there is no evidence of repeat instability in the very young mice despite the rapid 
rate of cell division during embryogenesis, again a parallel can be drawn between DM1 as 
little somatic instability is observed in DM1 newborns (Tachi et al., 1993). Other evidence 
against the rate of cell proliferation having an effect on the level of instability can be seen in 
the microdissection of the brain. Analysis of the regions of the brain exhibit a regional specific
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Figure 3.15
SP-PCR analysis of regional dependant somatic mosaicism in the brain of a Dmt- 
D mouse
A Small pool PCR reactions were carried on out on regions of the brain of a 12 month 
old D m t-D male mouse with a repeat length of 158. Between -1 0  and 100 molecules 
from each tissue were used as the template for duplicate amplifications. The products 
were resolved on a 1.25% agarose gel (w/v) and transfered onto a nylon membrane before 
Southern hybridisation with DM56. The molecular weight marker has been converted 
to indicate the number of triplet repeats.
B Histograms of repeat length distribution of the cerebellum and striatum of the male 
mouse shown in A. The molecule length was derived by SP-PCR amplification at low 
concentrations (1-5 molecules).
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pattern of instability including increases beyond 80 repeats from the progenitor observed in 
the striatum. Yet the neuronal cells are post mitotic, indeed although the majority of brain cells 
are glial, the rate of division of these cells is at a rate of less than once in a mouse older than 
four months (Cameron, 1970; McCarthy and Leblond, 1988). This data suggests that the 
repeat expansions are accumulating in nondividing cells.
Single molecule analysis of the kidney has revealed multi-modality in the allele distribution 
with at least 3 distinct cell populations displaying different repeat dynamics. Examination of 
the instability in the different regions again revealed a regional specific pattern of mosaicism. 
This and indeed the brain data suggest, perhaps not surprisingly that the repeat instability is 
not only dependent on the tissue type but in fact the type of cell. The kidney cell population 
includes nervous, lymph and vascular system in common with tissues exhibiting more stable 
repeat dynamics suggesting that the dramatically unstable cell population does not have its 
origin here but within a highly specialised cell in perhaps the nephron. Identification of these 
cell types may allow further insight into the mechanism of instability yet methods to 
investigate such cellular differences in vivo will require further development.
That the other lines, Dmt-B, -C and -E exhibited minimal instability highlight the role played 
by the integration site on the instability levels of the transgenic repeat tracts. It is known that 
transgenes may be subject to silencing effects at some integration sites (Clark, 1997), or have 
integrated into regions which were already rich in chromatin. The transgene itself may have 
been subject to mutation, a point mutation being enough to reduce the purity of the tract. The 
SCA type 1 CAG repeat in normal range individuals contains a CAT repeat which is not 
present in expanded alleles and is thought to confer a stabilising effect (Jodice et al., 1994).
However, the instability observed in the otherwise stable line Dmt-E after it had developed 
tumours suggests that other factors also play a role repeat instability. Recalling that each 
individual within a Dmt line is identical other than the length of the repeat tract, factors 
effecting the stability of the repeat in one of the stable lines have been acquired by the 
individual over their lifetime. The deletions observed in the Dmt-E mice occurred either within 
the tumours themselves or the tissue from which the tissue had been derived. This suggests a 
mutation event has occurred which effects the integrity of the repeat.
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Chapter 4
Gametic instability in the Dmt transgenic lines
4.1 Introduction
The analysis of DM1 pedigrees has revealed that the size of the repeat transmitted from a 
DM1 parent to its offspring is dependent on the repeat size carried by the parent as well as the 
parents sex (Ashizawa et al., 1994; Brunner et al., 1993; Harley et al., 1993; Jansen et al., 
1994; Lavedan et al., 1993a). In pedigree studies based on leukocyte DNA, more than 90% of 
transmissions resulting in an increase in the repeat length observed in the offspring and only 6- 
7% resulting in a decrease (Ashizawa et al., 1994; Brunner et al., 1993). Monckton et al 
(1995), Martorell et al (2000) carried out intergenerational studies and examined the pattern of 
instability in germline DNA as well as the leukocyte DNA of DM1 males. The somatic cells 
studied revealed a bias towards increasing allele length and a lower boundary to the variation 
shown by the disease range repeat. Events producing alleles smaller than this boundary were 
rare. Examination of sperm DNA revealed extensive expansion variation in the disease range 
allele, with a pattern distinct from that observed in the soma but consistent with the 
phenomenon of anticipation observed in DM1 transmissions. There was little correlation 
between the progenitor repeat length and the variation observed in the sperm. Within the pool 
of germline alleles repeat contraction events were also observed including reductions of the 
disease range allele into a normal repeat range but such dramatic events were rare. The 
majority of observed deletions from the progenitor repeat size are likely not to be deletions. It 
is more likely that when determining the progenitor repeat size in an individual, repeat events 
have already started to occur in the tissue shifting the mean, and that the mutation rate in the 
tissue which the progenitor rate has been determined from (leukocyte) is higher than in the 
germline.
The sex of the transmitting parent influences the size of the repeat transmitted. It has been 
observed (Bell, 1948), and confirmed with the identification of the associated mutation 
(Aslanidis et al., 1992; Brook et al., 1992; Buxton et al., 1992; Fu et al., 1992; Harley et al., 
1992; Mahadevan et al., 1992), that the transmitting grandparent in DM1 pedigrees is most 
often male. Indeed when the transmission event results in a small increase of not more than 
100 repeats, the transmitting parent is more likely to be male (Brunner et al., 1993; Lopez de 
Munain et al., 1995; Wieringa, 1994). While maternal transmissions account for the larger 
expansions (Harley et al., 1993; Lavedan et al., 1993a; Redman et al., 1993) and account for
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the majority of transmissions which result in cDM offspring (Redman et al., 1993; Tsilfidis et 
al., 1992). This suggests a gametic mechanism of expansion dependent on differing sex 
dependent factors. However, it is possible that in addition to or perhaps instead of, expansions 
occur in a newly formed zygote and that these expansion events may be influenced not 
exclusively by the sex of the transmitting parent but by the sex of the gamete (Kovton et al., 
2000). Studies by Kovton et al (2000) on male transmissions of R6/1 Huntington’s model 
mice has found that the male offspring are more likely to carry repeats larger than their parent 
while females were more likely to carry deletions.
Examination of the Dmt repeat transmission patterns in young male and female mice, found 
gametic instability present in all five of the Dmt lines, Dmt-A, -B -C, -D and -E and that the 
instability pattern exhibited varied depending on the sex of the transmitting parent repeats 
(Monckton et al., 1997). That is maternal transmissions which did result in a repeat size 
different to that of the transmitting parent were deletion biased and could result in offspring 
with a repeat size as many as 7 repeats smaller than that of the parent. Germline mutation rates 
across the females of all of the Dmt lines was consistent at around 60%, and with exception of 
the multi integrant transgenic line Dmt-A, the mutation events were made up of small deletion 
events. Paternal transmissions were expansion biased and could result in offspring, which 
carried a repeat different to that of the transmitting parent by as many as +7. The mutation rate 
in male transmissions was found to be line dependent, from less than 10% in Dmt-E to almost 
70% in Dmt-D.
The transmission pattern of the Dmt heterozygotes was examined for segregation distortion. 
That is the Dmt transgene was present in significantly more births than one in two.
Segregation distortion has been observed in favour of the larger CTG repeat in DM1 at a rate 
of 56.4% (Carey et al., 1994) and 58.1% (Hurst et al., 1995). Analysis of the rate of the 
transmission of the Dmt repeat in the different lines, found the transgene present in 52 % of 
the births in Dmt-A, 50% of the births in Dmt-D and 46% of the births in Dmt-E these rates of 
transmission did not deviate significantly from the norm. However, significant segregation 
distortion in favour of the transgene did appear to be taking place in Dmt-B and Dmt-C with 
transgene transmission rates of 66% and 70% respectively (Monckton et al., 1997). These 
transmission rates were for all births and not separated according to the sex of the parent.
The effect of age of the parent on the size of the repeat transmitted has been observed in 
paternal transmissions of Huntington’s disease and DRPLA (Duyao et al., 1993; Sato et al., 
1999). The maternal transmissions of a targeted Sea type 1 model also exhibited an age of 
parent at transmission effect, with the average size of deletion transmitted to the offspring
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increasing as the mouse ages (Lorenzetti et al., 2000).
An expanded CAG repeat originating from a SCA type 1 patient was used to generate two 
mouse lines, one D02, contained (CAG)82, the other, C01, (CAG)30 (Kaytor, 1997). 
Intergenerational instability in these lines was observed only in maternal transmissions, and 
these were deletion biased. Transmission studies observed that the transmitted deletion 
increased with the age of the mother. Furthermore examination of unfertilised oocytes at 
different timepoints found that oocytes isolated from a seven week old female to carry the 
same repeat size as the female. However, oocytes isolated from a 20 week old transgenic 
female found the oocytes to carry a repeat size smaller than that of the transmitting female.
4.2 Transmission studies
For the lines Dmt- D and Dmt-E, the size of the transgenic repeat carried by the offspring 
relative to that of the transmitting parent was determined over the lifetime of both transgenic 
male and female parents. All of the mice were on a FVB/n background and each mating was 
set up between a parent hemizygous for the transgene Dmt (+/-) while the other was wild type 
Dmt (-/-). This meant that all of the subsequent mice, if transgenic, were hemizygous for the 
transgene. The transgenic mice were identified as in Chapter 3.2 and the repeat size difference 
between parent and offspring determined by resolution of the fluorescently labelled transgenic 
repeat PCR product on a 6% acrylamide gel.
FVB/n was chosen as the strain on which the Dmt lines are based was due to several factors, it 
has a fully inbred genetic background and was reported to have a vigorous reproductive 
performance resulting in large litters. The fertilised eggs have large and noticeable pronuclei 
which favour the microinjection of DNA (Festing, 1998) and which have a higher level of 
survival than C57/BL6 (Taketo et al., 1991). We found the FVB/n mice to be aggressive. This 
aggression was observed mostly in males although it was also seen in females. Littermates 
were often found to develop aggressive behaviour shortly after weaning. At its most extreme 
the resulting fighting would require the sacrifice of the whole cage of mice. There was no line 
specific pattern to the aggression observed. Several measures were taken to alleviate the 
aggression. These included the placing of the mice into fresh and not just clean cages each 
time the cage was due to be cleaned. This was found to have little effect. The use of larger 
cages and “toys” to alleviate boredom were judged to increase aggression. On a more basic 
level, the aggressive mice were housed singly. However, the most affective measure taken was 
the splitting of the colony into 2 separate rooms, the first housed only males, the second
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housed the females and breeding cages. This reduced the level of fighting observed. Another 
unusual behaviour was the constant, unidirectional circling of certain mice. This behaviour 
was neither line nor sex specific. A consequence of these behaviours was that a large 
proportion of breeding pairs set up failed to result in live young. More than half of the 
transgenic females in breeding pairs failed to produce live young. The rate of successful 
paternal transmissions of the repeat was higher than that for maternal transmissions because a 
transgenic male can be paired with multiple wild type females, and only one of these 
combinations was required to be successful. As the success of specific matings was 
unpredictable attempts to focus on matings involving particular repeats i.e. larger or smaller 
than average were unsuccessful.
4.3 Dmt transgene allele sizing by fluorescent PCR using Genescan® 
software
The number of Dmt transgenic repeats carried by each transgenic mouse was determined using 
Genescan® software on an Applied Biosystems 373 A sequencer by the University of 
Glasgow’s Molecular Biology Support Unit. The repeat size of each transgenic mouse was 
determined on a gel that also contained the repeat of the transmitting parent. Fluorescently 
labelled primers and dNTPs are vulnerable to degradation by exposure to light, therefore the 
exposure of the primer to daylight before and after incorporation were minimised wherever 
possible. An effort was made to prevent the oil overlaying the PCR products contaminating 
the samples resolved on the Genescan® gel.
The amplification of the DNA for estimation of repeat size using Genescan® software was 
optimised. In the first instance fluorescently labelled PCR products were generated by 
incorporating fluorescently labelled dNTPs during the PCR amplification. Initially a low 
concentration dNTP PCR buffer was used in tandem with fluorescently labelled dNTPs to 
increase the efficiency of the incorporation of the fluorescently labelled dNTPs. For each 
amplification, 1 pi of tail lysate (1 ng of DNA) in a 7 pi reaction containing 1 mM each of 
DM-H and DM-DR with IX low dNTP concentration PCR buffer with and 0.175 units of Taq 
polymerase and R110, blue, fluorescently labelled dNTP’s (0.017 mM). The sizing reactions 
were cycled 30 times, under standard PCR conditions, with an annealing temperature of 68°C. 
The success of the PCR amplification was checked in the first instance by resolving 3 pi of the 
PCR product on a 1.5 % agarose check gel (w/v). The PCR product was prepared for 
resolution on the Genescan® gel by mixing in a 1:1 ratio with Genescan mix. The samples
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were mixed and then heated to 90°C for 2 minutes and placed on ice until they have been 
loaded onto the 6% acrylamide gel (v/v).
A single PCR product was expected for each Dmt transgene amplified whose size in base pairs 
and subsequently be determined. In the first instance when the products of this PCR 
amplification were resolved on an agarose gel, multiple bands were present (Figure 4.1.A). 
These bands were also seen when the PCR products were resolved on the Genescan® gel (not 
shown). To improve this position the concentration of fluorescently labelled dNTPs was 
varied (0.006-0.017M), the annealing temperature of the PCR amplification varied (68 - 74°C) 
and the number of cycles of PCR varied (25-30). In the first instance none of these 
combinations reduced the number of bands, just their intensity. It was observed that the 
multiple bands visible on the agarose gel were visible on the Genescan® gel and while all 
samples were run on agarose gels, only a small selection was resolved using Genescan® 
acrylamide gels, as these were a more limited resource.
Use of the alternative primer combination to amplify across the repeat, DM-C and DM-BR 
also resulted in multiple bands as did the replacement of the blue fluorescent dNTP mix,
R110, with green fluorescent dNTP, R6G (Figure 4.1.B). However, replacement of the low 
dNTP concentration PCR buffer, with standard PCR buffer resulted in discrete bands for each 
primer combination. Comparison of the DM-H / DM-DR PCR products and the DM-C / DM- 
BR PCR products when generated with the green dNTPs found the dye band that was 
generated resolved on both the 6% and the alternative 4.75% acrylamide gel (v/v) in the same 
location as the PCR product, obscuring the interpretation of the results (not shown). The DM- 
H / DM-DR primer combination that was used widely for the SP-PCR analysis was chosen has 
the primer pair of preference for tail sizing. The substitution of the fluorescently labelled 
dNTPs with the fluorescently labelled primer DM-DRF (Figure 4.1.C) ensured that all of the 
PCR product generated was fluorescently labelled and eliminated the problem of the dye band 
distorting the PCR product size. The efficiency of the tail typing PCR amplification was 
further improved by reducing the concentration of the template DNA. The optimal PCR 
amplification conditions for the estimation of the transgenic repeat size by Genescan® software 
were determined to be 0.5 pi of diluted tail lysate (~0.5 ng), 0.25 Units of Bioline Taq, 1 X 
PCR buffer and DM-H and DM-DRF to a final concentration of lpM in a 10 pi volume. If 
Promega Ampli Taq was used instead of Bioline Taq then the PCR reaction also contained 5% 
DMSO. Each reaction was cycled 28 times under standard conditions, with an annealing 
temperature of 68 °C. The samples were resolved on a 6% acrylamide gel using the ROX 2500 
marker (Figures 4.2 and 4.3). Comparison of the same samples between a 4.75% and a 6% gel
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Figure 4.1
PCR amplification for Genescan analysis
Multiple PCR reactions were carried out on mouse tails to determine conditions suitable 
for the amplification of mouse tails DNA for analysis using Genescan software.
1 pi of tail lysate (1 ng of DNA) in a 7 pi reaction containing 1 mM each of DM-H 
and DM-DR with IX PCR buffer with and 0.175 units of Taq polymerase and fluorescently 
labelled dNTPs (0.017 ul mM). The sizing reactions were cycled 30 times, under 
standard PCR conditions, with an annealing temperature of 68°C. The success of the 
PCR amplification was checked in the first instance by resolving 31 of the PCR product 
on a 1.5 % agarose check gel (w/v).
(A) Shows PCR products generated with blue fluorescently labelled dNTPs (R110).
(B) Shows PCR products generated with green fluorescently labelled dNTPs (R6G).
(C) Shows PCR products generated with fluorescently labelled DM-DRF, fluorescently 
labelled dNTPs were not incorporated into these reactions.
The marker has been converted to triplet repeats.
93
84
5
ouudsjjo
_ -  juajud
7 $ S<n ■?
(dq) j 3>|ju l u  jq o [ 3 A \  JC|n33joiu
94
Fi
gu
re
 
4.
2
Dm
t-E
 
m
ou
se
 
tai
ls 
re
so
lv
ed
 
on 
a 
Ge
ne
sc
an
 
ge
l
Fl
uo
re
sc
en
tly
 
la
be
lle
d 
Dm
t 
PC
R 
pr
od
uc
ts 
am
pl
ifi
ed
 
fro
m 
the
 
tai
l 
DN
A 
of 
Dm
t-E
 
m
ic
e.
Th
e 
pa
re
nt
, 
26
54
 
(m
al
e)
 i
s 
sh
ow
n 
in 
lan
es
 
11
. 
In
di
ca
te
d 
are
 
lan
es
 
co
nt
ai
ni
ng
 
of
fs
pr
in
g 
of 
26
54
, 
in
cl
ud
in
g 
32
54
(la
ne
 
24
) 
an
d 
32
56
 
(la
ne
 
26
). 
Th
e 
pr
of
ile
s 
of 
the
 
in
di
ca
te
d 
lan
es
 
are
 
sh
ow
n 
in 
Fi
gu
re
 
4.
3.
g*
8£9
8S
<0
CO
§eg
8
a□
95
Fi
gu
re
 
4.
3
Ge
ne
sc
an
 
pr
of
ile
s 
of 
3 
D
m
t-E 
m
ou
se
ta
ils
Th
e 
tri
pl
et 
of 
eac
h 
D
m
t-E 
m
ou
se
, 
B:
 2
65
4,
 th
e 
tra
ns
m
itt
in
g 
ma
le 
pa
re
nt
, 
C:
 3
25
4,
 a
nd 
D:
 3
25
6 
bo
th 
ma
le 
of
fsp
rin
g 
we
re 
re
so
lv
ed
 
ag
ain
st 
D:
 a 
RO
X 
25
00
 
m
ol
ec
ul
ar
 w
eig
ht
 m
ar
ke
r. 
Th
e 
m
ol
ec
ul
ar
 w
eig
ht
 o
f 
26
54
, 
32
54
 
and
 
32
56
 
we
re 
de
ter
m
in
ed
 
as 
63
1,
 6
38 
an
d 
63
5 
bp
s 
and
 
14
9, 
151
 a
nd
 
150
 
re
pe
ats
 r
es
pe
ct
iv
el
y.
found the repeat resolution to be clearer using a 6% gel. The estimation of the repeat size of a 
particular mouse varied by several base pairs when resolved on different gels despite 
maintenance of constant conditions. Comparison of the same sample and 3 different gels 
found variation of between 1 and 4 bases (data not shown), this meant that the discrepancy 
was not greater than one repeat. The variation was attributed to minuscule differences in the 
proportions of the acrylamide gel that resulted from discrepancies in the weighing and 
measuring of the components of the gel. This disparity was minimised by making up an 
acrylamide gel batch mix for 10 gels at a time thus reducing the level of variation from gel to 
gel. It was also decided that as the important observation was the differences in repeats of the 
parent when compared to the offspring the parental repeat was always resolved on the same 
gel as the offspring.
4.4 Transmission studies in Dmt-D and Dmt-E male and female mice
Initial observation of the transmission pattern of the Dmt transgene reported the frequency of 
transgenic transmission to be 50% for Dmt-D (40 transgenic mice out of 80 transmissions) and 
46% (58 transgenic mice out of 126 transmissions) for Dmt-E (Monckton et al., 1997). In 
contrast at the end of this study the transmission rate was 58% in Dmt-D (n=291) and 59% 
(n=208) for Dmt-E. Analysis of transmission using the Chi square test found both rates of 
transmission to be significantly different than the expected value, (p=0.5), in both cases. 
Combining the results from both studies the transmission rate for Dmt-D was 56% and Dmt-E 
was 54%.
Dmt- D Sex of parent
male female total
Wild type 75 48 123
Dmt- D 92 76 168
total 167 124 291
% transgene 55 61 58
Table 4.1 Germline transmission of the Dmt-D transgene
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Dmt-E Sex of parent
male female total
Wild type 40 46 86
Dmt-E 77 45 122
total 117 91 208
% transgene 65 49 59
Table 4.2 Germline transmission of the Dmt-E transgene
Examination of the transmission rate in each line and each sex found the transmission of the 
transgenic repeat by Dmt-E males was significantly different from the expected 50%, (p=0.01) 
but the female transmission pattern was not. While examination of the transmission rate in 
Dmt-D males was significantly higher then expected, (p=0.9) but especially so in Dmt-D 
females (p=0.5).
4.4.1 Repeat transmission pattern in Dmt-D and Dmt-E
The difference in repeats between parent and offspring was determined by
Offspring repeat size - Parental repeat size = Difference in repeats
Examination of the transmission pattern of male Dmt-D mice (n=84), female Dmt-D mice 
(n=57) was determined (Figure 4.4.A) and male Dmt-E mice (n=93), female Dmt-E mice 
(n=45) was determined (Figure 4.4.B). Not all of the Dmt-D and Dmt-E mice were sized due 
to time constraints.
As demonstrated in Monckton et al (1997) the male transmissions are prone to expansions 
while the female transmissions are deletion prone. However, a difference in the degree of 
variability of the transmitted repeat is visible between the two lines, with a greater degree of 
variation observed in both sexes by the Dmt-D mice. Monckton et al (1997) had previously 
observed there to be a greater variation in the male Dmt-D transmissions than the male Dmt-E 
transmissions.
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Figure 4.4
The Dmt repeat difference between parent and offspring
The difference between the parental transgenic repeat size and offspring transgenic 
repeat size is shown for male and females: A: D m t-E transmissions and B: Dmt-D  
transmissions.
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deletions (%) no change
(%)
expansions
(%)
mean repeat 
difference
Dmt-D females 63 9 28 -5.9
Dmt-D males 19 15 66 +2.7
Dmt-E females 64 10 25 -1.8
Dmt- E males 31 22 47 +0.7
Table 4.3 Rate of repeat mutation in Dmt-D and Dmt-E males and females
The parent offspring repeat difference observed in female Dmt-D mice is between -12 (mean 
deletion) and +4 (mean expansion) repeats compared to a range of —4 (mean deletion) and + 4 
(mean expansion) repeats in Dmt-E females. The majority of the Dmt-E female transmissions, 
64% were deletions. A similar effect was observed between the males in each line, with the 
mean range in repeat size in Dmt-D males being between -3  (mean deletion) and +6 (mean 
expansion) and -2  (mean deletion) and +3 (mean expansion) in Dmt-E males.
4.4.2 The effect of parental age and the repeat size transmitted in Dmt mice
To establish if the age of the parent when it transmitted the repeat to its offspring effected the 
size of the repeat transmitted, the age of each of the parents transmitting the transgene was 
determined on the day of conception for male and female Dmt-E and Dmt-D mice (Figure 
4.5). Linear regression analysis revealed no significant correlation between the age of the 
transmitting parent and the size of repeat transmitted in either of the lines or in either of the 
sexes. All statistical analysis in this thesis was carried out under the supervision of Mr Grant 
Hogg of the University of Glasgow. Direct comparison of the difference in repeat transmission 
pattern and the age of transmitting parent of the Dmt-D and Dmt-E males (Figure 4.6), 
revealed little variation in the Dmt-E mice, in Dmt-D however, although large parent offspring 
differences occur at all ages, some of the largest variations were observed in the older Dmt-D 
males. A similar comparison of the difference in repeat transmission pattern and the age of 
transmitting parent of the Dmt-D and Dmt-E females (Figure 4.6) also revealed little variety in 
the repeat transmitted despite the age of the parent in Dmt-E females, while most of the larger 
variations in repeat size in Dmt-D females were transmitted by older mice.
It has been suggested that the sex of the conceived mouse has an effect on the repeat size 
presented by that mouse (Kovton et al., 2000). To examine whether sex of the offspring has
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Figure 4.5
Age of parent against differences in repeat size transmitted
The difference between the Dmt repeat size between each parent and its offspring is 
plotted against the age of the parent (days) at the time the offspring was conceived for 
A: Dmt-D male and female mice and B: Dmt-E male and female mice.
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Figure 4.6
Comparison of repeat transmission pattern between Dmt-D and Dmt-E mice
The difference between the Dmt repeat size between each parent and its offspring is 
plotted against the age of the parent (days), at the time the offspring was conceived for 
A: femaleDmr-D and Dmt-E mice and B; male Dmt-D and Dmt-E mice.
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influenced the parent offspring difference, each of the four sets of data, the differences in 
repeat size for the Dmt-D male and female parents, and the Dmt-E male and female parents 
were themselves split into male and female groups (Figure 4.7 and Figure 4.8). Although the 
sex of the offspring made no apparent difference to the Dmt-D transmissions or the female 
Dmt-E transmissions, the size of repeat carried by the offspring of male Dmt-E mice split into 
two distinct modes with the females carrying repeats closer to that of the transmitting parent 
than the males. Application of the Kolmogorov Smimov test to each of these modes found that 
the 2 modes were significantly separate.
4.5 Examination of triplet repeat instability in the testes and sperm of Dmt- 
D mice at different time points
To investigate whether the instability observed in the tissues of Dmt-D mice was also visible 
in the germline of male mice, DNA was prepared from the sperm and testes of Dmt-D mice at 
2 and 13 months. The DNA was diluted to 1200 pgpl'1, 120 pgpl'1, 12 pgpl'1 in dilution buffer 
containing O.lpM DM-H. The 1200 pgpl'1 and 12 pgpl'1 concentrations were used as templates 
for multiple SP-PCR amplifications (Figure 4.9). The sperm DNA amplified poorly, while 
level of repeat variation in the testes DNA increases with age.
4.6 Amplification of single oocyte by PCR
To allow assessment of the repeat stability level in the unfertilised oocyte when compared to 
the repeat carried by the transgenic offspring, it was proposed that Dmt transgenic females be 
superovulated using PMSG and HCG, before mating with a vasectomised male (Methods 
2.2.5.4) to bring a maximum number of ova to a common mature state before they were 
harvested by flushing from the oviduct into M2 media. Single ova were manipulated using a 
mouth pipette into 200 pi thin walled PCR tubes. The presence of each ova, which was 
isolated in ~ 10 pi of M2 media, was confirmed by checking the contents of each tube 
underneath the microscope and ~ 20 pi of mineral oil placed over the contents of each tube to 
prevent loss of contents by evaporation. The ova were stored on ice until the harvest was 
completed. From this point onwards, all of the manipulation of the ova was carried out in a 
laminar flow hood.
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Figure 4.7
The sex distibution of the parent offspring difference in Dint-D repeat transmissions
The distribution of the D mt-D parent offspring repeat difference in the offspring of A: 
D m t-D females and B; Dmt-D males.
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Figure 4.8
The sex distibution of the parent offspring difference in Dmt-E repeat transmissions
The distribution of the Dmt-E parent offspring repeat difference in the offspring of A: Dmt- 
E females and B; D mt-E males.
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Figure 4.9
Small pool PCR amplification of the sperm and testes of Dmt-D mice
Between -1 0  and 100 molecules from the mature tail, testes and sperm of a 2month old 
Dmt-D  mouse with a repeat size of 172, and a 13 month old D mt-D mouse with a repeat 
size of 160 were used as the template for duplicate small pool PCR amplifications which 
were resolved on a 1.25% (w/v) agarose gel before transfer to a nylon membrane and 
Southern hybridisation with DM56. The molecular weight marker has been converted to 
indicate the number of triplet repeats.
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Each ovum was lysed using a modified method based on that described in, Kaytor et al. 
(1997). 5(xl KOH lysis buffer was overlaid onto the oil in each tube and the contents mixed by 
gentle tapping of the tube, incubated at 65 °C for 10 minutes before neutralising by adding 
5.2pl of 200mM Tricene. In the first attempt only the transgenic repeat was amplified using 
DM-H and DM-BR. Assuming that the final volume for each lysed oocyte was ~ 20 pi, a 40 
pi reaction was set up using IX PCR buffer, 0.035 Units of Taq and 0.2 pM each of DM-H 
and DM-BR. Each PCR amplification was cycled 30 times under standard conditions with an 
annealing temperature of 68 °C. However, the failure of the oocyte to act as template for the 
PCR amplification (possibly due to failure of oocyte lysis) could not be discerned from the 
failure to amplify the repeat. This was because the oocyte did not contain the transgene as all 
of the superovulated mice were hemizygous for the transgene. In subsequent attempts, the 
lysed oocytes were used as the template for PCR to amplify the mouse Usf2 gene, using 
mUSF-A and mUSF-BR and the transgenic repeat, using DM-H and DM-BR in the same PCR 
amplification. As all of the oocytes should contain the mouse Usft gene, the presence of this 
PCR product should confirm that the oocyte had indeed been successfully lysed and amplified 
from. Assuming that the final volume for each lysed oocyte was ~ 20 pi, a 40 pi reaction was 
set up using IX PCR buffer, 0.035 Units of Taq and 0.2 pM each of DM-H, DM-BR, mUSF- 
A and mUSF-BR. Each PCR amplification was cycled 30 times under standard conditions 
with an annealing temperature of 63 °C. Initially 1 pi of this PCR product was used as a 
template to amplify the transgenic repeat using IX PCR buffer, 0.035 Units of Taq and 0.2 
pM each of DM-H and DM-DR in a 7 pi volume for 30 cycles under standard PCR reactions 
with an annealing temperature 68 °C. If the mouse Usf2 primer pair had also been used then a 
further 1 pi of first round of PCR amplification was used as a template to amplify the mouse 
Usf2 product using IX PCR buffer, 0.035 Units of Taq and 0.2 pM each of mUSF-A and 
mUSF-BR in a 7pl volume for 30 cycles under standard PCR reactions with an annealing 
temperature 63 °C. Amplifying the PCR products a second time did not identify the presence 
of any transgenic oocytes that were not identified in the first round.
All of the PCR products, from both rounds of amplification were resolved on a 1.5% agarose 
gel before transfer to nylon membrane and Southern hybridisation with an appropriate probe. 
The first round of the PCR amplification was kept to use as the template for subsequent 
Genescan® reactions to size the repeat in transgenic oocytes. It was decided that the second 
amplifications were not necessary.
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4.6.1 Amplification of a single oocyte from Dmt-D and Dmt-E by PCR
In the first instance a single Dmt-D mouse, aged 15 weeks was superovulated and of the four 
oocytes present, 3 were isolated, lysed and subjected to two rounds of PCR amplification. Of 
the 3 oocytes, 1 of the 3 resulted in the amplification of the transgenic repeat. Having 
discerned in the first instance that the transgenic repeat could be isolated in this manner further 
mice were subjected to superovulation and PCR amplification in the presence of mUSF-A / 
mUSF-BR. The superovulation experiments are summarised in table 4.2 (Figure 4.10). The 
yield of oocytes from the superovulated mice was very poor when compared to that obtained 
from other mice in the same facility, where as many as 40 oocytes were isolated from a single 
female. In the first instance (attempts 1 and 2) the low yield was attributed to the failure of the 
PMSG to stimulate oocyte production, it was observed in at least 3 of the mice that one of the 
oviducts yielded nothing at all, which was observed to be unusual. An alternative source of 
PMSG was used for attempt 3, however, the number of isolated oocytes continued to be low. 
This could have been accounted for by the age of the mice as mice aged less than 10 weeks are 
recommended for the isolation of embryos for cryopreservation. However, the nature of the 
question addressed by this experiment requires that older mice be studied. It is possible that 
the Dmt-D and -E transgenic lines do by their nature yield fewer oocytes than wildtype FVB/n. 
However, this observation has not been made for Dmt-D and -E  or indeed Dmt-C, although 
the Dmt-B litter sizes dropped to half that expected. Attempts to lyse the isolated oocytes and 
ascertain the presence of the transgene were unsuccessful at subsequent attempts. This was 
possibly due to the failure of lysis of the oocyte, in each case. It was suggested that the 
presence of the M2 buffer could be inhibiting the lysis or alternatively the efficiency of the 
tricene buffer to neutralise the solution, which in turn resulted in the inhibition of the PCR 
amplification. It was also around this time that the mUSF-A primer batch in use failed to 
work. If this was responsible for the lack of mouse usf2 DNA amplified, the transgenic repeat 
primer pair may still have worked. However, it was thought necessary to ascertain the number 
of oocytes containing the transgene accurately, as well as the number of repeats present.
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Figure 4.10
Oocytes isolated from Dmt mice after superovulation
After superovulation, individual oocytes wereisolated and lysed before being used as templates 
for SP-PCR amplification. IX  PCR buffer, 0.035 Units of Taq and 0.2 pM each of DM-H and 
DM-DR in a 7pi volume for 30 cycles under standard PCR conditions with an annealing 
temperature 63*C. The PCR products are resolved on a 1.5% gel before transfer to a nylon 
membrane and hybridisation with DM56.
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Attempt Dmt line Age of mouse super 
ovulated (weeks)
Oocytes
isolated
Transgenic 
repeat amplified
1 Dmt- D (3110) 15 weeks 4 1
2 Dmt- D (3178) 11 weeks 12 6
2 Dmt- D (3179) 11 weeks 17 2
2 Dmt- E (3253) 15 weeks 6 none identified
2 Dmt- E (3254) 15 weeks 10 none identified
3 Dmt- D (3107) 23 weeks 2 none identified
3 Dmt- E (3051) 25 weeks 18 none identified
Table 4.2 Summary of oocytes isolated from Dmt mice after superovulation
The isolation of oocytes from the Dmt strains proved inefficient and inconclusive. The 
isolation of gametes from Dmt mice on alternative strain background may prove more 
successful.
4.7 Discussion
The observation of sex differences in repeat transmission patterns of the Dmt lines is in 
common with observations made in triplet repeat diseases although these patterns are disorder 
dependent. DM1 females carrying large repeats transmit larger repeats to their offspring. 
Maternal DM1 transmissions account for the majority of CDM cases (Ashizawa et al., 1994; 
Tachi et al., 1997) suggesting that location of repeat does effect its repeat transmission 
instability profile. The degree of this variation differs between Dmt-D and Dmt-E, transgenes 
that have different integration sites and this highlights the role that must be played by cis 
acting factors. Seznec et al (2000) observe the transmission patterns of several DM1
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transgenic lines which contain ~300 repeats. The DM 300-328, DM 300-1112 and DM 300- 
1177 lines were generated from a transgene which encodes the expanded DM1 repeat within ~ 
45 kb of flanking genomic sequence including the coding sequence for DMPK, DMWD and, 
SIX5. Observation of the differences between the repeat transmitted between parent and 
offspring for each line observed DM 300-328, DM 300-1112 and DM 300-1177 transmitted 
86.5%, 88% and 95.5% expansions respectively. The effect of the transmitting parent sex on 
the repeat size was not reported. Each of the different lines presented different ranges of repeat 
events, the range for DM 300-328 was between +1 and +60, for DM 300-1112, between +3 
and +10 and for DM 300-1177, +2 and +42. This suggests that despite the influence of the 
genomic DM1 DNA on the repeat, variations in the integration sites of the lines also effects 
the repeat instability profile presented.
The effect of the age of the parent at the conception of its offspring on the parent offspring 
repeat difference was also examined by Seznec et al (2000). They observed a positive 
correlation between the increasing age of transmitting fathers and the increase in the repeat 
size transmitted to their offspring. No correlation was reported in maternal transmissions. The 
absence of correlation between the age of the transmitting parent and the size of the repeat 
transmitted in either of the Dmt lines may be due to the nature of the Dmt transgene. The lack 
of DM1 flanking DNA may effect this in the same way as differences in the integration site 
effect the size of the transmitted repeat. As an age / repeat size effect has been observed in 
DM 300 mice it is less likely that the lack of correlation is due to possible differences in 
gamete development in humans and mice. Age of parent repeat effects have also been reported 
for mouse models (Kaytor, 1997; Lorenzetti et al., 2000). Interestingly, the splitting of the 
four groups of transmitted data, that is maternal and paternal Dmt-E and Dmt-D transmissions 
into subsets consisting of the sex of the offspring reveal no obvious pattern in the maternal 
transmissions of either line. However, the paternal transmissions of the Dmt-E mice clearly 
splits into two distinct sex dependent modes. Kovten et al (2000) report a similar effect in 
male transmissions of (R6/1) Huntington’s model mice, although no data is given about 
female transmission patterns. They suggest that the intergenerational repeat differences 
observed are due at least in part to events occurring within the zygote. This may be possible, 
though if this was happening in Dmt-E mice it might be expected that more than one 
transgenic progenitor repeat size would be present in at least some of the tissues. Perhaps the 
sex of the sperm cell after division but preimplantation is influencing the repeat in some way. 
Trans acting factors associated with the Y chromosome but not the X chromosome or vice
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versa may effect the manner in which misalignments of the repeat are dealt with. In all other 
ways the mice are on a uniform genetic background.
Examination of instability in the sperm of Dmt-D mice was uninformative, although it was 
observed that the testes became more unstable with age. Pedigree data revealed no correlation 
between the increasing age of the transmitting father and the size of the repeat transmitted, 
although most of the large parental offspring repeat differences were observed in older 
parents. It is possible that there may be a correlation, but that the number of mice studied must 
be increased.
That segregation distortion was observed in Dmt-D and Dmt-E transmissions was in line with 
observations made of DM1 transmissions (Carey et al., 1994; Hurst et al., 1995).
More interesting however, was the influence of the sex of the transmitting parent on the 
segregation distortion observed, with 65% of male transmissions resulting in offspring 
carrying the transgene while female transmissions of the transgene were not significantly 
distorted. While male and female Dmt-E transmissions were significantly more likely to result 
in offspring carrying the transgene, females were more likely to transmit the transgene than 
males. Again these differences between the lines may be in some way accounted for by the 
differences of the Dmt-D and Dmt-E integration site.
I l l
Chapter 5
Investigation of transcription levels of the Dmt transgenes
5.1 Introduction
It has been demonstrated in Chapter 3 that the Dmt transgene exhibits variation in the somatic 
stability of the transgenic repeat depending on the line. As the Dmt transgenic lines contain 
similar numbers of repeats and the effect of the flanking transgenic DNA is thought to be 
minimal, the differences observed in the four Dmt lines must be due to differences in the 
integration of the transgenes into the mouse genome. That is, that the repeat in each line is 
subjected to different cis acting factors and these differences might explain the different 
stability levels observed in each transgenic line.
It may be possible that the instability mechanism effecting repeat stability might involve the 
transcription process (Figure 5.1). If the transgene was transcribed, then the paired triplet 
repeats are disrupted to allow transcription of the region. When the strands reanneal it is 
possible that the repeats fail to anneal “in register”, resulting in unpaired loops of repeats. If 
the DNA repair system was to recognise such “loop outs” as aberrant and “repair” them it 
could result in a difference in repeat length? Indeed if such a process resulted in expansions, 
the more often this annealing / reannealing occurred, the more likely it would be that the 
repeat would increase in size. As it appears that the larger a repeat is the more vulnerable it is 
to expansion, possibly due to the increased likelihood that the larger an expanded repeat tract 
the greater the chances that the repeat strands realign out of register. Therefore it could be that 
the degree to which the repeat region is transcribed could correlate with the level of instability 
observed in that tissue.
It has been observed that DMPK is expressed in a tissue specific manner (Erikkson et al., 
2000), meaning that the repeat is transcribed more frequently in some tissues. Could the 
differences observed in the stability of the transgenic repeat in the different lines be explained 
by the transcription of, or lack of transcription of the repeat? Indeed could the instability 
observed in Dmt-D be because it has integrated downstream of a promoter region and is 
transcribed frequently, while Dmt-B, -C and -E have not and are not? Speculation as to the 
nature of the integration site in Dmt-D is that it is in some way
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repeat tract
paired DNA strand
Paired DNA strands separate 
to allow transcription
After transcription the reannealling 
repeats align out of register
The resulting loopouts are recognised 
as aberrant by the mismatch repair complex
resulting in repeat deletion no change resulting in repeat expansion
The more often the repeat region is 
transcribed, the larger the repeat 
expansion will become
Figure 5.1
How the transcription of an unstable triplet repeat tract could result in expansion
The figure demonstrates how a functioning MMR complex could result in a change in the repeat 
length whilst the transgene is being transcribed. Indicated are the mismatch repair heterodimers as 
outlined in figure 3.1.
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incorporated into a kidney related gene and that there would be some correlation of 
transcription levels of the transgene and nature of instability observed in Dmt-D.
An alternative hypothesis suggested that more than one transgene had integrated downstream 
of a promoter region and was therefore transcribed but differences in stability levels could be 
influenced by the orientation of the integrated CTG*CAG transgene. To investigate these 
theories a series of experiments based on reverse transcription PCR were carried out.
5.2 Transcription of the Dmt transgene
5.2.1 Transgenic transcription in Dmt-B, -C, -D, and -E
To determine whether the Dmt transgene was being transcribed in any of the lines, total RNA, 
that is RNA from the lysed nucleus as well as the cytoplasm was prepared from the heart, 
brain and kidney of mice from each line and from a wild type FVB/n mouse. The mice were 
aged between 2 and 4 months, with the exception of the Dmt-B mouse, which was 20 months. 
3.0 pg of RNA in 5 X RNA loading buffer was electrophoresed on a 1% agarose, 0.1 % SDS 
gel in 1 X TAE (w/v) and stained by shaking in ~ 0.15 ng ml _1EtBr in distilled water. This 
allowed assessment of the quality of the RNA and the accuracy of the estimations of the 
concentration (Figure 5.2). If the RNA was of poor quality, the extraction was repeated where 
possible, with the exception of Dmt-B, where the source of archived tissue was limited. If the 
estimation of the concentration was inefficient the readjustment of the concentration was made 
by using the Kodak ID sizing programme to estimate the concentration of the bands relative to 
each other.
For each sample, cDNA was generated using 2.5 pg of each RNA as a template to make 
cDNA with 50 ng of random prime hexamers (Methods, 2.2.12). The reaction that was carried 
out with Superscript II reverse transcriptase was referred to as (+RT). A control reaction 
without reverse transcriptase, (-RT) was carried out for each tissue to check for genomic 
contamination. There should be only RNA in the -RT control. When this was used as template 
for a PCR amplification there should be not be a resulting product. If however, there is 
genomic DNA present in the template RNA this will be amplified and the resulting band will 
be indicative of genomic contamination.
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Figure 5.2 
RNA check gels
Each lane contains 2.5 g of RNA as determined by spectrophotometer on a 
1% agarose gel, 0.1% SDS in 1XTAE stained by shaking in distilled water 
iwith ~ 0.15 ng ml -1 EtBr w/v for 1 hour.The location of ribosomal RNA 
bands is indicated.
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Initially the PCR amplification of the mouse Gapdh product was used to determine the success 
of the reverse transcriptase reaction and to identify the presence of genomic DNA 
contamination in the RNA template (Figure 5.3). Controls to check for contamination were 
carried out for each set of PCR amplifications. This meant a -RT reaction for each sample. 
Both the +RT and -RT products were amplified with the mouse Gapdh primers, GAPDHA 
and GAPDHBR under standard PCR conditions with an annealing temperature of 68°C, which 
would amplify a product size of 696 bp. If genomic contamination was identified the RNA 
template was subjected to further DNase treatment (Methods, 2.2.9.1) until genomic 
contamination could no longer be detected. If cDNA could not be amplified using the mouse 
Gapdh primers, the +/- RT reactions were repeated for that RNA sample.
It is known that triplet repeats can be difficult templates for enzymes to interact with, as 
enzymes are known to “stall” as they progress through repeat tracts (Parsons et al., 1998) and 
that reverse transcriptase needs time to read the template. The contact time of the reverse 
transcriptase enzyme with the repeat tract during incubation was increased from the 50 
minutes recommended in standard protocols to 90 minutes in each case.
PCR was carried out on the RT +/- samples using CLW2F / CLW4R forward and reverse 
primers located in exon 2 and exon 4 of the mouse Dmpk gene respectively. The PCR 
amplifications were carried out under standard PCR conditions with an annealing temperature 
of 61°C. This primarily revealed a genomic transcript, 563 bp in size indicating the presence 
of heteronucleic RNA and spliced product, 232 bp in size (Figure 5.3).
RT-PCR was then carried out on the RT +/- samples using transgenic primers. DM-H / DM- 
DR flank the repeat and result in a product size dependent on the repeat number carried by the 
Dmt transgenic mouse and DM-R / DM-PRENK, which amplify a non repeat region of the 
Dmt transgene and results in a product 276 bp in size (Figure 5.4.A). These PCR 
amplifications were carried out under standard PCR conditions with an annealing temperature 
of 68°C. The products from each RT-PCR amplification were resolved on a 1.5% agarose gel 
(w/v) and a photograph taken before the PCR products were transferred via squash blotting 
(2.2.3.6) to a nylon membrane. The DM-H / DM-DR product was probed with DM-56,
(Figure 5.4A)
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Figure 5.3
Amplification of cDNA generated with random prime hexamers amplified with
A. CLW2F / CLW4R
B.GAPDHA/GAPDHBR
2.5 pg of total RNA from each tissue was used as a template for the generation of 
cDNA, which was primed using 50ng of random prime hexamers. The presence of the 
reverse transcriptase enzyme in the reaction is indicated by + (with), or - (without), lp l 
of cDNA product was used as the template for RT-PCR amplification using either A: 
CLW2 / CLW4 primers located in exon 2 and exon 4 of dmpk respectively or B: 
G A PD H A / GAPDHBR which amplifies a 696 bp gapdh product All PCR products 
were resolved on a 1.5 % agarose gel (w/v).
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and the DM-R / DM-PRENK product was probed with a DM-F / DM-PRENK PCR product, 
(Figure 5.4.B). The Dmt transgene was transcribed in all of the lines both in the flanking 
region and through the repeat. However, there were differences in the tissue specificity and 
transcription levels between the lines. Dmt-D showed high levels of transcription in all tissues, 
with bands visible on an agarose gel. Lines Dmt-B, -C and -E exhibited tissue specificity with 
transcription levels lower than that of the Dmt-D tissues. These bands were visible after 
Southern hybridisation. Transcription was observed in the brain in all lines, as well as the 
heart of Dmt-C.
5.2.2 Transcription in multiple tissues of Dmt-D
Transcription in Dmt-D appears to be transcribed in the three tissues studied. To investigate 
this further and any possible link between repeat stability levels, total RNA was made from a 
range of tissues from a 6 week old male mouse with 173 repeats. These included the 
quadriceps, total brain, liver, kidney, lung, heart, spleen, colon and testes (Figure 5.5.A). To 
investigate any age effects that may occur the quadriceps, total brain, liver, kidney, lung, heart, 
spleen, colon, testes and tongue from a mature Dmt-D mouse aged 14 months with 159 repeats 
were also examined (Figure 5.5.B). It appears that the Dmt-D transgene is ubiquitously 
transcribed in all of the examined tissues and that the level of transcription remains at a high 
level independent of the age of the mouse. It is likely that Dmt-D has integrated downstream 
of the promoter region of a housekeeping gene, although nothing is known about its proximity 
to the transgene.
5.2.3 Transcription in multiple tissues of Dmt-E
In order to determine whether any tissues other than the brain were transcribed multiple tissues 
from a mature Dmt-E male of 20 months with a repeat size of 162, were also examined. 
Although the quadriceps, total brain, spleen, liver, kidney, lung, heart, eye, colon, testes and 
tongue were all examined, the Dmt-E transgene was transcribed only in brain, lung, eye and 
testes (Figure 5.6).
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Figure 5.4
Transcription of transgene in D m t-B , -C, -D and -E
To determine whether the transgene is transcribed in thzDm t mice, total RNA was 
made from the heart, kidney and brain of a 2 month old wild type FVB/N, a 20 month 
old Dmt-B  mouse with 133 repeats, a 3 month old Dmt-C  mouse with 159 and 162 
repeats, a 4 month old Dmt-D mouse with 184 repeats and a 2 month old D mt-E 
mouse with 158 repeats. 2.5 pg of total RNA from each tissue was used as a template 
for the generation of cDNA, which was primed using 50ng of random prime hexamers. 
The presence of the reverse transcriptase enzyme in thereaction is indicated by + 
(with), or - (without), lp l of cDNA product was used as the template for RT-PCR 
using either A: DM-H / DM-DR to amplify across the transgenic repeat or B: DM- 
R / DM-PRENK which amplifies a non repetative region of the transgene, 276 bp in 
size. All PCR products were resolved on a 1.5 % agarose gel before transfer to a 
nylon membrane and hybridisation with A: DM56 or B: DM-F / DM-PRENK PCR 
product.
276 bp
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Figure 5.5
Transcription of transgene in multiple tissues of D m t-D
To determine whether the transgene is transcribed in all tissues of Dmt-D  and if the age of the 
mouse effects this transcription. RNA was prepared from the quadriceps, brain, liver, kidney, 
lung, spleen, heart, colon and testes of a 6 week old mouse with 179 repeats and the quadriceps, 
brain, liver, kidney, lung, spleen, heart, eye, colon, testes and tongue of a 14 month old mouse 
with 166 repeats.
2.5 pg of total RNA from each tissuewas used as a template for the generation of cDNA, which 
was primed using 50ng of random prime hexamers. The presence of the reverse transcriptase 
enzyme in thereaction is indicated by + ,(with) or -, (without), lp l of cDNA product was used 
as the template for RT-PCR using either DM-H / DM-DR to amplify across the transgenic repeat. 
All PCR products were resolved on a 1.5 % agarose gel before transfer to a nylon membrane 
and hybridisation with DM56.
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5.3 Orientation of the Dmt transgenes within their integration site
To allow investigation of the orientation of the CTG repeats within their integration sites 
cDNA was generated using 2.5 pg of total brain RNA from each line, Dmt-B, -C, -D, and -E. 
The cDNA was primed with 0.045 mM of GAPDHA and either 0.045 mM of DM-H or 0.045 
mM of DM-DR in the final reaction volume. The cDNA was amplified with GAPDHA / 
GAPDHBR to check the success of the reverse transcriptase reaction (data not shown) and 
with DM-H / DM-DR to determine the orientation of the repeat from this pool of first strand 
cDNA. In an attempt to corroborate the preceding experiment cDNA was also generated using 
0.045mM of GAPDHA and either 0.045mM of DM-R or 0.045mM of DM-PRENK in the 
final reaction volume. The ability to amplify the PCR product in one direction and not the 
other would indicate the orientation that the transgene had integrated in. The DM-H / DM-DR 
amplification was inconclusive as multiple bands were present on the 1.5% agarose gel (w/v) 
(Figure 5. 7.A) with patterns apparently common to the primer the cDNA was generated with. 
There were 2 distinct band patterns depending on orientation. Each band was the same size in 
each mouse. These visible bands did not hybridise with DM56. Other bands did however, 
hybridise with DM56 (Figure 5.7.B). These bands were probably transgenic in origin, an 
assumption made because of the apparent size difference present in the different mice. They 
also occurred in both orientations. DM-H is a 20mer and DM-DR is a 20mer with annealing 
temperatures of 74 °C and 68 °C respectively. It is likely that these primers are not specific 
enough and that the PCR product has been primed at an alternative site during the reverse 
transcriptase reaction which was incubated at the recommended temperature of 42 °C.
The DM-R / DM-PRENK amplification when hybridised with the DM-F / DM-PRENK PCR 
product also revealed bands (Figure 5.8.B) not visible on the 1.5% agarose gel (w/v) (Figure 
5.8.A). These single bands when present were present in the CAG orientation in Dmt-C, -D 
and -E and the CTG orientation in Dmt-E and -D. However, although a bias of band intensity 
was visible in the in the CAG orientation for Dmt-D, it was difficult to draw conclusions from 
this experiment.
It was suggested that the reverse transcriptase enzyme could function at 55 °C, but attempts to 
generate transgene specific cDNA at this temperature were unsuccessful (data not shown). As 
an alternative, transgenic 12mer primers were designed with annealing
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Figure 5.7
First strand DNA generated with DM-H or DM-DR is used to determine the orientation 
of integration of the Dmt transgenes
2.5 pg of total RNA from the brain of a 2 month old wild type FVB/N, a 20 month old Dmt- 
B mouse with 133 repeats, a 3 month old Dmt-C  mouse with 159 and 162 repeats, a 4 month 
old D m t-D mouse with 184 repeats and a 2 month old D m t-E mouse with 158 repeats was 
used as a template for the generation of cDNA.
First strand cDNA was generated for each tissue using either 0.045 mM of DM-H and 0.045 
mM of GAPDHA or 0.045 mM of DM-DR and 0.045 mM of GAPDHA in the final reaction 
volume. The presence of the reverse transcriptase enzyme in the reaction is indicated by + 
(with), or - (without).
lp l  of each cDNA product was used as the template for RT-PCR amplification with DM-H / 
DM-DR the PCR products were resolved on (A) a 1.5 % agarose gel (w/v) before transfer to 
a nylon membrane and (B) hybridisation with DM56.
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Figure 5.8
First strand DNA generated with DM-R or DM-PRENK are used to determine the orientation 
of integration of the Dmt transgenes
2.5 |ig of total RNAfrom the brain of a 2 month old wild type FVB/N, a 20 month old D mt-B mouse 
with 133 repeats, a 3 month old Dmt-C  mouse with 159 and 162 repeats, a 4 month old D mt-D mouse 
with 184 repeats and a 2 month old D m t-E mouse with 158 repeats was used as a template for the 
generation of cDNA.
First strand cDNA was generated for each tissue using either 0.045 mM of DM-R and 0.045 mM of 
GAPDHA or 0.045 mM of DM-PRENK and 0.045 mM of GAPDHA in the final reaction volume. The 
presence of the reverse transcriptase enzyme in the reaction is indicated by + (with), or - (without), 
lp l  of each cDNA product was used as the template for RT-PCR amplification with DM-R / DM- 
PRENK,the PCR products were resolved on (A) a 1.5 % agarose gel (w/v) before transfer to a nylon 
membrane and (B) hybridisation with DM-F / DM-PRENK PCR product.
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temperatures of 40 °C. It was hoped that DM-H12 and DM-DR12 would improve the 
specificity of the reverse transcriptase reaction. Transgene specific cDNA was generated using
2.5 ng of total RNA from the brain of a wild type FVB/n and Dmt-B, -C, -D, and -E  mice, 
with 0.045mM GAPDHA and either 0.045mM DM-H12 or 0.045mM DM-DR12 in the final 
reaction volume. RT-PCR was carried out with both GAPDHA / GAPDHBR and DM-H / 
DM-DR.
Again the agarose gel (Figure 5.9 A) was uninformative, but transfer of the DM-H / DM-DR 
PCR products to nylon membrane and probing with DM56 revealed single bands of transgenic 
size for each line. Although bands could be observed in both orientations in all four examined 
lines, there was a bias in intensity in each case. It is thought that Dmt-C, -D, and -E are 
transcribed primarily in the CAG orientation and that Dmt-B is primarily transcribed as a CTG 
repeat (Figure 5.9 B).
It was suggested that the GAPDHA primer could be priming across the transgenic repeat in 
both directions and this would account for the presence of bands in both orientations. To 
further investigate the effect of the GAPDHA, 3 further cDNAs were generated using 2.5 pg 
of Dmt-D brain total RNA, with 0.045mM DM-H12 or 0.045mM DM-DR12 or 0.045mM 
GAPDHA in the final reaction volume of 11.5 pi. RT- PCR was carried out on each cDNA 
using DM-H / DM-DR. Each PCR product was resolved on a 1.5% agarose gel (w/v) before 
transfer to a nylon membrane. Southern hybridisation of the cDNAs with DM-56 revealed a 
strong band with the DM-H12 cDNA product and a weaker band for the DM-DR12 cDNA 
RT-PCR product. The band which hybridised with the GAPDHA cDNA RT-PCR product was 
weaker still (Figure 5.10). This suggests that the presence of GAPDHA in the RT-PCR 
reaction when generating the orientation specific first strand cDNA was contributing to the 
band which hybridised with DM56. However, this experiment would appear to confirm that 
although Dmt-D is transcribed in both orientations it is primarily as a CAG transcript.
5.4 Investigation of the presence of the transcribed transgenes in the 
cytoplasm
Experiments to ascertain whether the transcribed transgenes were present in the cytoplasm or 
restricted to the nucleus of the 4 transcribed lines were carried out. If the transgenes were
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Figure 5.9
Determination of the orientation of the Dwr-transgene by the ability to amplify the 
transgene from pools of first strand DNA generated with DM-H12 or DM-DR12
2.5 pg of total RNA from the brain of a 2 month old wild type FVB/N, a 20 month old D mt-B 
mouse with 133 repeats, a 3 month old Dmt-C  mouse with 159 and 162 repeats, a 4 month old 
D m t-D mouse with 184 repeats and a 2 month old D mt-E mouse with 158 repeats was used as a 
template for the generation of cDNA.
First strand cDNA was generated for each tissue using either 0.045 mM of DM-H 12 and 0.045 
mM of GAPDHA or 0.045 mM of DM-DR12 and 0.045 mM of GAPDHA in the final reaction 
volume. The presence of the reverse transcriptase enzyme in the reaction is indicated by + ,(with) 
or -, (without).
lj.ll of each cDNA product was used as the template for RT-PCR amplification with DM-H / DM- 
DR and the PCR products were resolved on (A) a 1.5 % agarose gel (w/v) before transfer to a 
nylon membrane and (B) hybridisation with DM56.
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DM-H12 DM-DR12 GAPDHA
1353 bp
1078 bp
3 10  bp
Figure 5.10
To determine whether the prim er GAPDHA could generate a transgenic PCR 
product
2.5 f.ig of total RNA from the brain of a 4 month old D m t-D mouse with 184 repeats 
was used as a template for the generation of cDNA. First strand cDNA was generated 
for each tissue using either 0.045 mM of DM-H 12 or 0.045 mM of DM-DR12 or 
0.045 mM of GAPDHA in the final reaction volume. The presence of the reverse 
transcriptase enzyme in the reaction is indicated by + (with), or - (without), lp l  of 
each cDNA product was used as the template for RT-PCR amplification with DM-H 
/ DM-DR,the PCR products were resolved on a 1.5 % agarose gel (w/v)(not shown) 
before transfer to a nylon membrane and hybridisation with DM56 .
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found only in the nuclear fractions it could be assumed that they were located in intronic 
regions of the genome or that the integration of the repeat may have disrupted transcript 
processing in some way. The repeat may have made the export of the transcript out of the 
nucleus sterically unviable and it had therefore become trapped (Koch and Leffert, 1998).
5.4.1 The enrichment of polyA RNA from total RNA by using Dynabeads™ Oligo (dT)25 
100 pg of total RNA from wild type, Dmt-B, -C, -D and -E mouse brains were enriched for 
polyA RNA by passing through Dynabeads™ Oligo (dT)25 according to the Dynabeads™ 
protocol. 1 pi of this polyA enriched RNA was used as template for cDNA generated with 
0.09 mM of random prime hexamers in the final reaction volume. This cDNA was used as a 
template for RT-PCR carried out with GAPDHA / GAPDHBR which confirmed the success 
of the reverse transcriptase. Amplification across the repeat with DM-H / DM-DR resulted in a 
transgenic band in all of the transgenic lines. However, amplification with CLW2F / CLW4R 
revealed the presence of a heteronucleic RNA sized product as well as a spliced products 
(Figure 5.11). It is possible that this single round of enrichment was not enough to exclude 
none polyA products. Alternatively successful enrichment may have been achieved but the 
pool of polyA products included polyadenylated transcripts, where not all of the introns had 
been removed by splicing as well as messenger RNA. Transcription levels in all lines except 
Dmt-D require Southern hybridisation to be detectable and this sensitive method could be 
detecting heteronucleic product that has already acquired a polyA tail. To continue this study 
alternative strategies were adopted.
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5.4.2 First Strand cDNA synthesis with XYT primer
First Strand cDNA synthesis was carried out on 2.5 pg of total RNA isolated from the brain of 
wild type, Dmt-B, -C, and -D mice using 0.09mM of the XYT primer (Friedrich et al., 1993) 
in the final 11.5 pi reaction volume. The XYT primer is a polyT primer designed to anneal to 
RNA transcripts with a polyA tail. The success of the reverse transcriptase was confirmed by 
amplifying GAPDHA / GAPDHBR. The amplification of the repeat resulted in a band in the 
transgenic lines. Again however, amplification between introns 2 and 4 revealed the presence 
of multiple products as well as the product of the mRNA template (Figure 5.11).
To determine whether transcripts containing the transgene are exported into the cytoplasm a 
method to separate the nuclear and cytoplasmic RNAs would be necessary.
5.4.3 Separation of cytoplasmic and nucleic cell fractions
To separate nuclear and cytoplasmic fractions with complete confidence of having eliminated 
cross contamination was thought to be difficult when using tissues. Separation of the nuclear 
fraction by centrifugation could be achieved, but the cytoplasmic fraction might still be 
contaminated by nuclei lysed in the initial tissue homogenisation and only complete 
confidence in the purity of a pure cytoplasmic fraction could conclusively demonstrate that the 
transgenes were exported to the cytoplasm.
Alternatively cell lines can be lysed using a gentle chemically based method that allows the 
purification of cytoplasmic and nuclear RNA fractions. Cell lines were available from Dmt-D 
mice only. The chosen cell line which was established from the kidney of a 5 week Dmt-D 
male had undergone few passages and this limited the possibility of rearrangements. A flask 
containing 3 X 106 cells from the Dmt-D 3111 kidney cell line were separated by a modified 
method (Hamshere et al., 1997) and RNA extracted using TRI REAGENT™.
0.09 mM of random prime hexamers in the final reaction volume was used to make cDNA 
using either 2.0 pg of cytoplasmic or 2.0 pg nucleic RNA as template. Reverse transcriptase 
PCR was carried out with the control primers GAPDHA / GAPDHBR. Amplification across 
exon 2 and 4 of DMPK revealed both a heteronucleic and spliced product from the nuclear 
fraction. However, only a spliced product was present when the
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cytoplasmic fraction was hybridised. The amplification across the CTG repeat using both 
cDNAs as template resulted in a band from the nuclear fraction only (Figure 5.12).
5.5 Conclusion
To summarise the results of this chapter all 4 of the Dmt transgenic lines examined are 
transcribed, although there is a difference in the nature of the transcription of these lines. 
Although the level of transcription has not been determined exactly, equivalent amounts of 
RNA from each line was used to generate the cDNA for each set of experiments. Equal 
volumes of the generated cDNA from each line and tissue were used as the template for each 
of the RT-PCR amplifications.
Dmt-B, -C and -E exhibit transcription in certain tissues with variation between the tissue 
types, that is transcription is detected in some tissues and not at all in others. Dmt-D however, 
demonstrates a higher level of transcription than that detected in the examined tissues of the 
other lines and the transcription is apparently ubiquitous. The transcription level observed in 
the kidney appears no different to that of the other examined tissues.
Investigation of the orientation of the transcribed repeats within their integration sites suggests 
Dmt-C, -D and -E are transcribed as CAG repeats, while Dmt-B has integrated in the CTG 
orientation. This eliminates the suggestion differences in the repeat orientation between Dmt- 
D and the other lines could account for the gross somatic instability associated with Dmt-D.
Attempts to determine whether the repeats are present in the cytoplasmic RNA fraction have 
been inconclusive for lines Dmt-B, -C and -E. However, it has been determined that the 
transcribed repeat is not present in the mRNA of the Dmt-D kidney cell line. This suggests 
that the Dmt transgene has probably integrated into an intron. Alternatively the integration site 
could be within a UTR but the expanded repeat could be preventing the export of the transcript 
into the cytoplasm (Koch and Leffert, 1998). The possibility of the integration site being 
within an exon is less likely. Again the repeats presence may sterically inhibit export. 
However, such an integration site would also effect the protein into which the transgene has 
integrated and no resulting phenotype has been observed in the Dmt-D mice. Dmt-D mice 
have survived as homozygotes. The arguments for UTR and exonic integration sites are again
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Figure 5.12
To determine the presence of the Dmt-D transgene in cytoplasmic and nuclear 
RNA fractions
Cytoplasmic and nuclear cDNA was generated with 2pg of each template RNA isolated 
from the Dmt-D 3111 kidney cell line, with a 165 repeat size, using 50 ng of random prime 
hexamers. The presence of the reverse transcriptase enzyme in the reaction is indicated by 
+ ,(with) or -, (without), lp l  of each cDNA product was used as the template for RT-PCR
A. Amplification of the cDNA with Dmpk primer pair hybridised with Dmpk PCR product and
B. Amplification of the cDNA across the transgenic repeat hybridised with DM56. The PCR 
products were resolved on a 1.5 % agarose gel (w/v) before transfer to a nylon membrane 
and hybridisation with (A) Dmpk PCR product and (B) DM56 .
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weakened with the observation that the expansion within the Dmt transgene may not be so 
large that their export into the cytoplasm would be prevented.
It has been hypothesised that part of the multifaceted nature of the instability exhibited by 
DM1 patients could be attributed to the transcribed CUG DM1 repeat forming hairpin 
structures. Such structures are retained within the nucleus and might act as protein “sinks” 
removing certain proteins from their correct cellular function (Phillips et al., 1998; Tian et al., 
2000). The grossly expanded Dmt-D transcribed repeats are CAG tracts and would not cause 
proteins that may be associated with DM1 phenotype to aggregate.
In conclusion although all of the Dmt lines are transcribed the major difference revealed 
between the somatically unstable line is in the nature of the transcription. It is possible that 
differences in the integration sites, i.e. the conformation of the DNA or transcription may 
account for the differences in stability observed in the somatic tissues between Dmt-D and the 
other lines. However, the significance of such an observation may be limited as the unstable 
repeat tract in DMPK is transcribed in a tissue specific manner.
Although the transcription of the repeat associated with DM1 is associated with the disease 
phenotype (Chapter 1.8), transcription does not appear to play a major role in repeat 
instability. None of the Dmt transgenic lines display a DM1 associated phenotype.
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Chapter 6
Investigation of the stability levels of the Dmt transgene on a 
background deficient in a mismatch repair protein
6.1 Introduction
The experiments in the previous chapters have shown that the Dmt-D transgenic repeat 
exhibits tissue specific expansion biased instability and somatic mosaicism. The instability 
does not appear to be related to the level of transgenic transcription or indeed the cell turnover 
of a particular tissue. Hypothesised mechanisms of instability involve the aberrant behaviour 
of a functioning mismatch repair (MMR) protein complex mistakenly interpreting misaligned 
repeat regions (Figure 3.1).
HNPCC kindreds are associated with the mutation in one of the genes associated with the 
MMR protein complex. Studies into the stability of microsatellite DNA in HNPCC cases 
showing a germline mutation in a mismatch repair gene also showed microsatellite instability 
in their tumours (Liu, 1996). While a study of the trinucleotide repeat of SBMA, SCA type 1 
and DM1 in early breast carcinoma tumours found triplet repeat instability in around 5% of 
the tumours. If instability was detected, it was present at all three loci, and among these three 
it was the DM1 locus which exhibited the greatest degree of instability (Shaw et al., 1996), 
demonstrating that although the MMR protein complex has a role to play in repeat instability, 
the level of instability shown is effected by cis acting factors. Accepting that the MMR protein 
complex does play a role in repeat instability, then what is the effect of a damaged MMR 
complex on an expanded triplet repeat, for example the Dmt transgene?
The MMR protein complex, role involves ‘proofreading’ DNA, this includes correcting errors 
in base pairing, unpaired regions and the removal of unusual DNA structures, which includes 
hairpins or loopout structures (Umar et al., 1994; Yu et al., 1995). MutLa is a heterodimer that 
forms part of the MMR protein complex. It consists of MLH1 and PMS2 and mutations in 
PMS2, account for a small number of HNPCC cases (Buermeyer et al., 1999). Baker et al. 
(1995) knocked out the function of Pms2 in mice by targeting the insertion of a neomycin 
cassette into the Pms2 locus (Figure 6.1). Initial observation of these Pms2 (-/-) mice showed 
the males to be sterile. Problems were observed in chromosome alignment and pairing 
indicating a role in meiosis (Baker et al., 1995), although sterility was also observed in male
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Pms2
mP2-3mP2-l
1. Amplification of PCR product 
from wildtype Pms2.
neomycin 
cassette.'
Pms2
m P2-l mP2-3
2. Insertion of the neomycin 
cassette into Pms2 knocks out 
the gene function and disrupts 
the mP2-3 primer site.
neomycinPms2 cassette 3. Amplification of PCR product from Pms2 knockout.
mP2-l mP2-2 
190 bp
Figure 6.1
The Pms2 knockout
The targeted insertion of a neomycin cassette into the Pms2 gene knocks out the function 
of the protein.
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and female Mlhl (-/-) mice (Baker et al., 1996). The Pms2 (-/-) female mice were observed to 
be fertile as were male and female Pms2 (+/-) mice. A study of Pms2 (-/-) mice observed 95% 
of the 20 mice studied developed tumours by 6 months, the majority of which were 
lymphomas and the remainder sarcomas (Qin et al., 1999). Comparison of the rate of mutation 
in long and short tracts of mononucleotide in Mlhl (-/-) or Pms2 (-/-) murine null 
homozygotes found the mutation rate in M lhl (-/-) mice to be 2-3 times higher than in Pms2 (- 
/-) mice (Yao et al., 1999). To study the effect of the MMR complex on Dmt repeat stability, 
Dmt-D and Dmt-E mice were crossed with mice deficient in Pms2.
6.2 Mouse typing for the Pms2 status of each mouse
To determine the Pms2 status of each mouse, 1 pi (~1 ng) of tail dilution was set up in a 7 pi 
PCR reaction containing 1 X PCR buffer, 0.35 units of Taq polymerase and 1 pM each of 
mP2-l, mP2-2 and mP2-3 and cycled 30 times under standard conditions, with an annealing 
temperature of 61 °C. The reaction volume was made up to 10 pi with loading dye and the 
complete volume resolved on a 1 % agarose, 2 % nusieve gel (w/v) at 100 V for ~ 2 hours 
before photographs were taken. The mP2-l and mP2-3 primer combination will amplify a 
band 357 bp in size from mice containing an undisrupted copy of Pms2. The mP2-l and mP2- 
2 primer combination will amplify a band of 190 bp in mice whose copy of Pms2 has been 
disrupted by the insertion of a neomycin cassette into exon 2. This disruption results in a null 
mutation (Baker et al., 1995). This mP2-l, mP2-2 and mP2-3 primer mix allows the 
identification Pms2 homozygotes (+/+), Pms2 heterozygotes (+/-) and Pms2 null homozygotes 
(-/-) (Figure 6.2). Although the PCR amplifications result in extra bands of a similar size to 
those of interest, the identity of the correct bands was confirmed by the sequencing of the PCR 
products resulting from the primer mix combination. After resolving the PCR products on a 
2% agarose gel, each band of interest was isolated, the products were purified from the 
agarose gel using the Qiagen PCR Purification Kit. Each isolated product was cloned into the 
pCR®2.1-TOPO vector using the TOPO TA Cloning kit™ as described in the kit’s protocol 
and transformed into the F Escherichia coli TOP 10 bacterial strain. Resulting white colonies 
were grown up overnight in LB and the plasmid isolated using the Qiagen Plasmid DNA Mini 
Prep Kit. The PCR products were then sequenced using plasmid specific primers and the ABI 
PRISM™ Dye Terminator Cycle Sequencing Ready Reaction Kit.
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Figure 6.2
Identification of Pm sl transgenic mice
PCR amplification to detect Pms2 homozygotes (+/+), hemizygotes (+/-) or null homozygotes 
(-/-) by amplifying lp l of tail lysate (~ 1 ng of DNA) in a 7pl volume containingl pM each 
of (1) m P2-l, mP2-2 and mP2-3, or (2) m P2-l, mP2-2 or (3) m P2-l, mP2-3. These primer 
combinations will amplify (1) both the positvie, 357bp and the negative, 190 bp, P m sl 
products. (2) The 190bp P m sl  product. (3) The 357bp P m sl  product. The PCR products 
were resolved on a 1 % agarose, 2 % nusieve gel (w/v) at 100 V for ~ 2 hours.
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The bands identified in Figure 6.2 as the correct Pm sl products were the only sequenced 
products that contained the correct primer combinations.
6.3 Matings between Dmt and Pm sl mice
Matings were set up in the first instance between Dmt-D or Dmt-E mice hemizygous, (+/-) for 
the Dmt transgene and mice hemizygous (+/-) for the Pms2 transgene. Matings were then set 
up from subsequent generations between Dmt (+/-) / Pm sl (+/-) mice and mice transgenic for 
only Pm sl (+/-). Although the Pm sl status of the mice varied, (+/+), (+/-) and (-/-), all of the 
Dmt mice bred were hemizygous for the transgene. The number of Dmt-D (+/-) / Pm sl (-/-) 
offspring generated was low, 20 mice, while only 2 Dmt-E (+/-) / Pm sl (-/-) were generated. 
The study of Dmt (+/-)> Pm sl (-/-) was difficult as the majority became ill before 6 months of 
age, developing paralysis of the hind legs, a condition which lead to rapid deterioration and 
subsequent sacrifice of the mouse. Analysis of a Dmt-D (+/-), Pms2 (-/-) mouse at the onset of 
this paralysis at 26 weeks and its apparently healthy Dmt-D (+/-), Pm sl (+/-) littermate after 
their sacrifice at the same timepoint found no tumours present in either mouse. Both mice 
were found to have leukaemia. These investigations were inconclusive.
6.4 Somatic mosaicism in a Dmt-E transgenic mouse on a P m sl (-/-) 
background
The effect of the loss of the Pm sl protein on the transgenic repeat in a stable line was 
examined by crossing the stable Dmt-E line onto a Pms2 deficient background. A Dmt-E (+/-), 
Pm sl (-/-) mouse, with a repeat size of 160 was sacrificed at 12 months because it had 
developed multiple muscle sarcomas. A selection of tissues were removed including the 
tumours and the associated muscle, as well as blood, heart, lung, kidney, colon and skin. DNA 
was prepared from the proteinase K lysate by phenol / chloroform extraction and the DNA 
concentration was determined by spectrophotometry before diluting to 1200 pgpT1, 120 pgpT1 
and 12 pgpT1. Duplicate SP-PCR amplifications were made using the 1200 pgpl'1 and the 12 
pgpT1 concentrations as templates. Instability of the transgenic repeat was observed in some of 
the tissues, including but not exclusively the tumours. The observed instability was deletion
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biased (Figure 6.3). This degree of instability had only been observed previously in the tumour 
associated tissues and blood of a 25 month Dmt-D mouse (Chapter 3.4.4).
6.5 Somatic mosaicism in Dmt-D, transgenic mice on a P m sl (-/-) or P m sl (- 
/+) background
A male Dmt-D (+/-), Pm sl -/- mouse, with a transgenic repeat size of 163 was sacrificed at 6 
months, after it had developed a tumour next to the spinal cord. Its female Dmt-D, Pm sl +/-, 
littermate, with a transgenic repeat size of 188 was sacrificed at the same timepoint. DNA was 
prepared from a selection of tissues using proteinase K lysis. The tissue lysates were diluted 
assuming that 1 pi of the lysate contained ~ 1 ng of DNA. Serial dilutions 1/10 (~ 1000 pgpl' 
x), 1/100 (~ 100 pgpl'1), 1/1000 (~ 10 pgpl'1) were carried out in dilution buffer containing 
0.1 pM DM-H. lp l of the 1/10 and 1/1000 serial dilutions were used as templates for duplicate 
and quadruplicate small pool PCR amplifications respectively. All SP-PCR conditions were 
consistent with those in Chapter 3. Initial comparison between the tissues of the two mice 
reveals apparent differences between the kidney samples. The kidney that has been reported as 
the most unstable of the Dmt-D tissues (Chapter 3), with instability visible at 6 months. 
However, there is apparently a difference in stability in the Dmt-D, Pm sl mouse when 
compared to its Dmt-D Pm sl +/- littermate. The kidney in the Dmt-D, Pm sl -/- mouse is 
apparently more stable. This means that any qualitative observations at this timepoint are very 
preliminary. At 6 months instability is only just becoming visible in tissues other than kidney 
as differences in tissue instability profiles begin to develop (Figure 6.4). Comparison between 
the heart and eye tissue of the littermates also suggests there may be differences in stability 
levels. However, no absolute conclusions could be drawn from these initial experiments, as 
quantification of the levels of stability of the different tissues was not carried out. At the time 
of this experiment these were the oldest mice available, and time restriction prevented 
quantification of the instability observed in the mice. Studies by Mr Mario Pereira and Miss 
Laura Ingram, (personal communication), carried out on 8 month old Dmt-D Pm sl -/- and 
Dmt-D Pm sl +/- littermates, which include quantification, observed that although the repeat 
does indeed appear to be more stable in the Dmt-D Pm sl -/- littermate, with fewer expansion 
events. However, large deletion events appear to occur more frequently.
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Figure 6.3
Somatic mosaicism in a 12 month old Dmf-E mouse with multiple tumours
DNA from a 12 month old Dmt-E female with a repeat size of 160 was extracted from 
multiple tissues including muscle sarcomas and the muscles associated with the tumours. 
Between 1 and 20 molecules of DNA were used as the template for duplicate SP-PCR 
amplifications, the PCR products were resolved on a 1.25 % agarose gel (w/v) before 
transfer to a nylon membrane and Southern hybridisation with DM56. The marker has been 
converted to show the number of repeats. The size of deletions have also been indicated.
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Figure 6.4
Comparision of tissue instability in Dmt-D / >/tis2 -/- and Dmt-D Pms2 +/- littermates
Comparision of tissue instability between a D m t-D Pms2 +/-mouse with a repeat size of 188 and 
its D m t-D Pw s2 -/- littermate with a repeat size of 178. Both mice were sacrificed at 6 months. 
Small pool PCR was carried out on between 1 and 20 molecules of template DNA/reaction. The 
samples were resolved on a 1.25% agarose gel (w/v) before transfer to nylon membrane and 
hybridisation with DM56. The marker has been indicated as number of repeats. Highlighted are 
the common tissues, brain and eye.
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6.6 Discussion
The hypothesis of the mismatch repair model for triplet repeat instability suggests that the 
mismatch repair complex provides the mechanism responsible for the expansion biased 
instability observed at microsatellite loci and expanded triplet repeat loci (Figure 3.1). This 
suggests that the loss of the mismatch repair complex could confer stability to regions of 
instability. This series of experiments was a preliminary investigation of the behaviour of the 
Dmt transgenic repeat on a Pms2 deficient background. The loss of Pms2 appears to have little 
effect on the stable line Dmt-E, except in tissues that have undergone a mutation event that has 
lead to tumour development. Such tissues exhibit a mosaicism in the repeat length and this 
instability is deletion biased. It should be noted that Dmt-E mice not lacking Pms2 have also 
exhibited instability after the development of tumours (3.4.4), although repeat deletions and 
expansions were observed in that case. Pereira and Ingram, (personal communication) also 
report that quantification of tissues from 8 month old Dmt-D Pms2 -/- and Dmt-D Pms2 +/- 
littermates, has revealed fewer expansions in the Dmt-D Pms2 -/- mouse although large 
deletion events appear to occur more frequently in the tissues of these mice. It could be that 
some mutation events leading to the development of tumours might also effect the 
mechanisms of repeat instability. Schumacher et al (1997) suggests the involvement of MMR 
in at least 2 pathways involved with repeat stability and it is already known that instability 
events in triplet repeat tracts contained in plasmids are influenced by the purity and length of 
the repeat tract (Jaworski et al., 1995) and the loss of MMR proteins. Repeat tracts in excess 
of 100 almost always result in deletion events greater than 8 repeats (Pamiewski et al., 2000), 
while observations of tracts made up of less than 100 repeats in found instability event of (+/-) 
one repeat more frequent. The loss of MMR proteins resulted in a reduction of instability 
events. The purity of the repeat tract also has an effect with purer repeat tracts being more 
vulnerable to repeat deletions. As all of the roles of repair complex proteins are not known, as 
cis acting factors vary depending on the transgene integration sites and as the purity of the 
repeat tract has not been discerned in either the lines or individual mice, the processes 
involved in these repeat events cannot be discerned. That some events involving tumour 
development do influence repeat instability can be inferred.
Preliminary comparison of the tissues of Dmt-D, Pms2 +/- and Dmt-D, Pms2 -/- siblings 
suggests that mice completely lacking in Pms2 exhibit a different somatic instability profile to 
its Pms2 heterozygous sibling and were less prone to expansions events. The effects due to the 
loss of a functioning MMR protein complex because of its lack of Pms2 requires further
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investigation. The use of older sib pairs may confirm the trend of repeat instability. Further 
comparisons with of Pms2 null homozygotes and heterozygote siblings with Pms2 
homozygote siblings may reveal differences in the instability profiles of all three. Does a 
partially functioning MMR complex confer the same level of instability to the Dmt-D repeat 
tract as the Pms2 homozygote? The quantification of such differences is also required. Studies 
by Manley et al, (1999), studied the effect on the somatic tissues of the Huntington’s disease 
triplet repeat expansion model mice generated by Mangiarini et al, (1997), when they were 
crossed with mice deficient in Msh2 (Andrew et al., 1999). The MSH2 protein is present in 
both of the MutS heterodimers of the MMR complex (Buermeyer et al., 1999). Tissue 
instability profiles were generated using Genscan® analysis. Comparison of the instability 
profiles of the CAG repeat in the striatum and heart of Msh2 +/+ mice with Msh2 -/- mice 
finds the range of repeat instability shown in Msh2 -/- mice to be less than that exhibited by 
mice with a functioning MMR complex. This in combination with the preliminary Pms2 
instability data supports the hypothesis of the role of the MMR complex in triplet repeat 
instability. HNPCC kindreds are most likely to be associated with MLH1 and MSH2 mutations 
with fewer than 10 % associated with PMS2 mutations leading to suggestions that the roles of 
MLH1 and MSH2 in MMR are critical, while the role of PMS2, although important may be 
carried out through alternative pathways.
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Chapter 7 
Discussion and future studies
7.1 Introduction
The initial aim of this study was to establish the suitability of the lines of mice generated with 
the Dmt transgene as models of triplet repeat instability. It was established that the triplet 
repeat in one of the lines, Dmt-D, models the gross, tissue specific, somatic instability 
observed in DM1 patients, being both expansion biased and increasing over the lifetime of the 
mouse. The other lines, Dmt-B, Dmt-C and Dmt-E exhibited only limited instability. As the 
lines are all derived from the Dmt transgene and in the absence of evidence of triplet tract 
rearrangement transgenic repeat stability differences must be explained by differences in the 
integration sites. Analysis of transmission data found that the size of the repeat transmitted 
was dependent on the sex of the transmitted parent, with males most likely to transmit 
expansions and females deletions in both of the lines studied, Dmt-D and Dmt-E.
Dmt- D and the stable lines were used to investigate candidate mechanisms of expansion in the 
first instance.
7.2 Mechanisms of somatic instability
Initial investigation of the levels of somatic instability in the different tissues, revealed there to 
be no correlation between the level of instability exhibited by a tissue and the rate of cell 
turnover in that tissue. No relationship between the degree of repeat instability shown and 
tissues that exhibit DM1 disease phenotype was observed. The sex of the mouse had no effect 
on the somatic instability profile of the tissues examined.
Quantification of the repeat length in the unstable Dmt-D tissue, the kidney, revealed that the 
repeat lengths split into at least three modes as the mouse aged beyond a year. Microdissection 
of the kidney, an organ containing many specialised cell types, suggests that the cell 
population in different regions are subject to different levels of repeat expansion events. So 
different cell populations, both between and within the same tissue, subject the repeat tract to
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differing numbers of repeat instability events. Comparison of the rate of replication and the 
level of transcription of the different tissues in Dmt-D found no obvious correlation. It may be 
the case that replication and / or transcription may result in repeat instability events, but not at 
a level that accounts for the inter and intra cell differences observed or, maybe replication and 
/ or transcription are necessary to the triplet repeat instability pathway, but not sufficient alone 
to promote instability at the observed levels.
Although PMS2 is not reported as the most important component of the MutLa complex, 
preliminary studies at the 6 month timepoint appears to reduce the level of expandability 
exhibited by somatic tissue. Subsequent studies carried out by Mr Mario Pereira and Miss 
Laura Ingram, an honours student, have confirmed that the repeat is more stable in a Dmt-D 
Pms2 -/- mouse than in its Dmt-D Pms2 +/- littermate when studying tissues of eight month 
old mice. However, initial analysis indicates that the differences in stability between the 
tissues of the littermates shows a tissue specific pattern.
The MSH2 protein is present in both of the MutS complexes of MMR (Buermeyer et al., 
1999). Mice containing the triplet repeat expansion in the Huntington’s disease transgenic 
mice generated by Mangiarini et al, (1997), were crossed with mice deficient in Msh2 
(Andrew et al., 1999) by Manley et al, (1999). Genscan® analysis was used to study the effect 
of the loss of Msh2 on the transgenic repeat instability exhibited by different tissues. 
Comparison of the instability profiles of the CAG repeat in the striatum and heart of Msh2 +/+ 
mice with Msh2 -/- mice finds the range of repeat expandability exhibited by the Msh2 -/- 
mice to be less than that exhibited by mice with a functioning MMR complex. These data and 
the preliminary Pms2 studies of the Dmt-D mice suggest that the MMR protein complex has a 
role in the expansion mechanism(s).
There are cells contained within the kidney which undergo a higher number of expansion 
biased repeat instability events than any of the other cells which have been studied. The 
mechanism of expansion involves a functioning MMR complex, but transcription and or 
replication events are not sufficient to account for the majority of instability events, although a 
role, possibly essential, has not been excluded.
The kidney contains highly specialised cells and as none of the other tissues, with which it has 
cell types in common, exhibit the extreme level of repeat expansion it is likely that the 
unstable cell type is among these specialised cells. My preliminary microdissection of kidney 
regions would suggest this is so. It has been observed that oxidative stress, a condition 
describing the production of oxygen radicals beyond a threshold for proper antioxidant
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neutralisation has been implicated in the pathological mechanism of several neurodegenerative 
disorders, including Huntington’s disease (Borlongan et al., 1996). A study by Usuki and 
Ishiura (1998) on the effect of oxidative stress on a cell line containing DMPK with an 
expanded CTG repeat (CTG)46 observed that the DMPK expanded repeat increased the cells 
susceptibility to oxidative stress. Usuki and Ishiura (1998) suggest that the expansion may in 
some disrupt the pathway controlling signalling molecules effecting the redox state.
I hypothesise that the cell type which is exhibiting the high level of repeat expansion events, is 
subject to a high level of oxidative stress. This damages the DNA that requires the action of 
the MMR mechanism to repair it. A functioning mismatch repair protein complex can 
misinterpret the repeat strands and instability events occur. An excess of oxygen radicals in 
these cells damage the DNA, including the areas of the Dmt repeat expansion, which reanneal 
out of register after the DNA has been repaired, in a similar manner to that outlined in Figure 
5.1. The functioning MMR system misinterprets the misaligned repeats and repairs them, 
resulting in a change in the repeat size. A threshold for reach instability events of around 100 
repeats has been hypothesised, beyond this threshold, repeat instability events are more likely 
to be expansions (Schumacher et al., 1997). The more oxidative stress a cell is subjected to, 
the more likely it is that the DNA is damaged and requires repair.
That the Dmt-D repeat is more vulnerable to these events than the other lines then I further 
hypothesise that the context of the Dmt-D integration site is more vulnerable to damage by 
oxidative stress than the integration sites of the other lines. For example if Dmt-D has 
integrated into a gene rich region it will be regularly accessible for transcription, but also 
vulnerable to damage which therefore requires repair.
7.3 Transmission studies
The size of the repeat expansion and the sex of the parent it is transmitted by, influences the 
size of the repeat transmitted to a DM1 patient (Lavedan et al., 1993b). Parental age has been 
confirmed to influence the size of repeat in Huntington’s and DRPLA transmissions (Duyao et 
al., 1993; Sato et al., 1999). Observation of transmission patterns of Dmt-D and Dmt-E has 
seen a sex dependent difference in the pattern, with the males of both lines being more likely 
to transmit an expansion than the females which are most likely to transmit deletions. Despite 
each line carrying almost identical transgenes, the variation in transmitted repeat length is 
greater in the offspring of Dmt-D mice underline that factors other than parental sex are 
influencing the size of the repeat observed in the offspring.
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No correlation was observed between the age of the transmitting parent and the size of the 
repeat transmitted. Such a correlation was observed in male transmissions of DM-300 DM1 
model mice outlining a role for the genomic DNA flanking the DM1 repeat as these transgenic 
models contain an expanded DM1 repeat within 45kb of outlying DNA, including DMPK, 
SIX5 and DMWD.
The observation that the sex of the offspring of the Dmt-E males influences the size of the 
repeat that it carries, suggests the influence of the sex chromosome within the gamete on the 
repeat. Perhaps the influences a required repair event prior to fertilisation or a role for somatic 
instability in the initial stages of the zygotes development, although the mechanism involved, 
and the effect that any initial germline instability may have on subsequent events is unknown. 
That the pattern of segregation distortion observed in the Dmt-D and Dmt-E male and female 
transmissions was dependent on the sex and the line indicates firstly that there are sex 
differences effecting the size of the repeat transmitted to the offspring and secondly the effect 
of the integration site of the transgene on the repeat size transmitted to the offspring.
7.4 DM1 transgenic mice models
When this work was begun it had been established that the Dmt mice generated by Monckton 
et al. (1997), from DM1 patient genomic DNA consisting of a (CTG) 162 tract flanked by 
~800 bp of DNA, exhibited intergenerational instability and limited somatic instability (Figure 
1.3). Another DM1 derived transgene, (DM 55) was generated by Gourdon et al. (1997), 
(Figure 1.3). This transgene consisted of a (CTG)55 tract contained within ~ 45 kb of 
sequence including the coding sequence for DMPK, DMWD and, SIX5. As with the Dmt 
transgenic lines, the (DM 55) lines also integrated randomly into the genome. Unlike the Dmt 
transgenic lines the effect of the murine integration site was less likely to influence the 
transgenic repeat because of the amount of flanking DNA. Of the seven DM55 transgenic 
lines generated, six of the lines exhibited gametic instability and they contained between one 
and four copies of the transgene at a single integration site. Of the total progeny studied, 6.8% 
exhibited a repeat size differing to that of its transmitting parent. A more in depth analysis of 
the DM55 DM1 murine models was carried out by Lia et al. (1998). Inter tissue comparison of 
the repeat in the lung, kidney, pancreas, liver, ovary, eye, skeletal muscle (quadriceps), 
gastronemius and heart in individuals aged between 4 and 19 months from the two single copy 
transgenic lines, DM55/86 and DM55/85 was carried out. Analysis revealed tissue specific, 
expansion biased, instability that increased with the age of the mouse. The order of instability
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that the studied tissues could be placed in, i.e. liver and kidney most unstable, lung most 
stable, was similar between the lines. However, the instability profile of the tissues was not 
identical, despite the large amount of transgenic DNA, which flanks the repeat and the fact 
that both lines have been generated on the same inbred strain. That the level of instability 
presented by each tissue is not identical between the two lines is a reflection that DNA 
outlying the transgene is also having an effect. It is possible that DMWD and SIX5 are not the 
only genes in cis to DMPK that may influence the repeat instability. Other genes have been 
reported in the polygenic region around DMPK, (Alwazzan et al., 1998). Within the 300kb 
that include DMPK, SYMPLEKIN, a polypeptide encoded by 1147 aa is found upstream of 
SIX5 while two further genes were found downstream of DMPK, the GASTRIC INHIBITOR 
POLYPEPTIDE RECEPTOR GENE (GIPR) and 20D7, which is expressed predominantly in 
the testis. These genes may have roles in repeat tract instability and or DM1 phenotypes. The 
DM55 transgene did not include these genes. The differences in the integration sites of 
DM55/85 and DM55/86 are still affecting the behaviour of the repeat despite the large amount 
of flanking DNA.
Quantification of the level of instability observed in DM55/86 in a 4 month and a 19 month 
old individual using small pool PCR analysis confirmed the somatic instability to be 
expansion biased. In common with the observations of Dmt-D the heart was observed to be 
particularly stable. The muscle and eye also had instability profiles similar to those observed 
in Dmt-D. The kidney and the liver of 19 month old DM55/86 were the most unstable tissues 
studied with expansions of ~+15 from the progenitor repeat size. The kidney of Dmt-D also 
exhibits the greatest instability profile although the expansions observed are greater. These 
data probably indicate a balance between the effect of the flanking DNA and the effect of the 
number of repeats.
To assess whether the level of transgenic transcription might be influencing the somatic 
instability observed in the DM55 lines, semi quantitative RT-PCR analysis was carried out to 
assess the level of transcription of transgenic DMWD, DMPK and SIX5 in the brain, heart, 
muscle and kidney. Transcripts of all three genes were found in all seven lines. Moreover the 
tissue specific expression pattern observed in DMWD and DMPK was conserved in the DM55 
mice. As all of the DM55 lines exhibited gametic or somatic instability, (no gametic instability 
had been observed in the somatically unstable DM55/85), Lia et al, 1998 feel transcription of 
the repeat may be instrumental to the instability observed, although the most unstable tissues, 
the kidney and the liver, did not undergo the highest level of transcription.
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As with the Dmt-D line, there was no correlation between the level of cell turn over ((Messier 
and Leblond, 1960), summarised in table 3.2) and the degree of repeat instability observed in 
each tissue. The tissues associated with the DM1 disease phenotype, i.e. muscle, eye and heart 
did not exhibit instability greater than unaffected tissues such as the kidney and liver. This 
observation is also in common with Dmt-D. The lack of availability of DM1 patient tissue 
means that a parallel observation has not been made in DM1 patients. However, the somatic 
studies of the Dmt and DM55 lines may suggest that a similar observation will be observed in 
DM1 patients.
To further investigate the effect of the flanking DNA of DM1 patients, and how it may relate 
to the length of the repeat tract, transgenic lines additional to DM55 were generated (Seznec et 
al., 2000). The DNA used in the transgenes DM20 and DM300 originated from people in the 
same family as the patient who contributed the DM55 DNA. Studies found neither gametic or 
somatic instability in the DM20 lines. In contrast transmission studies of the DM300 lines 
revealed that a repeat larger than that of the transmitting parents was passed on in over 86% of 
the transmissions. Comparison of a range of tissues found them to exhibit somatic instability 
that varied from tissue to tissue. Again the order of instability of the tissues appeared to be in 
common with that observed in DM55/86 and DM55/85. The most unstable tissue, liver 
exhibited an expansion of ~100 repeats.
The difference in both the gametic and somatic stability levels observed in the DM20, DM55 
and DM300 lines parallels the thresholds of repeat stability observed in DM1 patients, 
suggesting when the repeat is contained within a similar genomic context, the repeat 
expansion thresholds are similar in both humans and mice (Seznec et al., 2000).
Analysis of the DM300 transmissions found that although the transmissions were expansion 
biased, the larger expansions were transmitted paternally. Indeed when the size of the repeat 
transmitted was compared to the age of the parent at conception, the size of paternal 
transmissions increased as the age of the mouse increased. No similar effect was observed in 
maternal transmissions.
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7.5 Complementary studies of the Dmt transgenic mice
Examination of the effect of cis acting factors is limited in Dmt lines. Dr Graham Brock of the 
University of Glasgow used vectorette PCR to isolate genomic sequence flanking Dmt-D and 
Dmt-E and to determine if possible the integration sites. The location of Dmt-E is unlikely to 
be elucidated due to its integration into a LINE-1 repetitive element, a motif found throughout 
the murine genome. Dmt-D has integrated into a novel region of chromosome 11. Although 
this region has not yet been sequenced as part of the murine sequencing project, the location 
Dmt-D will be identified as more murine genome is sequenced. While this in itself may not 
explain the instability pattern observed in the tissues of this line, information about the sort of 
DNA that Dmt-D has integrated into, and the nature of the gene which is causing Dmt-D to be 
transcribed may contribute to the understanding of the expansion mechanism.
The triplet repeat of DM1 is located within a CpG island. Dr Graham Brock investigated the 
methylation pattern of the 609 bp region of the transgene using bisulfite induced modification 
of genomic DNA, a reaction which will convert cytosine to uracil but does not effect 5-methyl 
cytosine (Brock and Monckton, 2000). The Dmt-E and Dmt-D transgenic lines in a number of 
tissues and timepoints were studied. A line specific difference was observed. In the first 
instance 18 month old mice were studied. The region flanking Dmt-D was found to become 
methylated over time in a tissue specific manner. The same tissues in Dmt-E mice had not 
become methylated at this location. Comparison of Dmt-D and Dmt-E mice at 2 months again 
found no methylation in the Dmt-E mice but partial methylation in the tissues of young Dmt-D 
mice, suggesting that the methylation pattern develops over time. An in depth examination of 
different tissues in Dmt-D mice revealed different level of methylation in different tissues at 
the same timepoint. Only the brain of Dmt-E revealed any change in the methylation pattern 
and this was partial. That Dmt-D does not appear to be methylated in young mice suggests that 
the methylation pattern of the Dmt-D transgene does not effect the stability pattern of Dmt-D. 
The methylation patterns observed do exhibit differences between the tissues. We hypothesise 
however, that the instability of the repeat tract in some way induces the methylation of the 
flanking region.
A number of Dmt-D tissues from a selection of timepoints have been used to establish cell 
lines by Mr Mario Pereira (Gomes-Pereira et al., 2001). The lines studied include ones derived 
from the eye, lung and kidney of a 6 month old male. Study of these cell lines over time has 
found the accumulation of multiple small expansion biased mutations observed in vivo in Dmt- 
D was also observed in the in vitro model. The repeat being particularly unstable in kidney
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cells. Observation of the cell lines over hundreds of days and passages found the repeat in the 
lung cell line to be particularly stable. In contrast the cultured kidney cells were particularly 
unstable. Suprisingly selection for larger alleles appeared to take place within the first few 
passages, that is some sort of bottleneck occurred and a mean increase from the progenitor 
repeat size recorded. These observations again suggest that different cell populations within a 
tissue type were subject to different levels of repeat expansion events.
7.6 Suggestions for future experiments
Although the Dmt-D model has been shown to be a suitable model for the unstable repeat in 
DM1, it has not lead to the elucidation of the mechanism of repeat expansion. The mechanism 
that leads to the somatic instability of an expanded repeat tract will probably be multifactorial. 
This makes the investigation of expansion mechanisms difficult. However, the Dmt-D 
transgenic line provides a DM1 model line on an isogenic background. The only differences 
between individuals being their repeat length. The controlled introduction of variants or the 
investigation of spontaneously occurring modifications / mutations may in some way explain 
the complexity of the instability process:
• The investigation of tumours occurring in the Dmt lines and their effect on the transgenic 
repeat if the nature of the mutations that have lead to the development of the tumour may 
be identified.
• Both Dmt-D and Dmt-E mice are currently being bred onto different inbred mouse 
backgrounds. The BalB C, Black 6 and C3 H mouse strains have been chosen because of 
their diversity from the FVB/n strain and each other. The level of repeat instability and 
how this relates to the disease phenotype of triplet repeat diseases can vary even between 
family members carrying similar repeat sizes. The diverse backgrounds of DM1 patients 
may suggest that polymorphisms that may result in simple and normally inconsequential 
variation in protein function or efficiency, may in individuals carrying a pre mutation or a 
disease range repeat expansion at a triplet repeat disease locus result in instability at the 
repeat loci, resulting in RNA transcripts which in someway disrupt cell function and leads 
to the disease phenotype. The introduction of the Dmt repeat onto the different strain 
backgrounds will expose the repeat to different trans acting factors. Examination of the 
tissue instability on these different backgrounds may reveal differences, which may be 
traced to polymorphisms in particular proteins. For example mutations to proteins that 
form part of the MMR complex, which may have subtle effects on the efficiency of repair.
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• It is also possible that the mice may present reduced aggression levels on a different strain 
background and that the incidence of successful matings may increase as may the 
efficiency of subsequent superovulation.
• Murine knockouts for M lhl and Msh2 genes that code for other proteins in the MMR 
complex also exist. The effect of the loss of these gene products on Dmt-D repeat 
instability may also allow further elucidation of the effect of MMR on repeat instability 
(Andrew et al., 1997; Baker et al., 1996). Further characterisation of the effect of a 
deficient Pms2 background on the Dmt repeat instability levels should be carried out.
• I have hypothesised that the cell population in kidney that results in the dramatic 
expansions are subject to oxidative stress, that this results in a level of DNA damage 
unrivalled in other cell populations. To identify regions of the kidney that are subject to 
oxidative stress transverse sections of both wildtype and Dmt-D kidneys should be isolated 
and the level of oxidative stress that different regions are subject to detection using an 
antibody to a marker of oxidative stress, i.e. superoxidase dismutase. If this correlates with 
regions in which the highest level of repeat instability occur then they may be a connection 
between cells subjected to high levels of oxidative stress and high levels of repeat 
instability.
• The effect of other mechanisms of repair on the Dmt-D expanded repeat tract could be 
investigated. Mutants of genes involved in transcription coupled nucleotide excision repair 
may also be found to influence repeat stability levels.
• The isolation of mature sperm cells of Dmt-E mice and the elucidation of the repeat size 
and the sex chromosome carried by that cell may narrow the window in which repeat 
instability events occur which are influenced by the offsprings sex.
7.7 Conclusions
The mechanism involved in the expansion of triplet repeats is multifactorial, as is the level of 
instability a repeat tract will exhibit.
The mechanism of actual triplet repeat expansion is in some way related to the MMR 
mechanism. While the nature of the instability event(s) that the repeat tract experiences, 
whether there is an expansion or a deletion, may depend on the length of the repeat. There is a 
threshold of repeat length beyond which a repeat tract becomes more prone to expansions 
(Schumacher et al., 1997).
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• There was no obvious correlation between the level of tissue replication and the level of 
instability found in that tissue.
• There was no obvious correlation between the level a tissue was transcribed and the level 
of instability found in that tissue.
• The role that transcription and or replication may play in triplet repeat instability has not 
been determined, just that neither relates directly to the gross level of triplet repeat tract 
instability observed in Dmt-D. Transcription and or replication may play a role essential in 
the instability event pathway, but this has not been determined in this series of 
experiments.
• That Dmt-D exhibits tissue specific repeat instability that is not observed in the other lines 
indicates the importance of the genomic context in which the repeat tract lies. For example 
if the chromatin structure is such that the repeat may be transcribed at a high level, the 
DNA may be vulnerable to other factors such as free radical damage. The repair of this 
damage may result in repeat instability events. Continuing levels of transcription might 
result in further DNA damage and repeat instability events.
• If a particular cell is subject to events that may damage its DNA, it will be subject to DNA 
repair mechanisms more often. Thus a repeat tract, if present will be subject to multiple 
small changes in repeat length, more often than other cells, which may be located in the 
same tissue, but due to their role undergo less damage to their DNA and are thus subject to 
fewer DNA repair events.
• Gametic instability follows different patterns in each of the sexes; Male and female 
gametes follow different maturation pathways with the oocyte perhaps being more 
vulnerable to DNA damaging events as it is present for the lifetime of the mouse.
However, the DNA that flanks the integration site of the Dmt-D and Dmt-E transgenes 
influence the size of the transmitted repeat.
This series of experiments has examined the somatic instability in a range of tissues in stable 
and unstable triplet repeat expansion models. That Dmt-D does model tissue specific 
expansion biased instability suggests that this is a model suitable for addressing questions 
posed by DM1 and other expanded triplet repeat diseases. It is known that DM1 exhibits 
different levels of somatic mosaicism in different tissues, as revealed by the leukocyte / 
muscle studies of Monckton et al. (1995) and also a regional variation within the brain (Ishii et 
al., 1996), which is in common with the neurodegenerative triplet repeat diseases. What is not
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known, due to the limited availability of archived repeat disease tissue is how the repeat 
instability profile varies from tissue to tissue and over time. These experiments have 
demonstrated that even the most stable tissues exhibit a degree of expansion biased instability 
over the lifetime of the mouse and the most unstable tissues studied do not correlate with the 
tissues that exhibit a disease phenotype in DM1, although it should be noted that Dmt mice do 
not model DM1 symptoms. However, this observation may suggest that the expansion alone is 
not sufficient to cause the disease phenotype but that it is a combination of the role of the cell 
in which the expansion occurs and the expansion which result in the disease phenotype. This 
sort of idea moves forward the thinking around triplet repeat diseases, which without murine 
models would still be confined to archive tissues.
A great deal has mean made in this thesis about elucidating the mechanism of repeat 
expansion, but the reasons for doing this have not been outlined. The correlation between the 
triplet repeat expansions and disease phenotypes is well known, as is the incidence of these 
diseases within family pedigrees. If the mechanisms of expansion are understood then this 
allows the development of therapies targeting these molecular mechanisms. Current treatments 
for these diseases involve the treatment of the symptoms.
Finally, the Dmt mice, most specifically the Dmt-D mice, provide a model for studying other 
genetic effects which may be too subtle to detect within diverse human populations, but upon 
their characterisation may be found to occur within humans. The Dmt-D transgene is currently 
presented on an isogenic background. The study of this transgene on other isogenic 
backgrounds may result in variations in the tissue instability profiles presented. These 
variations would be accounted for by the genetic differences between the strains, identification 
of these factors may lead to the identification of subtle but key factors that effect not only 
repeat instability but other mutations events, for example cancer.
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